LHC GROUP, INC.
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
ANNUAL REPORT
PURSUANT TO SECTIONS 13 OR
15(d)
OF THE SECURITIES EXCHANGE ACT
OF 1934
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended
December 31, 2006
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period
from to
|
Commission file number: 0-8082
LHC GROUP, INC.
(Exact Name of Registrant as
Specified in Charter)
|
|
|
Delaware
|
|
71-0918189
|
(State or Other Jurisdiction
of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
420 West Pinhook Rd,
Suite A
Lafayette, LA 70503
|
(Address of principal executive
offices)
|
(337) 233-1307
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Exchange Act:
|
|
|
Common Stock, par value
$.001 per share
|
|
Nasdaq Global Market
|
(Title of each class)
|
|
(Name of each exchange on which
registered)
|
Securities registered pursuant to Section 12(g) of the
Exchange Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined by Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer. See definition of accelerated filer and large
accelerated filer in
Rule 12b-2
of the Exchange Act.
Large accelerated
filer o Accelerated
filer þ
Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). Yes o No þ
As of June 30, 2006, the aggregate market value of the
registrants common stock held by non-affiliates of the
registrant was $220,921,804 based on the closing sale price as
reported on the Nasdaq Global Market. For purposes of this
determination shares beneficially owned by officers, directors
and ten percent shareholders have been excluded, which does not
constitute a determination that such persons are affiliates.
There were 17,868,320 shares of common stock, $.01 par
value, issued and outstanding as of March 8, 2007.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the Registrants Annual Report to stockholders
for the fiscal year ended December 31, 2006 are
incorporated by reference in Part II of this
Form 10-K.
Portions of the Registrants Proxy Statement for its 2007
Annual Meeting of Stockholders are incorporated by reference in
Part III of this annual report on
Form 10-K.
LHC
GROUP, INC.
TABLE OF
CONTENTS
2
This report contains forward-looking statements.
Forward-looking statements relate to our expectations, beliefs,
future plans and strategies, anticipated events or trends and
similar expressions concerning matters that are not historical
facts or that necessarily depend upon future events. In some
cases, you can identify forward-looking statements by words like
may, will, should,
could, would, expect,
plan, anticipate, believe,
estimate, project, predict,
potential and similar expressions. Specifically,
this report contains, among others, forward-looking statements
about:
|
|
|
|
|
our expectations regarding financial condition or results of
operations for periods after December 31, 2006;
|
|
|
|
our critical accounting policies;
|
|
|
|
our business strategies and our ability to grow our business;
|
|
|
|
the reimbursement levels of Medicare and other third-party
payors;
|
|
|
|
our future sources of and needs for liquidity and capital
resources;
|
|
|
|
the outcomes of various routine and non-routine governmental
reviews, audits, and investigations;
|
|
|
|
our expansion strategy and the successful integration of recent
acquisitions;
|
|
|
|
the value of our propriety technology;
|
|
|
|
the impact of legal proceedings;
|
|
|
|
our insurance coverage;
|
|
|
|
the costs of medical supplies;
|
|
|
|
our competitors and our competitive advantages;
|
|
|
|
the payment of dividends;
|
|
|
|
our compliance with environmental laws and regulations;
|
|
|
|
the impact of federal and state government regulation on our
business; and
|
|
|
|
the impact of changes in or future interpretations of fraud,
anti-kickback or other laws.
|
The forward-looking statements included in this report reflect
our current views about future events. They are based on
assumptions and are subject to known and unknown risks and
uncertainties. Many factors could cause actual results or
achievements to differ materially from future results or
achievements that may be expressed in or implied by our
forward-looking statements. Many of the factors that will
determine future events or achievements are beyond our ability
to control or predict. Important factors that could cause actual
results or achievements to differ materially from the results or
achievements reflected in our forward-looking statements
include, among other things, the factors discussed on
pages 27 to 37 of this report under the heading Risk
Factors.
You should read this report, the information incorporated by
reference into this report and the documents filed as exhibits
to this report completely and with the understanding that our
actual future results or achievements may be materially
different from what we expect or anticipate.
3
The forward-looking statements contained in this report reflect
our views and assumptions only as of the date this report is
filed with the Securities and Exchange Commission. Except as
required by law, we assume no responsibility to update any
forward-looking statements.
Before you invest in our common stock, you should understand
that the occurrence of any of the events described in the Risk
Factors section, located in Part I, Item 1A in this
annual report on
Form 10-K
or incorporated by reference into this annual report on
Form 10-K
and other events that we have not predicted or assessed could
have a material adverse effect on our earnings, financial
condition and business. If the events described in the Risk
Factors or other unpredicted events occur, then the trading
price of our common stock could decline, and you may lose all or
part of your investment.
We qualify all of our forward-looking statements by these
cautionary statements. In addition, with respect to all of our
forward-looking statements, we claim the protection of the safe
harbor for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995.
Unless otherwise indicated, LHC Group,
we, us, our, and the
Company refer to LHC Group, Inc. and our consolidated
subsidiaries.
4
PART I
Overview
We provide post-acute healthcare services primarily to Medicare
beneficiaries in rural markets in the southern United States. We
provide home-based services, primarily through home nursing
agencies and hospices, and facility-based services, primarily
through long-term acute care hospitals and outpatient
rehabilitation clinics. Through our wholly and majority-owned
subsidiaries, equity joint ventures, and controlled affiliates,
we currently operate in Louisiana, Mississippi, Arkansas,
Alabama, Texas, Kentucky, Florida, Tennessee, Georgia, and West
Virginia. As of December 31, 2006, we owned and operated
106 home nursing locations, six hospices, a diabetes self
management company, and a home health pharmacy. We also managed
four home nursing agencies and one hospice as of
December 31, 2006 in which we have no ownership interest.
With respect to our facility-based services operations, as of
December 31, 2006, we also owned and operated four
long-term acute care hospitals with a total of seven locations,
an outpatient rehabilitation clinic, a critical access hospital,
a pharmacy, a medical equipment company, a health club, and
provided contract rehabilitation services to third parties.
We provide home-based post-acute healthcare services through our
home nursing agencies and hospices. Our home nursing locations
offer a wide range of services, including skilled nursing,
nursing, physical, occupational, and speech therapy and
medically-oriented social services. The nurses, home health
aides and therapists in our home nursing agencies work closely
with patients and their families to design and implement
individualized treatment responsive to a physician-prescribed
plan of care. Our hospices provide palliative care to patients
with terminal illnesses through interdisciplinary teams of
physicians, nurses, home health aides, counselors and
volunteers. Of our 114 home-based services locations in which we
maintain an ownership interest, 78 are wholly-owned by us and 36
are majority-owned or controlled by us through joint ventures.
For the years ended December 31, 2006, 2005, and 2004, our
home-based services provided $164.7 million,
$105.6 million and $81.6 million, respectively, of our
net service revenue.
We provide facility-based post-acute healthcare services through
our long-term acute care hospitals, outpatient rehabilitation
clinic, and critical access hospital. As of December 31,
2006, we owned and operated four long-term acute care hospitals
with seven locations, with a total of 156 licensed beds. Our
long-term acute care hospitals, of which six locations are
within host hospitals, provide services primarily to patients
who have transitioned out of a hospital intensive care unit with
complex medical conditions that remain too severe for treatment
in a non-acute setting. We provide outpatient rehabilitation
services through physical therapists, occupational therapists
and speech pathologists at our outpatient rehabilitation clinic
in which we maintain an ownership interest. We also provide
outpatient rehabilitation services on a contract basis. Our
critical access hospital provides much needed access to
healthcare in a rural community. In addition, we manage the
operations of one inpatient rehabilitation facility in which we
have no ownership interest. Of our 12 facility-based services
locations in which we maintain an ownership interest, six are
wholly-owned by us and six are majority-owned or controlled by
us through joint ventures. For the years ended December 31,
2006, 2005 and 2004, our facility-based services provided
$50.5 million, $47.1 million and $34.5 million,
respectively, of our net service revenue.
Our founders began operations in September 1994 as St. Landry
Home Health, Inc. in Palmetto, Louisiana. After several years of
expansion, in June 2000, our founders reorganized their business
and began operating as Louisiana Healthcare Group, Inc. In March
2001, Louisiana Healthcare Group, Inc. reorganized and became a
wholly owned subsidiary of The Healthcare Group, Inc., also a
Louisiana business corporation. Effective December 2002, The
Healthcare Group, Inc. merged into LHC Group, LLC, a Louisiana
limited liability company, with LHC Group, LLC being the
surviving entity. In January 2005, LHC Group, LLC established a
wholly owned Delaware subsidiary, LHC Group, Inc. Effective
February 9, 2005, LHC Group, LLC merged into LHC Group,
Inc. LHC Group, Inc. is a Delaware corporation; our principal
executive offices are located at 420 West Pinhook Road,
Suite A, Lafayette, Louisiana, 70503; and our telephone
number is
(337) 233-1307.
Our website is www.lhcgroup.com.
5
Industry
and Market Opportunity
According to the Medicare Payment Advisory Committee, or MedPAC,
an independent federal body established in 1997 to advise
Congress on issues affecting the Medicare program, approximately
one-third of all general acute care hospital patients require
additional care following their discharge from the hospital.
Some of these patients receive less intensive care in settings
such as skilled nursing facilities, outpatient rehabilitation
clinics or the home, while others receive continuing care in
more intensive care settings such as inpatient rehabilitation
facilities or long-term acute care hospitals that are either
freestanding or co-located within general acute care facilities.
According to MedPAC estimates, Medicare spending totaled
$17.1 billion in 2005 for the two primary post-acute
sectors in which we operate: home nursing and long-term acute
care hospitals.
MedPAC estimates Medicare spending on home nursing services
totaled $12.6 billion in 2005. The Centers for
Medicare & Medicaid, or CMS, estimates that there were
approximately 8,802 Medicare-certified home nursing agencies in
the United States in 2006, the majority of which are operated by
small local or regional providers. CMS has estimated that
approximately 32.0% of these agencies are hospital-based or
not-for-profit,
freestanding agencies, and MedPAC estimates that approximately
37.0% were located in rural markets in 2005. CMS predicts that
Medicare spending on home nursing will increase at an average
annual growth rate of 5.7% between 2006 and 2016. Growth is
being driven by:
|
|
|
|
|
a U.S. population that is getting older and living longer;
|
|
|
|
patient preference for less restrictive care settings;
|
|
|
|
incentives for general acute care hospitals to discharge
patients into less intensive treatment settings as quickly as
medically appropriate; and
|
|
|
|
higher incidences of chronic conditions and disease.
|
Long-term acute care hospitals provide specialized medical and
rehabilitative care to patients with complex medical conditions
requiring higher intensity care and monitoring that cannot be
provided effectively in other healthcare settings. These
facilities typically serve as an intermediate step between the
intensive care unit of a general acute care hospital and a less
intensive treatment setting, such as a skilled nursing facility
or the home. According to MedPAC estimates, Medicare spending
for services provided by long-term acute care hospitals grew
from $1.7 billion in 1997 to an estimated $4.5 billion
in 2005.
According to the U.S. Census Bureau, rural areas have a
higher percentage of residents over the age of 65, who account
for 12.8% of the total population in rural markets compared to
12.3% in urban markets. Additionally, according to the American
Public Health Association, or APHA, rural areas typically do not
offer the range of post-acute healthcare services that are
available in urban or suburban markets. As such, patients in
rural markets face challenges in accessing healthcare in a
convenient and appropriate setting. For example, APHA estimates
that although 21.0% of Americans live in rural areas, only 9.0%
of the nations physicians practice in rural areas.
According to APHA, individuals in rural areas may also have
difficulty reaching healthcare facilities due to greater travel
time required or a lack of public transportation. The economic
characteristics and population dispersion of rural markets also
make these markets less attractive to health maintenance
organizations and other managed care payors. Government studies
cited by APHA have shown rural residents also tend to have more
health complications than urban residents. Additionally, APHA
has noted that residents in rural areas are less likely to use
preventive screening services, and have a higher prevalence of
disabilities, heart disease, cancer, diabetes, and other chronic
conditions compared to urban residents. Therefore, we believe
our post-acute service provides valuable alternatives to this
underserved, rural patient population.
In our experience, because most rural areas have the population
size to support only one or two general acute care hospitals,
the local hospital often plays a significant role in rural
market healthcare delivery systems. Rural patients who require
home nursing frequently receive care from a small home care
agency or an agency that, while owned and run by the hospital,
is not an area of focus for that hospital. Similarly, patients
in these markets who require services typically offered by
long-term acute care hospitals are more
6
likely to remain in the community hospital, as it is often the
only local facility equipped to deal with severe, complex
medical conditions. By entering these markets through
affiliations with local hospitals, we usually face less
competition for the services we provide. Therefore, we believe
we are well positioned to foster community loyalty by building
and maintaining long-term relationships with local hospitals,
physicians and other healthcare providers and to become the
highest quality post-acute provider in our markets.
Business
Strategy
Our objective is to become the leading provider of post-acute
services to Medicare beneficiaries in rural markets in the
southern United States. To achieve this objective, we intend to:
Drive internal growth in existing markets. We
intend to drive internal growth in our current markets by
increasing the number of healthcare providers in each market
from whom we receive referrals and by expanding the breadth of
our services. We intend to achieve this growth by:
(1) continuing to educate healthcare providers about the
benefits of our services; (2) reinforcing the position of
our agencies and facilities as community assets;
(3) maintaining our emphasis on high-quality medical care
for our patients; and (4) providing a superior work
environment for our employees.
Achieve margin improvement through the active management of
costs. The majority of our net service revenue is
generated under Medicare prospective payment systems through
which we are paid pre-determined rates based upon the clinical
condition and severity of the patients in our care. Because our
profitability in a fixed payment system depends upon our ability
to manage the costs of providing care, we continue to pursue
initiatives to improve our margins and net income.
Expand into new rural markets. We will
continue expanding into new markets by developing new and
acquiring existing Medicare-certified home nursing agencies in
attractive markets. We currently plan to pursue expansion
opportunities in 15 contiguous states, and we have identified
over 700 potential non-profit hospital partners located in rural
markets within these states.
Pursue strategic acquisitions. We will
continue to identify and evaluate opportunities for strategic
acquisitions in new and existing markets that will enhance our
market position, increase our referral base and expand the
breadth of services we offer.
Services
We provide post-acute healthcare services primarily to Medicare
beneficiaries in rural markets in the southern United States.
Our services can be broadly classified into two principal
categories: (1) home-based services offered through our
home nursing agencies and hospices; and (2) facility-based
services offered through our long-term acute care hospitals,
outpatient rehabilitation clinic, and critical access hospital.
Home-Based
Services
Home Nursing. Our registered and licensed
practical nurses provide a variety of medically necessary
services to homebound patients who are suffering from acute or
chronic illness, recovering from injury or surgery, or who
otherwise require care or monitoring. These services include
wound care and dressing changes, cardiac rehabilitation,
infusion therapy, pain management, pharmaceutical
administration, skilled observation and assessment, and patient
education. We have also designed guidelines to treat chronic
diseases and conditions including diabetes, hypertension,
arthritis, Alzheimers disease, low vision, spinal
stenosis, Parkinsons disease, osteoporosis, complex wound
care and chronic pain. Our home health aides provide assistance
with daily activities such as housekeeping, meal preparation,
medication management, bathing, and walking. Through our medical
social workers we counsel patients and their families with
regard to financial, personal, and social concerns that arise
from a patients health-related problems. We also provide
skilled nursing, ventilator and tracheotomy services, extended
care specialties, medication administration and management, and
patient and family assistance and education. We also provide
management services to third party home nursing agencies, often
as an interim solution until proper state and regulatory
approvals for an acquisition can be obtained.
7
Our physical, occupational and speech therapists provide therapy
services to patients in their home. Our therapists coordinate
multi-disciplinary treatment plans with physicians, nurses and
social workers to restore basic mobility skills such as getting
out of bed, walking safely with crutches or a walker, and
restoring range of motion to specific joints. As part of the
treatment and rehabilitation process, a therapist will stretch
and strengthen muscles, test balance and coordination abilities,
and teach home exercise programs. Our therapists assist patients
and their families with improving and maintaining a
patients ability to perform functional activities of daily
living, such as the ability to dress, cook, clean, and manage
other activities safely in the home environment. Our speech and
language therapists provide corrective and rehabilitative
treatment to patients who suffer from physical or cognitive
deficits or disorders that create difficulty with verbal
communication or swallowing.
All of our home nursing agencies offer 24 hour personal
emergency response and support services through LifeLine
Systems, Inc. for patients who require close medical monitoring
but who want to maintain an independent lifestyle. These
services consist principally of a communicator that connects to
the telephone line in the subscribers home and a personal
help button that is worn or carried by the individual subscriber
and that, when activated, initiates a telephone call from the
subscribers communicator to LifeLines central
monitoring facilities. LifeLines trained personnel
identify the nature and extent of the subscribers
particular need and notify the subscribers family members,
neighbors,
and/or
emergency personnel, as needed. Our use of the LifeLine system
increases customer satisfaction and loyalty by providing our
patients a point of contact between our scheduled nursing
visits. As a result, we offer our patients a more complete
regimen of care management than our competitors in the markets
in which we operate, particularly in Mississippi and Louisiana
where we have an exclusive contract for these services with
LifeLine.
Hospice. Our Medicare-certified hospice
operations provide a full range of hospice services designed to
meet the individual physical, spiritual, and psychosocial needs
of terminally ill patients and their families. Our hospice
services are primarily provided in a patients home but can
also be provided in a nursing home, assisted living facility, or
hospital. Key services provided include pain and symptom
management accompanied by palliative medication; emotional and
spiritual support; inpatient and respite care; homemaker
services; dietary counseling; social worker visits; spiritual
counseling; and bereavement counseling for up to 13 months
after a patients death.
Facility-Based
Services
Long-term Acute Care Hospitals. Our long-term
acute care hospitals treat patients with severe medical
conditions who require high-level care along with frequent
monitoring by physicians and other clinical personnel. Patients
who receive our services in a long-term acute care hospital are
too medically unstable to be treated in a non-acute setting.
Examples of these medical conditions include respiratory
failure, neuromuscular disorders, cardiac disorders, non-healing
wounds, renal disorders, cancer, head and neck injuries, and
mental disorders. These impairments often are associated with
accidents, strokes, heart attacks and other serious medical
conditions. We also treat patients diagnosed with
musculoskeletal impairments that restrict their ability to
perform normal activities of daily living. As part of our
facility-based services, we operate an institutional pharmacy,
which focuses on providing a full array of institutional
pharmacy services to our long-term acute care hospitals and
inpatient rehabilitation facility. We also own and operate one
critical access hospital.
Rehabilitation Services. We provide
rehabilitation services in multiple settings, including both
inpatient and outpatient settings. In our facilities and through
our contractual relationships, we provide physical, occupational
and speech rehabilitation services. We also provide certain
specialized services such as hand therapy or sports performance
enhancement that treat sports and work related injuries,
musculoskeletal disorders, chronic or acute pain and orthopedic
conditions. Our patients are typically diagnosed with
musculoskeletal impairments that restrict their ability to
perform normal activities of daily living. These impairments are
often associated with accidents, sports injuries, strokes, heart
attacks and other medical conditions. Our rehabilitation
services are designed to help these patients minimize physical
and cognitive impairments and maximize functional ability. We
also design services to prevent short-term disabilities from
becoming chronic conditions. Our rehabilitation services are
provided by our physical, occupational and
8
respiratory therapists, and
speech-language
pathologists. We also provide management services to one
inpatient rehabilitation facility and operate one health and
wellness center located adjacent to one of our outpatient
rehabilitation clinics.
Operations
Financial information relating to the home- and facility- based
segments is found in the consolidated financial statements of
the Company which are included in this report. All of our
operations are based in the United States; therefore 100% of our
revenues from external customers for the years ended
December 31, 2006, 2005 and 2004 and 100% of our long-lived
assets were attributed to the United States.
Home-Based
Services
Each of our home nursing agencies is staffed with experienced
clinical home health professionals who provide a wide range of
patient care services. Our home nursing agencies are managed by
a Director of Nursing or Branch Manager who is also a licensed
registered nurse. Our Directors of Nursing and Branch Managers
are overseen by Regional Managers who report to Area Managers.
Our Area Managers report to our Chief Operating Officer. Our
patient care operating model for our home nursing agencies is
structured on a base model that requires a Medicare patient
minimum census of 50 patients. At the base model level, one
registered nurse is responsible for all aspects of the
management of each patients plan of care. A home nursing
agency based on this model is also staffed with an office
manager, a field-registered nurse, a field-licensed professional
nurse and a home health aide. All field staff are paid on a per
visit basis. If needed, we contract with local community
therapists as independent contractors to provide additional
therapy services. As the size and patient census of a particular
home nursing agency grows, these staffing patterns are increased
appropriately.
Our home nursing agencies use our Service Value Point system, a
proprietary clinical resource allocation model and cost
management system. The system is a quantitative tool that
assigns a target level of resource units to a group of patients
based upon their initial assessment and estimated skilled
nursing and therapy needs. The Service Value Point system allows
the Director of Nursing or Branch Manager to allocate adequate
resources throughout the group of patients assigned to
his/her
care, rather than focusing on the profitability of an individual
patient.
Patient care is handled at the home nursing agency level.
Functions that are centralized into the home office include
payroll, accounting, financial reporting, billing, collections,
regulatory and legal compliance, risk management, pharmacy, and
general clinical oversight accomplished by periodic
on-site
surveys. Each of our home nursing agencies is licensed and
certified by the state and federal governments, and 34 of them
also are accredited by the Joint Commission for Accreditation of
Healthcare Organizations, or JCAHO. Those not yet accredited are
working towards achieving this accreditation, which can take up
to six months.
Facility-Based
Services
Long-Term Acute Care Hospitals. Each of our
long-term acute care hospital locations is managed by a hospital
administrator, while the clinical operations are directed by a
Director of Nursing who is also a licensed registered nurse. The
individual hospital administrators are responsible for managing
the
day-to-day
operating activities of the hospital within appropriate
budgetary constraints. Each hospital administrator reports to
the Vice President of Facility-Based Services. Each Director of
Nursing reports directly to his or her respective hospital
administrator as well as indirectly to our Clinical Operations
Officer responsible for the oversight of the quality of patient
care services at the home office level. The medical management
of each patient is overseen by a Medical Director who is
responsible for ensuring the appropriateness of admissions, as
well as leading weekly patient care conferences.
We follow a clinical approach under which each patient is
discussed in weekly, multidisciplinary team meetings, at which
patient progress is assessed, compared to goals, and future
goals are set. Attendees at these meetings include a
patients family and referring physician. We believe that
this model results in higher quality care, predictable discharge
patterns and the avoidance of unnecessary delays.
9
All coding, medical records, human resources, case management,
utilization review, and medical staff credentialing are provided
at the hospital level. Centralized functions that are provided
by the home office include payroll, accounting, financial
reporting, billing, collections, regulatory and legal
compliance, risk management, pharmacy, and general clinical
oversight accomplished by periodic
on-site
surveys.
Rehabilitation Services. Our rehabilitation
services are overseen by an administrator, who is a licensed
physical therapist. Each clinic also has an
on-site
therapist responsible for addressing staffing needs and concerns
as well as managing the
day-to-day
operations of the outpatient rehabilitation clinic.
As with our long-term acute care hospitals, all coding, medical
records, human resources, charge/data entry, front end
collections, and marketing for our rehabilitation centers are
provided at the individual center level. Centralized functions
provided by the home office include payroll, accounting,
financial reporting, billing, collections, regulatory and legal
compliance, risk management, and general clinical oversight
accomplished by periodic
on-site
surveys.
Joint
Ventures
As of December 31, 2006, we have entered into 50 joint
ventures with respect to the ownership and operation of 40 home
nursing agency locations, three hospices, six long-term acute
care hospital locations, and one home health pharmacy. Our joint
ventures are structured either as equity joint ventures,
cooperative endeavors or agency leasing arrangements, as
permitted by applicable state laws and subject to business
considerations. As of December 31, 2006, we had 40 equity
joint ventures, two cooperative endeavors and eight agency
leasing arrangements. Of these 50 joint ventures, 37 are with
hospitals, four are with physicians, and nine are with other
parties. With respect to our four joint ventures with
physicians, three are for the ownership and operation of
long-term acute care hospitals, and one is for the ownership of
a home nursing agency.
Equity
Joint Ventures
As of December 31, 2006, we have entered into 40 equity
joint ventures for the ownership and operation of home nursing
agencies, hospices, outpatient rehabilitation clinics and
long-term acute care hospitals. Our equity joint ventures are
structured as limited liability companies in which we own a
majority equity interest and our partners own a minority equity
interest ranging from 1.0% to 49.0%. At the time of formation,
we and our partners each contribute capital to the equity joint
venture in the form of cash or property. We believe that the
amount contributed by each party to the equity joint venture
represents their pro-rata portion of the fair market value of
the equity joint venture. None of our partners are required to
make or influence referrals to our equity joint ventures. In
fact, each of our hospital joint venture partners must follow
the same Medicare discharge planning regulations as they would
if they owned 100.0% of the home health agency. For example,
each of our hospital joint venture partners must offer each
Medicare patient a list of available Medicare-certified home
nursing agency options and must allow the patient to make their
own choice of provider.
Generally, we serve as the manager of our equity joint ventures
and oversee their
day-to-day
operations. In two of our equity joint ventures with parties
other than hospitals or physicians, our partners provide
business development services and, in one case, administrative
services. The management of our equity joint ventures are
typically governed by a management committee, which is
comparable to a board of directors. We generally possess a
majority of the total votes available to be cast by the members
of the management committee. However, in three of these joint
ventures where we have partnered with
not-for-profit
hospitals, the hospital controls a majority of the total
management committee votes. In such instances we possess the
right to withdraw from the equity joint venture at any time upon
notice to our partner in exchange for the receipt of a payment
in an amount calculated in accordance with a predetermined fair
market value formula. Each member of all but one of our equity
joint ventures participates in profits and losses in proportion
to their equity interests. We have two equity joint ventures in
which participation in the losses of the ventures are limited
per quarter to three times the amount of rent paid monthly by
the equity joint ventures to the parent companies of our joint
venture partners for space used in the operation of the equity
joint ventures. The
10
amounts of these monthly rental payments are currently $4,200
and $2,867 respectively. Distributions from our equity joint
ventures are not based on referrals made to the equity joint
venture by any of the members.
The 40 equity joint ventures individually contribute between
0.1% and 11.4% of our total net service revenue, with only two
of these equity joint ventures accounting for greater than 5.0%
of our total net service revenue for the twelve months ended
December 31, 2006. One of these is St. Landry Extended Care
Hospital, a long-term acute care hospital equity joint venture
in which we own 98.7% of the membership interests, with the
remaining 1.3% ownership divided among four individual
physicians. Any party may withdraw from this equity joint
venture upon 90 days advance written notice. The
second entity is Extended Care Hospital of Lafayette, a
long-term acute care hospital in which we own 76.5% of the
membership interests, with the remaining 23.5% ownership divided
among 19 individual physicians. Any member may withdraw from
this equity joint venture upon 90 days advance
written notice.
In addition to these conversion rights, several of our equity
joint ventures grant a buy/sell option that will require us to
either purchase or our joint venture partner(s) to sell all of
the exercising members membership interests in the equity
joint venture within 30 days of the receipt of notice of
the exercise of the buy/sell option. The purchase price under
these buy/sell provisions is typically based on a multiple of
the historical or future earnings before income taxes,
depreciation and amortization of the equity joint venture at the
time the buy/sell option is exercised.
Cooperative
Endeavors
As of December 31, 2006, we have entered into two
arrangements that involve the sharing of profits and losses,
which we call cooperative endeavors. Unlike our equity joint
venture relationships, our cooperative endeavor partners do not
own an equity interest in the venture. Instead, our partners
have only a contractual right to participate in the sharing of
profits and losses. This right is part of the consideration we
pay to acquire a home nursing agency from the entity that is a
party to the cooperative endeavor. In these cooperative
endeavors, we possess interests in the net profits and losses
ranging from 67.0% to 80.0%. In one instance, there is a limit
on the losses attributable to our cooperative endeavor partner
equal to the amount of rent payments made to our cooperative
endeavor partner during the preceding twelve months for the
lease of space used in the operation of the cooperative
endeavor. For the years ended December 31, 2006 and 2005,
these payments totaled $27,252 and $26,747, respectively. As
with the equity joint ventures, we oversee the
day-to-day
operations of the arrangement, but the management of our
cooperative endeavors is governed by a management committee,
where we possess a majority of the total votes available to be
cast.
Agency
Leasing Arrangements
As of December 31, 2006, we have entered into two
agreements to lease, through our wholly owned subsidiaries, the
right to hold the home health licenses necessary to operate
seven of our home nursing agency locations and one hospice.
These leases are entered into in instances where state law would
otherwise prohibit the alienation and sale of home nursing
agencies or the local hospital is reluctant to sell its home
health agency due to state imposed limits on the number of
certificates of need or permits of approval issued. The leasing
fees for one of these agency leasing arrangements is fixed at
$243,000 per year for the initial term and the other arrangement
provides for fees equal to 33.33% of the net quarterly profits
not to exceed $159,380. Of the initial five-year terms for our
two agency leasing arrangements, one expires on October 1,
2008 and the other on July 1, 2010. These leasing
arrangements provide for five-year terms with optional renewal
periods. One of these leasing arrangements provides that if we
choose not to renew, the lessor can require us to purchase the
agency. In the other leasing arrangement, we have a right of
first refusal in the event that the lessor intends to sell the
leased agency to a third party.
One of our agency leasing arrangements, relating to the lease of
the license for Mississippi Home Care of Jackson, LLC accounted
for greater than 5.0% of our total net service revenue for the
year ended December 31, 2006. This leasing arrangement with
a Mississippi hospital is for the lease of the right to hold the
provider number and home health license for the agency. The
terms of this lease provide for fixed monthly payments over an
initial five-year term. Upon the expiration of the second year
of the initial term, either party may
11
terminate this leasing arrangement upon 180 days
written notice. The lease is automatically renewed for one
consecutive five-year term unless we receive written notice of
the lessors desire to terminate the lease at least
180 days prior to the expiration of the initial term.
Management
Services Agreements
As of December 31, 2006, we have six management services
agreements under which we manage the operations of four home
nursing agencies, one hospice and one inpatient rehabilitation
facility. We currently have no ownership interest in the
agencies and facilities that are the subject of these management
services agreements. In five of these arrangements, we are
responsible for all direct and indirect costs associated with
the operations and receive a management fee equal to the amount
of our direct and indirect costs plus a percentage of the net
income of those operations. Under the remaining agreement, we
receive a flat fee for management. The term of these
arrangements is typically five years, with an option to renew
for an additional five-year term. The initial termination dates
for our management services agreements range from June 1,
2008 to August 1, 2010.
Competition
The home healthcare market is highly fragmented. According to
CMS, there are approximately
8,802 Medicare-certified
home nursing agencies in the United States, of which
approximately 32% are hospital-based or
not-for-profit,
freestanding agencies. MedPAC estimates that 37% of these home
nursing agencies are located in non-urban markets. Although
there are a small number of public home nursing companies with
significant home nursing operations, they generally do not
compete with us in the rural markets that we currently serve. As
we expand into new markets, we may encounter public companies
that have greater resources or greater access to capital.
Competition in our markets comes primarily from small local and
regional providers, many of which are undercapitalized. These
providers include facility- and hospital-based providers,
visiting nurse associations, and nurse registries. We are
unaware of any competitor offering our breadth of services and
focusing on the needs of rural markets.
Although several public and private national and regional
companies own or manage long-term acute care hospitals, they
generally do not operate in the rural markets that we serve.
Generally, the competition in our markets comes from local
healthcare providers. We believe our principal competitive
advantages over these local providers are our diverse service
offerings, our collaborative approach to working with healthcare
providers, our focus on rural markets and our patient-oriented
operating model.
Compliance
and Quality Control
We have had a Compliance Committee since 1996. Our Compliance
Committee oversees a comprehensive company-wide compliance
program that provides for:
|
|
|
|
|
the appointment of a compliance officer and committee;
|
|
|
|
adoption of codes of business conduct and ethics;
|
|
|
|
employee education and training;
|
|
|
|
monitoring of an internal system, including a toll-free hotline,
for reporting concerns on a confidential, anonymous basis;
|
|
|
|
ongoing internal compliance auditing and monitoring programs;
|
|
|
|
means for enforcing the compliance programs
policies; and
|
|
|
|
a system to respond to and correct detected problems.
|
As part of our ongoing quality control, internal auditing and
monitoring programs, at least annually we conduct internal
regulatory audits and mock surveys at each of our agencies and
facilities. If an agency or facility does not achieve a
satisfactory rating, we require it to prepare and implement a
plan of correction. We
12
then perform a
follow-up
audit and survey to verify that all deficiencies identified in
the initial audit and survey have been corrected.
As required under the Medicare conditions of participation, we
have a continuous quality improvement program, which involves:
|
|
|
|
|
ongoing education of staff and quarterly continuous quality
improvement meetings at each of our agencies and facilities and
at our home office;
|
|
|
|
quarterly comprehensive audits of patient charts performed by
each of our agencies and facilities; and
|
|
|
|
at least annually, a comprehensive audit of patient charts
performed on each of our agencies and facilities by our home
office staff.
|
If an agency or facility fails to achieve a satisfactory rating
on a patient chart audit, we require it to prepare and implement
a plan of correction. We then conduct a
follow-up
patient chart audit to verify that appropriate action has been
taken to prevent future deficiencies.
The effectiveness of our compliance program is directly related
to the legal and ethical training that we provide to our
employees. Compliance education for new hires is initiated
immediately upon employment with corporate video training and
subsequently reinforced through corporate orientation at which
the Chief Compliance Officer conducts a comprehensive compliance
training seminar. In addition, all of our employees are required
to receive continuing compliance education and training each
year.
We continually expand and refine our compliance and quality
improvement programs. Specific written policies, procedures,
training and educational materials and programs, as well as
auditing and monitoring activities, have been prepared and
implemented to address the functional and operational aspects of
our business. Our programs also address specific problem areas
identified through regulatory interpretation and enforcement
activities. Additionally, our policies, training, standardized
documentation requirements, reviews and audits specifically
address our financial arrangements with our referral sources,
including fraud and abuse laws and physician self-referral laws.
We believe our consistent focus on compliance and continuous
quality improvement programs provide us with a competitive
advantage in the market.
Technology
and Intellectual Property
Our Service Value Point system is a proprietary information
system that assists us in, among other things, monitoring use
and other cost factors, supporting our healthcare management
techniques, internal benchmarking, clinical analysis, outcomes
monitoring and claims generation, revenue cycle management and
revenue reporting. This proprietary home nursing clinical
resource and cost management system is a quantitative tool that
assigns a target level of resource units to each patient based
upon their initial assessment and estimated skilled nursing and
therapy needs. We designed this system to empower our direct
care employees to make appropriate
day-to-day
clinical care decisions while also allowing us to manage the
quality and delivery of care across our system and to monitor
the cost of providing that care both on a patient-specific and
agency-specific basis.
In addition to our Service Value Point system, our business is
substantially dependent on other non-proprietary software. We
utilize a third-party software information system for our
long-term acute care hospitals. Our various home nursing agency
databases were fully consolidated into an enterprise-wide system
during the first half of 2005. These conversions have improved
the accuracy, reliability, and efficiency of processing and
management reporting.
Further, we have two major patient billing systems that we use
across the enterprise: one system for our home-based services
and one for our facility-based services. Both of these systems
are fully automated and contain functionality that allows us to
calculate net service revenue at both the payor and patient
level.
The software we use is based on client-server technology and is
highly scalable. We believe our software and systems are
flexible,
easy-to-use,
and allow us to accommodate growth without difficulty through
development and acquisitions. Technology plays a key role in our
organizations ability to expand operations
13
and maintain effective managerial control. We believe that
building and enhancing our information and software systems
provides us with a competitive advantage that will allow us to
grow our business in a more cost-efficient manner and will
result in better patient care.
Reimbursement
Medicare
The federal governments Medicare program, governed by the
Social Security Act of 1965, reimburses healthcare providers for
services furnished to Medicare beneficiaries. These
beneficiaries generally include persons age 65 and older
and those who are chronically disabled. The program is primarily
administered by the Department of Health and Human Services, or
HHS, and CMS. Medicare payments accounted for 81.6%, 85.6%, and
86.3%, respectively, of our net service revenue for the years
ended December 31, 2006, 2005, and 2004. Medicare
reimburses us based upon the setting in which we provide our
services or the Medicare category in which those services fall.
Home Nursing. The Medicare home nursing
benefit is available to patients who need care following
discharge from a hospital, as well as patients who suffer from
chronic conditions that require ongoing but intermittent care.
The services received need not be rehabilitative or of a finite
duration; however, patients who require full-time skilled
nursing for an extended period of time generally do not qualify
for Medicare home nursing benefits. As a condition of coverage
under Medicare, beneficiaries must: (1) be homebound in
that they are unable to leave their home without considerable
effort; (2) require intermittent skilled nursing, physical
therapy, or speech therapy services that are covered by
Medicare; and (3) receive treatment under a plan of care
that is established and periodically reviewed by a physician.
Qualifying patients also may receive reimbursement for
occupational therapy, medical social services, and home health
aide services if these additional services are part of a plan of
care prescribed by a physician.
We receive a standard prospective Medicare payment for
delivering care over a base
60-day
period, or episode of care. There is no limit to the number of
episodes a beneficiary may receive as long as he or she remains
eligible. Most patients complete treatment within one payment
episode. The base episode payment, established through federal
legislation, is a flat rate that is adjusted upward or downward
based upon differences in the expected resource needs of
individual patients as indicated by clinical severity,
functional severity, and service utilization. The magnitude of
the adjustment is determined by each patients
categorization into one of 80 payment groups, known as home
health resource groups, and the costliness of care for patients
in each group relative to the average patient. Our payment is
also adjusted for differences in local prices using the hospital
wage index. We bill and are reimbursed for services in two
stages: an initial request for advance payment when the episode
commences and a final claim when it is completed. We receive
60.0% of the estimated payment for a patients initial
episode up-front (after the initial assessment is completed and
upon initial billing) and the remaining 40.0% upon completion of
the episode and after all final treatment orders are signed by
the physician. In the event of subsequent episodes,
reimbursement timing is 50.0% up-front and 50.0% upon completion
of the episode. Final payments may reflect one of five
retroactive adjustments to ensure the adequacy and effectiveness
of the total reimbursement: (1) an outlier payment if the
patients care was unusually costly; (2) a low
utilization adjustment if the number of visits was fewer than
five; (3) a partial payment if the patient transferred to
another provider before completing the episode; (4) a
change-in-condition
adjustment if the patients medical status changes
significantly, resulting in the need for more or less care; or
(5) a payment adjustment based upon the level of therapy
services required in the population base. Because the
applicability of a change is dependent upon the completion date
of the episode, changes in our reimbursement could impact our
financial results up to 60 days in advance of the effective
date and recognition of the change. We submit all Medicare
claims through two fiscal intermediaries for the federal
government.
We verify benefits at the time of admission and through this
verification process are able to determine the payor source and
eligibility for reimbursement for each patient. Accordingly, we
do not have any material reimbursement amounts that are pending
approval based on the eligibility of a patient to receive
reimbursement from the applicable payor program. Further, we
only provide limited services to patients who are
14
ineligible for reimbursement from a third party payor;
therefore, do not have any material reimbursement from patients
who are self pay.
The current base payment rate for Medicare home nursing is
$2,339. Since the inception of the prospective payment system in
October 2000, the base episode rate payment has varied due to
both the impact of annual market basket based increases and
Medicare-related legislation. Home health payment rates are
updated annually by either the full home health market basket
percentage, or by the home health market basket percentage as
adjusted by Congress. CMS establishes the home health market
basket index, which measures inflation in the prices of an
appropriate mix of goods and services included in home health
services. Section 5201(c) of the Deficit Reduction Act
(DRA) of 2005 provided for an adjustment to the home health
market basket percentage update for 2007 and subsequent years
depending on the submission of quality data by home health
agencies, or HHAs. HHAs that submit the required quality data
using the Outcome and Assessment Information Set (OASIS) will
receive payments based on the full home health market basket
update of 3.3 percent for 2007. If an HHA does not submit
quality data, the home health market basket update will be
reduced by 2 percentage points to 1.3 percent for
2007. Rural home health agencies that participate in the ongoing
quality reporting effort will receive an average estimated
3.6 percent increase in payment, while urban agencies who
continue to provide quality data will experience an estimated
3.1 percent increase in payment. We intend to participate
in quality reporting programs.
CMS is currently developing a proposal that would update and
refine the basic case mix adjustment system. We are unable to
predict the timing or outcome of such action.
On November 1, 2006, CMS released the final rule updating
the home health perspective payment systems for calendar year
2007. The rule finalizes the market basket increase of 3.3%, a
0.2% increase over the proposed rule. This equates to a 3.1%
update for urban HHAs and a 3.6% update for rural HHAs after
accounting for changes in the wage index. The update increases
the national
60-day
episode payment rate for urban home health agencies from the
current level of $2,264.38 to $2,339.00. Under the final rule,
HHAs will get the full home health market basket as long as they
submit required quality data using OASIS. With some limited
exceptions, if an HHA does not provide this data, then its home
health market basket update of 3.3% will be reduced by two
percentage points. The final rule discontinues the temporary 5%
add-on payment for rural HHAs in 2007, except for episodes that
begin before January 1, 2007. The final rule does not
modify the current case-mix methodology for 2007.
The Office of Inspector General of Health and Human Services, or
OIG, has a responsibility to report both to the Secretary of HHS
and to Congress any program and management problems related to
programs such as Medicare. The OIGs duties are carried out
through a nationwide network of audits, investigations and
inspections. The OIG has recently undertaken a study with
respect to Medicare reimbursement rates. No estimate can be made
at this time regarding the impact, if any, of the OIGs
findings.
Hospice. In order for a Medicare beneficiary
to qualify for the Medicare hospice benefit, two physicians must
certify that, in the best judgment of the physician or medical
director, the beneficiary has less than six months to live,
assuming the beneficiarys disease runs its normal course.
In addition, the Medicare beneficiary must affirmatively elect
hospice care and waive any rights to other Medicare benefits
related to his or her terminal illness. Each benefit period, a
physician must recertify that the Medicare beneficiarys
life expectancy is six months or less in order for the
beneficiary to continue to qualify for and to receive the
Medicare hospice benefit. The first two benefit periods are
measured at
90-day
intervals and subsequent benefit periods are measured at
60-day
intervals. There is no limit on the number of periods that a
Medicare beneficiary may be recertified. A Medicare beneficiary
may revoke his or her election at any time and begin receiving
traditional Medicare benefits. There is no limit on how long a
Medicare beneficiary can receive hospice benefits and services,
provided that the beneficiary continues to meet Medicare hospice
eligibility criteria.
Medicare reimburses for hospice care using a prospective payment
system. Under that system, we receive one of four predetermined
daily or hourly rates based upon the level of care we furnish to
the beneficiary.
15
These rates are subject to annual adjustments based on inflation
and geographic wage considerations. Our base Medicare rates
effective October 1, 2006 depend upon which of the
following four levels of care we provide:
|
|
|
|
|
Routine Home Care. We receive between $109.11
and $140.95 per day for routine home care, depending on the
geographic location. We are paid the routine home care rate for
each day a patient is under our care and not receiving one of
the other categories of hospice care. This rate is not adjusted
for the volume or intensity of care provided on a given day.
This rate is also paid when a patient is receiving hospital care
for a condition unrelated to the terminal condition.
|
|
|
|
General Inpatient Care. We receive between
$490.65 and $622.62 per day for general inpatient care,
depending on the geographic location.
|
|
|
|
Continuous Home Care. We receive between
$636.81 and $822.67 per day for continuous home care,
depending on the geographic location. This daily continuous home
care rate is divided by 24 in order to arrive at an hourly rate.
The hourly rate is paid for every hour that continuous home care
is furnished, up to 24 hours in a single day. A minimum of
eight hours must be provided in a single day to qualify for this
rate.
|
|
|
|
Respite Care. We receive between $116.68 and
$142.64 per day for respite care, depending on the
geographic location. Respite care is provided when the family or
caregiver of a patient requires temporary relief from his or her
care giving responsibilities for certain reasons. We can receive
payment for respite care provided to a given patient for up to
five consecutive days. Our payment for any additional days of
respite care provided to the patient is limited to the routine
home care rate.
|
Medicare limits the reimbursement we may receive for inpatient
care services. Under the so-called
80-20 rule,
if the number of inpatient care days furnished by us to Medicare
beneficiaries exceeds 20.0% of the total days of hospice care
furnished by us to Medicare beneficiaries, Medicare payments to
us for inpatient care days exceeding the inpatient cap will be
reduced to the routine home care rate. This determination is
made annually based on the twelve-month period beginning on
November 1st of each year. This limit is computed on a
program-by-program
basis. None of our hospices have exceeded the cap on inpatient
care services during 2005 or 2004. We have not received
notification that any of our hospices have exceeded the cap on
inpatient care services during 2006.
Our Medicare hospice reimbursement is also subject to a cap
amount calculated by the Medicare fiscal intermediary at the end
of the hospice cap period, which runs from
November 1st of each year through
October 31st of the following year. Total Medicare
payments to us during this period are compared to the cap
amount for this period. Payments in excess of the cap
amount must be returned by us to Medicare. The cap amount is
calculated by multiplying the number of beneficiaries electing
hospice care during the period by a statutory amount that is
indexed for inflation annually. The cap amount for the
twelve-month period ending October 31, 2006 was $20,585.
The hospice cap amount is computed on a
program-by-program
basis. None of our hospices have exceeded the cap on per
beneficiary limits during 2005 or 2004. We have not received
notification that any of our hospices have exceeded the cap on
per beneficiary limits during 2006.
We are required to file annual cost reports with HHS on each of
our hospices for informational purposes and to submit claims on
the basis of the location where we actually furnish the hospice
services. These requirements permit Medicare to adjust payment
rates for regional differences in wage costs.
Long-term Acute Care Hospitals. We are
reimbursed by Medicare for services provided by our long-term
acute care hospitals under the long-term acute care hospital
prospective payment system, which was implemented on
October 1, 2002. Although CMS regulations allowed for a
phase-in period, we have elected to be paid solely on the basis
of the long-term care diagnosis-related groups established by
the new system. All of our eligible long-term acute care
hospitals have implemented the prospective payment system.
Under the prospective payment system, each patient discharged
from our long-term acute care hospitals is assigned a long-term
care diagnosis-related group. CMS establishes these long-term
care diagnosis-related groups by grouping diseases by diagnosis,
which group reflects the amount of resources needed to treat a
given diseases. We are paid a pre-determined fixed amount
applicable to the particular long-term care
16
diagnosis-related group to which that patient is assigned. This
payment is intended to reflect the average cost of treating a
Medicare patient classified in that particular long-term care
diagnosis-related group. For select patients, the amount may be
further adjusted based on length of stay and facility-specific
costs, as well as in instances where a patient is discharged and
subsequently readmitted, among other factors. Similar to other
Medicare prospective payment systems, the rate is also adjusted
for geographic wage differences. Effective for discharges on or
after October 1, 2005, CMS has published the new relative
weights applicable to the long-term care diagnosis-related group
system. CMS has stated its intention to develop long-term acute
care hospital patient-specific criteria to refine the definition
of such facilities.
To this end, CMS awarded a contract to Research Triangle
Institute (RTI) for the purpose of evaluating patient and
facility level characteristics for long-term care hospitals in
order to differentiate the role of long-term acute care
hospitals from general acute care hospitals. RTI recently
released its study results, many of which are similar to
MedPACs findings released in a 2004 report. Like MedPAC,
RTI recommended the development and use of facility and patient
criteria as a method of ensuring that patients admitted to
long-term acute care hospitals, LTACHs, are medically complex
and have a good chance of improvement. Also, while MedPAC
recommended that quality improvement organizations (QIOs) review
LTACH admissions for medical necessity and monitor whether
facilities comply with the criteria, RTI recommended that CMS
clarify QIO roles in overseeing the appropriateness of LTACH
admissions. Additionally, RTI examined several key issues that
MedPAC had not yet researched. The RTI report is advisory in
nature, and it is uncertain which, if any, of its
recommendations will be enacted, many of which require
Congressional approval.
In order to qualify for payment under the long-term acute care
prospective payment system, a facility must be certified as a
hospital by Medicare and have an average Medicare inpatient
length of stay of greater than 25 days. Prior to qualifying
under the long-term acute care hospital prospective payment
system, facilities are classified as short-term acute care
hospitals and therefore receive lower payments under the acute
or inpatient rehabilitation facility prospective payments
systems. New long-term acute care hospitals continue to be paid
under these systems for a minimum of six months while they
establish the required average length of stay and meet certain
additional Medicare long-term acute care hospital requirements.
All of our LTACHs are currently qualified to receive full
payment under the long-term acute care prospective payment.
On May 12, 2006, CMS published a final rule maintaining the
Medicare payment rates for long-term acute care hospitals at
$38,086.04 for patient discharges taking place on or after
July 1, 2006 through June 30, 2007. In this rule, the
agency declined to apply its one-time budget neutrality
adjustment, set the cost outlier fixed loss threshold at
$14,877, and made an addition to the reimbursement calculation
for discharges defined as short stay outliers.
Long-term acute care hospitals are typically operated either as
stand-alone facilities or as separate provider units within
traditional acute care hospitals. All but one of our long-term
acute care hospitals are located within host hospitals. These
hospitals within a hospital must satisfy additional standards. A
hospital within a hospital must establish itself as a hospital
separate from its host by, among other things, obtaining
separate licensure and certification, not having common control
with its host hospital or a common parent organization, and
having a separate chief executive officer, chief medical officer
and medical staff. Further, there are financial penalties
associated with the failure to limit the number of total
Medicare patients discharged to the host hospital and
subsequently readmitted to the long-term acute care hospital to
no greater than 5.0%. None of our long-term acute care hospitals
exceeded this 5.0% limitation through the year ended
December 31, 2006.
In August 2004, CMS announced final regulatory changes
applicable to long-term acute care facilities operated as
hospitals within hospitals (HwHs). Effective for cost reporting
periods beginning on or after October 1, 2004, long-term
acute care HwHs would have to limit the number of Medicare
admissions from their co-located host hospital according to
specified thresholds. Medicare discharges over the specified
threshold would be paid at a reduced payment rate, specifically,
the inpatient prospective payment system rate.
This new policy was subject to a four year phase-in period for
existing LTACH HwHs, satellites and LTACHs under formation. All
of our LTACHs met the requirements for the four year phase-in
period. The first year of the phase-in period (cost reporting
periods beginning on or after October 1, 2004 and before
October 1,
17
2005) was a hold harmless year with no
admission percentage threshold followed by a percentage
transition over the three years beginning in FY 2006
(October 1, 2005 to September 30, 2006) as set
forth in the table below:
|
|
|
|
|
|
|
|
|
|
|
Allowable Admissions
|
|
|
|
from Host Hospital
|
|
|
|
Before Payment
|
|
|
|
Reduction
|
|
Cost Report Period Beginning
|
|
MSAs
|
|
|
Non-MSAs
|
|
|
Until September 30, 2005
|
|
|
100.0%
|
|
|
|
100.0%
|
|
October 1, 2005
September 30, 2006
|
|
|
75.0%
|
|
|
|
75.0%
|
|
October 1, 2006
September 30, 2007
|
|
|
50.0%
|
|
|
|
50.0%
|
|
October 1, 2007
and thereafter
|
|
|
25.0%
|
|
|
|
50.0%
|
|
The HwH rule specified that for HwHs located in rural or non-MSA
locations, the final year phase in percentage would be 50%. For
HwHs located in an MSA the final phase-in percentage would be
25%.
We currently have a total of seven long-term acute care
hospitals. Six of our hospitals are classified as hospitals
within a hospital (HwH) and one as freestanding. Of the six HwH
facilities, four are located in rural or non-MSAs and are
therefore subject to a final admission percentage of 50% at the
end of the phase in period. Two of our six HwH facilities are
located in MSA or urban areas and will be subject to a final
admission percentage of 25% at the end of the phase-in period.
Of these six locations classified as HwHs, two facilities are
satellite locations of a parent hospital located in an MSA and
one is a satellite location of a parent hospital located in an
non-MSA. Based on our discussions with CMS, we believe these
satellite locations will be viewed as being located in a non-MSA
regardless of the location of its parent hospital and will be
treated independently from its parent for purposes of
calculating its compliance with the admissions limitations.
For the twelve months ended December 31, 2006, on an
individual basis, all of our long-term acute care hospital
locations admitted between 50.0% and 75.0% of their patients
from their host hospitals. We currently anticipate that these
hospitals will be under the proper threshold as of
September 30, 2007. Our remaining long-term acute care
hospital is not a hospital within a hospital; therefore, it is
not subject to these limits on host hospital referrals.
In February 2007, CMS proposed to subject freestanding LTAC
hospitals to the same admission restrictions as HwH facilities.
Freestanding facilities would be prevented from admitting more
than 25% of its Medicare admissions from a single referring
hospital. Our current freestanding facility would not be
affected by this proposed rule change because we currently do
not receive more than 25% of our Medicare admissions from any
single referring hospital.
Outpatient Rehabilitation Services. Medicare
requires that outpatient therapy services be reimbursed on a fee
schedule, subject to annual limitations. Outpatient therapy
providers receive a fixed fee for each procedure performed,
adjusted by the geographical area in which the facility is
located. Medicare also imposes annual per Medicare beneficiary
caps. For 2006, these annual caps limited Medicare coverage to
$1,740 for outpatient rehabilitation services (including both
physical therapy and
speech-language
pathology services) and $1,740 for outpatient occupational
health services, including deductible and co-insurance amounts.
These caps were replaced for 2007 by annual cap amounts of
$1,780. Historically, Congress has acted to bypass the cap and
impose a moratorium on its operation. The Deficit Reduction Act
of 2005 and the Tax Relief and Health Care Act of 2006 provided
for an exceptions process that effectively prevents
application of the caps. The exceptions process ends
January 1, 2008. We are unable to predict whether Congress
will extend the exceptions process for 2008. We cannot be
assured that one or more of our outpatient rehabilitation
clinics will not exceed the caps in the future.
Historically, outpatient rehabilitation services have been
subject to scrutiny by the Medicare program for, among other
things, medical necessity, appropriate documentation,
supervision of therapy aides and students, and billing for group
therapy. CMS has issued guidance to clarify that services
performed by a student are not
18
reimbursable even if provided under line of sight
supervision of the therapist. Likewise, CMS has reiterated that
Medicare does not pay for services provided by aides regardless
of the level of supervision. CMS also has issued instructions
that outpatient physical and occupational therapy services
provided simultaneously to two or more individuals by a
practitioner should be billed as group therapy services.
Inpatient Rehabilitation Facilities. Inpatient
rehabilitation facilities are paid under a prospective payment
system. Under this system, each patient discharged from an
inpatient rehabilitation facility is assigned to a case mix
group containing patients with similar clinical problems that
are expected to require comparable resources. An inpatient
rehabilitation facility is generally paid a predetermined, fixed
amount applicable to the assigned case mix group (subject to
certain case and facility level adjustments). The prospective
payment system for inpatient rehabilitation facilities also
includes special payment policies that adjust the payments for
some patients based on length of stay, facility costs, whether
the patient was discharged and subsequently readmitted, and
other factors.
Medicaid
Medicaid is a joint federal and state funded health insurance
program for certain low-income individuals. Medicaid reimburses
healthcare providers using a number of different systems,
including cost-based, prospective payment, and negotiated rate
systems. Rates are also subject to adjustment based on statutory
and regulatory changes, administrative rulings, interpretations
of policy by individual state agencies, and certain government
funding limitations. Medicaid payments accounted for 6.1%, 6.0%,
and 4.8%, respectively, of our net service revenue for the years
ended December 31, 2006, 2005, and 2004.
Non-Governmental
Payors
A portion of our net service revenue comes from private payor
sources. These sources include insurance companies,
workers compensation programs, health maintenance
organizations, preferred provider organizations, other managed
care companies, and employers, as well as patients directly.
Patients are generally not responsible for any difference
between customary charges for our services and amounts paid by
Medicare and Medicaid programs and the non-governmental payors,
but are responsible for services not covered by these programs
or plans, as well as for deductibles and co-insurance
obligations of their coverage. The amount of these deductibles
and co-insurance obligations on patients has increased in recent
years. Collection of amounts due from individuals is typically
more difficult than collection of amounts due from government or
business payors. However, the majority of our billed services
are paid in full by Medicare, Medicaid or private insurance.
Accordingly, co-payments from patients do not represent a
material portion of our billed revenue and corresponding
accounts receivable. To further reduce their healthcare costs,
most insurance companies, health maintenance organizations,
preferred provider organizations, and other managed care
companies have negotiated discounted fee structures or fixed
amounts for services performed, rather than paying healthcare
providers the amounts billed. Our results of operations may be
negatively affected if these organizations are successful in
negotiating further discounts. Payments from non-governmental
payors accounted for 12.3%, 8.4%, and 8.9%, respectively, of our
net service revenue for the years ended December 31, 2006,
2005, and 2004.
Government
Regulations
General
The healthcare industry is highly regulated, and we are required
to comply with federal, state and local laws, which
significantly affect our business. These laws and regulations
are extremely complex and, in many instances, the industry does
not have the benefit of significant regulatory or judicial
interpretation. Regulations and policies frequently change, and
we monitor these changes through trade and governmental
publications and associations. The significant areas of federal
and state regulatory laws that could affect our ability to
conduct our business include the following:
|
|
|
|
|
Medicare and Medicaid participation and reimbursement;
|
19
|
|
|
|
|
the federal Anti-Kickback Statute and similar state laws;
|
|
|
|
the federal Stark Law and similar state laws;
|
|
|
|
false and other improper claims;
|
|
|
|
the Health Insurance Portability and Accountability Act of 1996,
or HIPAA;
|
|
|
|
civil monetary penalties;
|
|
|
|
environmental health and safety laws;
|
|
|
|
licensing; and
|
|
|
|
certificates of need and permits of approval.
|
If we fail to comply with these applicable laws and regulations,
we could suffer civil or criminal penalties, including the loss
of our licenses to operate and our ability to participate in
federal and state healthcare programs. Although we believe we
are in material compliance with all applicable laws, these laws
are complex and a review of our practices by a court or law
enforcement or regulatory authority could result in an adverse
determination that could harm our business. Furthermore, the
laws applicable to us are subject to change, interpretation and
amendment, which could adversely affect our ability to conduct
our business.
Medicare
Participation
During the year ended December 31, 2006, 2005, and 2004,
81.6%, 85.6% and 86.3%, respectively, of our net service revenue
was received from Medicare. We expect to continue to receive the
majority of our net service revenue from serving Medicare
beneficiaries. Medicare is a federally funded and administered
health insurance program, primarily for individuals entitled to
social security benefits who are 65 or older or who are
disabled. To participate in the Medicare program and receive
Medicare payments, our agencies and facilities must comply with
regulations promulgated by CMS. Among other things, these
requirements, known as conditions of participation,
relate to the type of facility, its personnel and its standards
of medical care. Although we intend to continue to participate
in the Medicare reimbursement programs, we cannot assure you
that our agencies and programs will continue to qualify for
participation.
Under Medicare rules, the designation provider-based
refers to circumstances in which a subordinate facility
(e.g., a separately-certified Medicare provider, a
department of a provider or a satellite facility) is treated as
part of a provider for Medicare payment purposes. In these
cases, the services of the subordinate facility are included in
the main providers cost report and overhead
costs of the main provider can be allocated to the subordinate
facility, to the extent that they are shared. We operate three
long-term acute care hospitals that are treated as
provider-based satellites of certain of our other facilities. We
also provide contract rehabilitation and management services to
hospital rehabilitation departments that may be treated as
provider-based. These facilities are required to satisfy certain
operational standards in order to retain their provider-based
status.
Anti-Kickback
Statute
Provisions of the Social Security Act of 1965, commonly referred
to as the Anti-Kickback Statute, prohibit the payment or receipt
of anything of value in return for the referral of patients or
arranging for the referral of patients, or in return for the
recommendation, arrangement, purchase, lease or order of items
or services that are covered by a federal healthcare program
such as Medicare and Medicaid. Violation of the Anti-Kickback
Statute is a felony, and sanctions include imprisonment of up to
five years, criminal fines of up to $25,000, civil monetary
penalties of up to $50,000 per act plus three times the
amount claimed or three times the remuneration offered, and
exclusion from federal healthcare programs (including the
Medicare and Medicaid programs). Many states have adopted
similar prohibitions against payments that are intended to
induce referrals of Medicaid and other third-party payor
patients.
The OIG has published numerous safe harbors that
exempt some practices from enforcement action under the federal
Anti-Kickback Statute. These safe harbors exempt specified
activities, including bona-fide
20
employment relationships, contracts for the rental of space or
equipment, and personal service arrangements and management
contracts, so long as all of the requirements of the safe harbor
are met. The OIG has recognized that the failure of an
arrangement to satisfy all of the requirements of a particular
safe harbor does not necessarily mean that the arrangement
violates the Anti-Kickback statute. Nonetheless, we cannot
assure you that arrangements that do not satisfy a safe harbor
are not in violation of the Anti-Kickback Statute.
We are required under the Medicare conditions of participation
and some state licensing laws to contract with numerous
healthcare providers and practitioners, including physicians,
hospitals and nursing homes, and to arrange for these
individuals or entities to provide services to our patients. In
addition, we have contracts with other suppliers, including
pharmacies, ambulance services and medical equipment companies.
We have also entered into various joint ventures with hospitals
and physicians for the ownership and management of home nursing
agencies and long-term acute care hospitals. Some of these
individuals or entities may refer, or be in a position to refer,
patients to us, and we may refer, or be in a position to refer,
patients to these individuals or entities. We attempt to
structure these arrangements in a manner which meets a safe
harbor. However, some of these arrangements may not meet all of
the requirements of a safe harbor. We believe that our contracts
and arrangements with providers, practitioners and suppliers do
not violate the Anti-Kickback Statute or similar state laws. We
cannot assure you, however, that these laws will ultimately be
interpreted in a manner consistent with our practices.
From time to time, various federal and state agencies, such as
HHS, issue pronouncements, including fraud alerts, that identify
practices that may be subject to heightened scrutiny. For
example, the OIGs 2007 Work Plan describes, among other
things, the governments intention to examine outlier
payments to home health agencies, accuracy of claims coding for
Medicare home health resources groups, payments to long-term
acute care hospitals and average lengths of stay at long-term
acute care hospitals.
In June 1995, the OIG issued a special fraud alert that focused
on the home nursing industry and identified some of the illegal
practices the OIG has uncovered. In March 1998, the OIG issued a
special fraud alert titled, Fraud and Abuse in Nursing Home
Arrangements with Hospices. This special fraud alert focused
on payments received by nursing homes from hospices. We believe,
but cannot assure you, that our operations comply with the
principles expressed by the OIG in these special fraud alerts.
We endeavor to conduct our operations in compliance with federal
and state healthcare fraud and abuse laws, including the
Anti-Kickback Statute. However, our practices may be challenged
in the future, and the fraud and abuse laws may be interpreted
in a way that finds us in violation of these laws. If we are
found to be in violation of the Anti-Kickback Statute, we could
be subject to civil and criminal penalties, and we could be
excluded from participating in federal healthcare programs such
as Medicare and Medicaid. The occurrence of any of these events
could significantly harm our business and financial condition.
Stark
Law
Congress also passed significant prohibitions against certain
physician referrals of patients for healthcare services. These
prohibitions are commonly known as the Stark Law. The Stark Law
prohibits a physician from making referrals for particular
healthcare services (called designated health services) to
entities with which the physician, or an immediate family member
of the physician, has a financial relationship.
The term financial relationship is defined very
broadly to include most types of ownership or compensation
relationships. The Stark Law also prohibits the entity receiving
the referral from seeking payment under the Medicare and
Medicaid programs for services rendered pursuant to a prohibited
referral. If an entity is paid for services rendered pursuant to
a prohibited referral, it may incur civil penalties and could be
excluded from participating in the Medicare or Medicaid
programs. If an arrangement is covered by the Stark Law, the
requirements of a Stark Law exception must be met for the
physician to be able to make referrals to the entity for
designated health services and for the entity to be able to bill
for these services.
Designated health services under the Stark Law are
defined to include clinical laboratory services; physical
therapy services; occupational therapy services; radiology
services, including magnetic resonance imaging, computerized
axial tomography scans, and ultrasound services; radiation
therapy services and
21
supplies; durable medical equipment and supplies; parenteral and
enteral nutrients, equipment, and supplies; prosthetics,
orthotics, and prosthetic devices and supplies; home health
services; outpatient prescription drugs; and inpatient and
outpatient hospital services. The Stark Law defines a financial
relationship to include: (1) a physicians ownership
or investment interest in an entity and (2) a compensation
relationship between a physician and an entity. Under the Stark
Law, financial relationships include both direct and indirect
relationships.
Physicians refer patients to us for several Stark Law designated
health services, including home health services, inpatient and
outpatient hospital services, and physical therapy services. We
have compensation arrangements with some of these physicians or
their professional practices in the form of medical director and
consulting agreements. We also have operations owned by joint
ventures in which physicians have an investment interest. In
addition, other physicians who refer patients to our agencies
and facilities may own our stock. As a result of these
relationships, we could be deemed to have a financial
relationship with physicians who refer patients to our
facilities and agencies for designated health services. If so,
the Stark Law would prohibit the physicians from making those
referrals and would prohibit us from billing for the services
unless a Stark Law exception applies.
The Stark Law contains exceptions for certain physician
ownership or investment interests in and certain physician
compensation arrangements with entities. If a compensation
arrangement or investment relationship between a physician, or a
physicians immediate family member, and an entity
satisfies all requirements for a Stark Law exception, the Stark
Law will not prohibit the physician from referring patients to
the entity for designated health services. The exceptions for
compensation arrangements cover employment relationships,
personal services contracts, and space and equipment leases,
among others. The exceptions for a physician investment
relationship include ownership in an entire hospital and
ownership in rural providers. We believe our compensation
arrangements with referring physicians and our physician
investment relationships meet the requirements for an exception
under the Stark Law and that our operations comply with the
Stark Law.
The Stark Law also includes an exception for a physicians
ownership or investment interest in certain entities through the
ownership of stock. If a physician owns stock in an entity, and
the stock is listed on a national exchange or is quoted on
Nasdaq and the ownership meets certain other requirements, the
Stark Law will not apply to prohibit the physician from
referring to the entity for designated health services. The
requirements for this Stark Law exception include a requirement
that the entity issuing the stock have at least
$75.0 million in stockholders equity at the end of
its most recent fiscal year or on average during the previous
three fiscal years. As of December 31, 2006, we have
exceeded $75.0 million in stockholders equity.
If an entity violates the Stark Law, it could be subject to
civil penalties of up to $15,000 per prohibited claim and
up to $100,000 for knowingly entering into certain prohibited
referral schemes. The entity also may be excluded from
participating in federal healthcare programs (including Medicare
and Medicaid). If the Stark Law was found to apply to our
relationships with referring physicians and no exceptions under
the Stark Law were available, we would be required to
restructure these relationships or refuse to accept referrals
for designated health services from these physicians. If we were
found to have submitted claims to Medicare or Medicaid for
services provided pursuant to a referral prohibited by the Stark
Law, we would be required to repay any amounts we received from
Medicare for those services and could be subject to civil
monetary penalties. Further, we could be excluded from
participating in Medicare and Medicaid. If we were required to
repay any amounts to Medicare, subjected to fines, or excluded
from the Medicare and Medicaid Programs, our business and
financial condition would be harmed significantly.
Many states have physician relationship and referral statutes
that are similar to the Stark Law. These laws generally apply
regardless of payor. We believe that our operations are
structured to comply with applicable state laws with respect to
physician relationships and referrals. However, any finding that
we are not in compliance with these state laws could require us
to change our operations or could subject us to penalties. This,
in turn, could have a negative impact on our operations.
22
False
and Improper Claims
The submission of claims to a federal or state healthcare
program for items and services that are not provided as
claimed may lead to the imposition of civil monetary
penalties, criminal fines and imprisonment,
and/or
exclusion from participation in state and federally funded
healthcare programs, including the Medicare and Medicaid
programs. These false claims statutes include the Federal False
Claims Act. Under the Federal False Claims Act, actions against
a provider can be initiated by the federal government or by a
private party on behalf of the federal government. These private
parties are often referred to as qui tam relators, and relators
are entitled to share in any amounts recovered by the
government. Both direct enforcement activity by the government
and qui tam actions have increased significantly in recent
years. This development has increased the risk that a healthcare
company like us will have to defend a false claims action, pay
fines or be excluded from the Medicare and Medicaid programs as
a result of an investigation arising out of false claims laws.
Many states have enacted similar laws providing for the
imposition of civil and criminal penalties for the filing of
fraudulent claims. Because of the complexity of the government
regulations applicable to our industry, we cannot assure that we
will not be the subject of an action under the Federal False
Claims Act or similar state law.
Anti-fraud
Provisions of the Health Insurance Portability and
Accountability Act of 1996
In an effort to combat healthcare fraud, Congress included
several anti-fraud measures in HIPAA. Among other things, HIPAA
broadened the scope of certain fraud and abuse laws, extended
criminal penalties for Medicare and Medicaid fraud to other
federal healthcare programs, and expanded the authority of the
OIG to exclude persons and entities from participating in the
Medicare and Medicaid programs. HIPAA also extended the Medicare
and Medicaid civil monetary penalty provisions to other federal
healthcare programs, increased the amounts of civil monetary
penalties, and established a criminal healthcare fraud statute.
Federal healthcare offenses under HIPAA include healthcare fraud
and making false statements relating to healthcare matters.
Under HIPAA, among other things, any person or entity that
knowingly and willfully defrauds or attempts to defraud a
healthcare benefit program is subject to a fine, imprisonment or
both. Also under HIPAA, any person or entity that knowingly and
willfully falsifies or conceals or covers up a material fact or
makes any materially false or fraudulent statements in
connection with the delivery of or payment of healthcare
services by a healthcare benefit plan is subject to a fine,
imprisonment or both. HIPAA applies not only to governmental
plans but also to private payors.
Administrative
Simplification Provisions of HIPAA
HHSs final regulations governing electronic transactions
involving health information are part of the administrative
simplification provisions of HIPAA. These regulations are
commonly referred to as the Transaction Standards rule. The rule
establishes standards for eight of the most common healthcare
transactions by reference to technical standards promulgated by
recognized standards publishing organizations. Under the new
standards, any party transmitting or receiving health
transactions electronically must send and receive data in a
single format, rather than the large number of different data
formats currently used. This rule will apply to us in connection
with submitting and processing health claims. The Transaction
Standards rule also applies to many of our payors and to our
relationships with those payors. Since many of our payors might
not have been able to accept transactions in the format required
by the Transaction Standards rule by the original compliance
date, we filed a timely compliance extension plan with HHS. We
believe that our operations materially comply with the
Transaction Standards rule.
HHS also has final regulations implementing HIPAA that set forth
standards for the privacy of individually-identifiable health
information, referred to as protected health information. The
regulations cover healthcare providers, healthcare
clearinghouses and health plans. The privacy regulations require
companies covered by the regulations to use and disclose
protected health information only as allowed by the privacy
regulations. Specifically, the privacy regulations require
companies such as us to do the following, among other things:
|
|
|
|
|
obtain patient authorization prior to certain uses or
disclosures of protected health information;
|
23
|
|
|
|
|
provide notice of privacy practices to patients and obtain an
acknowledgement that the patient has received the notice;
|
|
|
|
respond to requests from patients for access to or to obtain a
copy of their protected health information;
|
|
|
|
respond to patient requests for amendments of their protected
health information;
|
|
|
|
provide an accounting to patients of certain disclosure of their
protected health information;
|
|
|
|
enter into agreements with the companies business
associates through which the business associates agree to use
and disclose protected health information only as permitted by
the agreement and the requirements of the privacy regulations;
|
|
|
|
train the companies workforce in privacy compliance;
|
|
|
|
designate a privacy officer;
|
|
|
|
use and disclose only the minimum necessary information to
accomplish a particular purpose; and
|
|
|
|
establish policies and procedures with respect to uses and
disclosures of protected health information.
|
These regulatory requirements impose significant administrative
and financial obligations on companies that use or disclose
individually identifiable health information relating to the
health of a patient. We have implemented new policies and
procedures to maintain patient privacy and comply with
HIPAAs privacy regulations. The privacy regulations are
extensive, and we may need to change some of our practices to
comply with them as they are interpreted and as we deal with
issues that arise.
In February 2003, HHS published the final security regulations
implementing HIPAA that govern the security of health
information. The compliance date for the security regulations
was April 21, 2005. The security regulations require the
implementation of policies and procedures that establish
administrative, physical, and technical safeguards for
electronic protected health information. Companies covered by
the security regulations are required to ensure the
confidentiality, integrity, and availability of electronic
protected health information. Specifically, among others things,
companies are required to:
|
|
|
|
|
conduct a thorough assessment of the potential risks and
vulnerabilities to confidentiality, integrity, and availability
of electronic protected health information and to reduce the
risks and vulnerabilities to a reasonable and appropriate level
as required by the security regulations;
|
|
|
|
designate a security officer;
|
|
|
|
establish policies relating to access by the companies
workforce to electronic protected health information;
|
|
|
|
enter into agreements with the companies business
associates whereby business associates agree to establish
administrative, physical, and technical safeguards for
electronic protected health information received from or on
behalf of the companies;
|
|
|
|
create a disaster and contingency plan to ensure the
availability of electronic protected health information;
|
|
|
|
train the companies workforce in security compliance;
|
|
|
|
establish physical controls for electronic devices and media
containing or transmitting electronic protected health
information;
|
|
|
|
establish policies and procedures regarding the use of
workstations with access to electronic protected health
information; and
|
|
|
|
establish technical controls for the information systems
maintaining or transmitting electronic protected health
information.
|
24
These regulatory requirements impose significant administrative
and financial obligations on companies like us that use or
disclose electronic health information. Our operations are in
compliance with the security regulations.
Civil
Monetary Penalties
The Secretary of HHS may impose civil monetary penalties on any
person or entity that presents, or causes to be presented,
certain ineligible claims for medical items or services. The
amount of penalties varies depending on the offense, from $2,000
to $50,000 per violation, plus treble damages for the
amount at issue and exclusion from federal healthcare programs
(including Medicare and Medicaid).
HHS also can impose penalties on a person or entity who offers
inducements to beneficiaries for program services, who violates
rules regarding the assignment of payments or who knowingly
gives false or misleading information that could reasonably
influence the discharge of patients from a hospital. Persons who
have been excluded from a federal healthcare program and who
retain ownership in a participating entity and persons who
contract with excluded persons may be penalized.
HHS also can impose penalties for false or fraudulent claims and
those that include services not provided as claimed. In
addition, HHS may impose penalties on claims:
|
|
|
|
|
for physician services that the person or entity knew or should
have known were rendered by a person who was unlicensed, or
misrepresented either (1) his or her qualifications in
obtaining his or her license or (2) his or her
certification in a medical specialty;
|
|
|
|
for services furnished by a person who was, at the time the
claim was made, excluded from the program to which the claim was
made; or
|
|
|
|
that show a pattern of medically unnecessary items or services.
|
Penalties also are applicable in certain other cases, including
violations of the federal Anti-Kickback Statute, payments to
limit certain patient services and improper execution of
statements of medical necessity.
Environmental
Health and Safety Laws
We are subject to federal, state and local regulations governing
the storage, use and disposal of materials and waste products.
Although we believe that our safety procedures for storing,
handling and disposing of these hazardous materials comply with
the standards prescribed by law and regulation, we cannot
completely eliminate the risk of accidental contamination or
injury from those hazardous materials. In the event of an
accident, we could be held liable for any damages that result,
and any liability could exceed the limits or fall outside the
coverage of our insurance. We may not be able to maintain
insurance on acceptable terms, or at all. We could incur
significant costs and the diversion of our managements
attention in order to comply with current or future
environmental laws and regulations. We do not have any material
estimated capital expenditures related to compliance with
environmental, health and safety laws through calendar year 2007.
Licensing
Our agencies and facilities are subject to state and local
licensing regulations ranging from the adequacy of medical care
to compliance with building codes and environmental protection
laws. In order to assure continued compliance with these various
regulations, governmental and other authorities periodically
inspect our agencies and facilities. Additionally, healthcare
professionals at our agencies and facilities are required to be
individually licensed or certified under applicable state law.
We take steps to ensure that our employees and agents possess
all necessary licenses and certifications.
The institutional pharmacy operations within our facility-based
services segment are subject to regulation by the various states
in which business is conducted as well as by the federal
government. The pharmacies are regulated under the Food, Drug
and Cosmetic Act and the Prescription Drug Marketing Act, which
are administered by the United States Food and Drug
Administration. Under the Comprehensive Drug Abuse Prevention
and Control Act of 1970, which is administered by the United
States Drug Enforcement
25
Administration, dispensers of controlled substances must
register with the Drug Enforcement Administration, file reports
of inventories and transactions and provide adequate security
measures. Failure to comply with such requirements could result
in civil or criminal penalties.
JCAHO is a nationwide commission that establishes standards
relating to the physical plant, administration, quality of
patient care and operation of medical staffs of hospitals.
Currently, JCAHO accreditation of home nursing agencies is
voluntary. However, managed care organizations use JCAHO
accreditation as a minimum standard for regional and state
contracts. As of December 31, 2006, JCAHO had accredited 34
of our home nursing agencies. Those not yet accredited are
working towards achieving this accreditation, which can take up
to six months.
Certificate
of Need and Permit of Approval Laws
In addition to state licensing laws, some states require a
provider to obtain a certificate of need or permit of approval
prior to establishing or expanding certain health services or
facilities. States with certificate of need or permit of
approval laws place limits on both the construction and
acquisition of healthcare facilities and operations and the
expansion of existing facilities and services. In these states,
approvals are required for capital expenditures exceeding
certain amounts that involve certain facilities or services,
including home nursing agencies. In addition, the state of
Louisiana has imposed a moratorium on the issuance of new
licenses for home nursing agencies that is effective until
July 1, 2008. Of the 15 states in which we intend to
pursue expansion opportunities, ten have certificate of need or
permit of approval laws: Alabama, Arkansas, Georgia, Kentucky,
Mississippi, North Carolina, South Carolina, Tennessee, Virginia
and West Virginia. The certificate of need or permit of approval
issued by the state determines the service areas for the
applicable agency or program.
State certificate of need and permit of approval laws generally
provide that, prior to the addition of new capacity, the
construction of new facilities or the introduction of new
services, a designated state health planning agency must
determine that a need exists for those beds, facilities or
services. The process is intended to promote comprehensive
healthcare planning, assist in providing high quality healthcare
at the lowest possible cost and avoid unnecessary duplication by
ensuring that only those healthcare facilities and operations
that are needed will be built and opened.
Employees
As of December 31, 2006 we had 3,959 employees, of which
2,478 were full-time and 1,481 were part-time employees, and
approximately 775 independent contractors. None of our employees
are subject to a collective bargaining agreement. We consider
our relationships with our employees and independent contractors
to be good.
Insurance
We are subject to claims and legal actions in the ordinary
course of our business. To cover claims that may arise, we
maintain professional malpractice liability insurance, general
liability insurance, automobile liability insurance, and
workers compensation/employers liability in amounts
that we believe are appropriate and sufficient for our
operations. We maintain professional malpractice and general
liability insurance that provide primary coverage on a
claims-made basis of $1.0 million per incident and
$3.0 million in annual aggregate amounts. We maintain
workers compensation insurance that meets state statutory
requirements with a primary employer liability limit of
$1.0 million for Louisiana, Mississippi Alabama, Arkansas,
Texas, Tennessee, Georgia, Florida, and Kentucky and $500,000 in
West Virginia. We maintain Automobile Liability for all owned,
hired, and non-owned autos with a primary limit of
$2.0 million. In addition, we currently maintain multiple
layers of umbrella coverage in the aggregate amount of
$25.0 million that provides excess coverage for
professional malpractice, general liability, automobile
liability and employers liability. We also currently
maintain Directors and Officers liability insurance in the
aggregate amount of $15.0 million. The cost and
availability of such coverage has varied widely in recent years.
While we believe that our insurance policies and coverage are
adequate for a business enterprise of our type, we cannot assure
you that our
26
insurance coverage is sufficient to cover all future claims or
that it will continue to be available in adequate amounts or at
a reasonable cost.
Available
Information
Our Annual Reports on
Form 10-K,
Quarterly Reports on
Form 10-Q,
Current Reports on
Form 8-K,
proxy statements and amendments to those reports, are available
free of charge on our internet website at www.lhcgroup.com as
soon as reasonably practicable after such reports are
electronically filed with or furnished to the Securities and
Exchange Commission, or SEC. The SEC also maintains an internet
site (www.sec.gov) that contains reports, proxy and information
statements, and other information regarding issuers that file
electronically with the SEC.
You should carefully consider the risks described below
before investing in the Company. The risks and uncertainties
described below are not the only ones we face. Other
risks and uncertainties that we have not predicted or assessed
may also adversely affect us.
If any of the following risks occurs, our earnings, financial
condition or business could be materially harmed, and the
trading price of our common stock could decline, resulting in
the loss of all or part of your investment.
More
than 80% of our net service revenue is derived from Medicare. If
there are changes in Medicare rates or methods governing
Medicare payments for our services, or if we are unable to
control our costs, our net service revenue and net income could
decline materially.
For the years ended December 31, 2006, 2005 and 2004, we
received 81.6%, 85.6% and 86.3%, respectively, of our net
service revenue from Medicare. Reductions in Medicare rates or
changes in the way Medicare pays for services could cause our
net service revenue and net income to decline, perhaps
materially. Reductions in Medicare reimbursement could be caused
by many factors, including:
|
|
|
|
|
administrative or legislative changes to the base rates under
the applicable prospective payment systems;
|
|
|
|
the reduction or elimination of annual rate increases;
|
|
|
|
the imposition or increase by Medicare of mechanisms, such as
co-payments, shifting more responsibility for a portion of
payment to beneficiaries;
|
|
|
|
adjustments to the relative components of the wage index used in
determining reimbursement rates;
|
|
|
|
changes to case mix or therapy thresholds;
|
|
|
|
the reclassification of home health resource groups or long-term
care diagnosis-related groups; or
|
|
|
|
further limitations on referrals to long-term acute care
hospitals from host hospitals.
|
We generally receive fixed payments from Medicare for our
services based on the level of care provided to our patients.
Consequently, our profitability largely depends upon our ability
to manage the cost of providing these services. Medicare
currently provides for an annual adjustment of the various
payment rates, such as the base episode rate for our home
nursing services, based upon the increase or decrease of the
medical care expenditure category of the Consumer Price Index,
which may be less than actual inflation. This adjustment could
be eliminated or reduced in any given year. Our base episode
rate for home nursing services is also subject to an annual
market basket adjustment. For 2007, the home health market
basket percentage increase is 3.3%. Further, Medicare routinely
reclassifies home health resource groups and long-term care
diagnosis-related groups. As a result of those
reclassifications, we could receive lower reimbursement rates
depending on the case mix of the patients we service. If our
cost of providing services increases by more than the annual
Medicare price adjustment, or if these reclassifications result
in lower reimbursement rates, our net income could be adversely
impacted.
27
We are
subject to extensive government regulation. Any changes in the
laws governing our business, or the interpretation and
enforcement of those laws or regulations, could cause us to
modify our operations and could negatively impact our operating
results.
As a provider of healthcare services, we are subject to
extensive regulation on the federal, state and local levels,
including with regard to:
|
|
|
|
|
agency, facility and professional licensure, certificates of
need and permits of approval;
|
|
|
|
conduct of operations, including financial relationships among
healthcare providers, Medicare fraud and abuse, and physician
self-referral;
|
|
|
|
maintenance and protection of records, including the Health
Insurance Portability and Accountability Act of 1996, or HIPAA;
|
|
|
|
environmental protection, health and safety;
|
|
|
|
certification of additional agencies or facilities by the
Medicare program; and
|
|
|
|
payment for services.
|
The laws and regulations governing our operations, along with
the terms of participation in various government programs,
regulate how we do business, the services we offer, and our
interactions with patients and other providers. These laws and
regulations, and their interpretations, are subject to frequent
change. Changes in existing laws or regulations, their
interpretations, or the enactment of new laws or regulations
could increase our costs of doing business and cause our net
income to decline. If we fail to comply with these applicable
laws and regulations, we could suffer civil or criminal
penalties, including the loss of our licenses to operate and our
ability to participate in federal and state reimbursement
programs.
We are subject to various routine and non-routine governmental
reviews, audits, and investigations. In recent years federal and
state civil and criminal enforcement agencies have heightened
and coordinated their oversight efforts related to the
healthcare industry, including with respect to referral
practices, cost reporting, billing practices, joint ventures and
other financial relationships among healthcare providers. A
violation or change in the interpretation of the laws governing
our operations, or changes in the interpretation of those laws,
could result in the imposition of fines, civil or criminal
penalties, the termination of our rights to participate in
federal and state-sponsored programs, or the suspension or
revocation of our licenses to operate. If we become subject to
material fines or if other sanctions or other corrective actions
are imposed upon us, we may suffer a substantial reduction in
net income.
If any
of our agencies or facilities fail to comply with the conditions
of participation in the Medicare program, that agency or
facility could be terminated from Medicare, which would
adversely affect our net service revenue and net
income.
Our agencies and facilities must comply with the extensive
conditions of participation in the Medicare program. These
conditions of participation vary depending on the type of agency
or facility, but in general require our agencies and facilities
to meet specified standards relating to personnel, patient
rights, patient care, patient records, administrative reporting
and legal compliance. If an agency or facility fails to meet any
of the Medicare conditions of participation, that agency or
facility may receive a notice of deficiency from the applicable
state surveyor. If that agency or facility then fails to
institute and comply with a plan of correction to correct the
deficiency within the time period provided by the state
surveyor, that agency or facility could be terminated from the
Medicare program. We respond in the ordinary course to
deficiency notices issued by state surveyors, and none of our
facilities or agencies have ever been terminated from the
Medicare program for failure to comply with the conditions of
participation. Any termination of one or more of our agencies or
facilities from the Medicare program for failure to satisfy the
Medicare conditions of participation would adversely affect our
net service revenue and net income.
In addition, if our long-term acute care hospitals fail to meet
or maintain the standards for Medicare certification as
long-term acute care hospitals, such as for average minimum
length of patient stay, they will
28
receive reimbursement under the prospective payment system
applicable to general acute care hospitals rather than the
system applicable to long-term acute care hospitals. Payments at
rates applicable to general acute care hospitals would likely
result in our long-term acute care hospitals receiving less
Medicare reimbursement than they currently receive for their
patient services. Moreover, all of our long-term acute care
hospitals are subject to additional Medicare criteria because
they operate as separate hospitals located in space leased from,
and located in, a general acute care hospital, known as a host
hospital. This is known as a hospital within a
hospital model. These additional criteria include
requirements concerning financial and operational separateness
from the host hospital. If several of our long-term acute care
hospitals were subject to payment as general acute care
hospitals or fail to comply with the separateness requirements,
our net service revenue and net income would decline.
CMS
has adopted regulations that could materially and adversely
impact the revenue and net income of our long-term acute care
hospitals.
In August 2004, CMS announced final regulatory changes
applicable to long-term acute care facilities operated as
hospitals within hospitals (HwHs). Effective for cost reporting
periods beginning on or after October 1, 2004, long-term
acute care HwHs would have to limit the number of Medicare
admissions from their co-located host hospital according to
specified thresholds. Medicare discharges over the specified
threshold would be paid at a reduced payment rate, specifically,
the inpatient prospective payment system rate.
This new policy was subject to a four year phase-in period for
existing LTACH HwHs, satellites and LTACHs under formation. All
of our LTACHs met the requirements for the four year phase-in
period. The first year of the phase-in period (cost reporting
periods beginning on or after October 1, 2004 and before
October 1, 2005) was a hold harmless year
with no admission percentage threshold followed by a percentage
transition over the three years beginning in FY 2006
(October 1, 2005 to September 30, 2006) as set
forth in the table below:
|
|
|
|
|
|
|
|
|
|
|
Allowable Admissions
|
|
|
|
from Host Hospital
|
|
|
|
Before Payment Reduction
|
|
Cost Report Period Beginning
|
|
MSAs
|
|
|
Non-MSAs
|
|
|
Until September 30, 2005
|
|
|
100.0%
|
|
|
|
100.0%
|
|
October 1, 2005
September 30, 2006
|
|
|
75.0%
|
|
|
|
75.0%
|
|
October 1, 2006
September 30, 2007
|
|
|
50.0%
|
|
|
|
50.0%
|
|
October 1, 2007
and thereafter
|
|
|
25.0%
|
|
|
|
50.0%
|
|
We currently have a total of seven long-term acute care
hospitals. Six of our hospitals are classified as hospitals
within a hospital (HwH) and one as freestanding. Of the six HwH
facilities, four are located in rural or non-MSAs and are
therefore subject to a final admission percentage of 50% at the
end of the phase in period. Two of our six HwH facilities are
located in MSA or urban areas and will be subject to a final
admission percentage of 25% at the end of the phase-in period.
Of these six locations classified as HwHs, two facilities are
satellite locations of a parent hospital located in an MSA and
one is a satellite location of a parent hospital located in an
non-MSA. Based on our discussions with CMS, we believe these
satellite locations will be viewed as being located in a non-MSA
regardless of the location of its parent hospital and will be
treated independently from its parent for purposes of
calculating its compliance with the admissions limitations.
In February 2007, CMS proposed to subject freestanding LTAC
hospitals to the same admission restrictions as HwH facilities.
Freestanding facilities would be prevented from admitting more
than 25% of its Medicare admissions from a single referring
hospital. Our current freestanding facility would not be
affected by this proposed rule change because we currently do
not receive more than 25% of our Medicare admissions from any
single referring hospital.
29
Our ability to quantify the potential reduction in our
reimbursement rates resulting from the implementation of these
new regulations is contingent upon a variety of factors, such as
our ability to reduce the percentage of admissions that are
derived from our host hospitals and, if necessary, our ability
to relocate our existing long-term acute care hospitals to
freestanding locations. We may not be able to successfully
restructure or relocate these operations without incurring
significant expense or in a manner that avoids reimbursement
reductions. If these new regulations result in lower
reimbursement rates, our net service revenue and net income
could decline. As a result of these new rules, we do not intend
to expand the number of hospital within a hospital long-term
acute care hospitals that we operate.
We are reimbursed by Medicare for services we provide in our
long-term acute care hospitals based on the long-term care
diagnosis-related group assigned to each patient. CMS
establishes these long-term care diagnosis-related groups by
grouping diseases by diagnosis, which group reflects the amount
of resources needed to treat a given disease. These new rules
reclassify certain long-term care diagnosis-related groups,
which could result in a decrease in reimbursement rates.
Further, the new rules kept in place the financial penalties
associated with the failure to limit the total number of
Medicare patients discharged to a host hospital and subsequently
readmitted to a long-term acute care hospital located within the
host hospital to no greater than 5.0%. If we fail to comply with
these readmission rates or if our reimbursement rates decline
due to the reclassification of certain long-term care
diagnosis-related groups, our net service revenue and net income
could decline.
Legislative
initiatives could negatively impact our operations and financial
results.
In recent years, an increasing number of legislative initiatives
have been introduced or proposed in Congress and in state
legislatures that would result in major changes in the
healthcare system, either at the national or state level. Many
of these proposals have been introduced in an effort to reduce
costs. For example, the Medicare Modernization Act of 2003, MMA
allocated significant additional funds to Medicare managed care
providers in order to promote greater participation in those
plans by Medicare beneficiaries. If these increased funding
levels achieve their intended result, the rate of growth in the
Medicare
fee-for-service
market could decline. For the years ended December 31,
2006, 2005 and 2004, we received 81.6%, 85.6%, and 86.3%,
respectively, of our net service revenue from the Medicare
fee-for-service
market. Among other proposals that have been introduced are
insurance market reforms to increase the availability of group
health insurance to small businesses, requirements that all
businesses offer health insurance coverage to their employees
and the creation of government health insurance or plans that
would cover all citizens and increase payments by beneficiaries.
We cannot predict whether any of the above proposals, or any
other future proposals, will be adopted. If adopted, we could be
forced to expend considerable resources to comply with and
implement such reforms.
More
than 60% of our net service revenue is currently generated in
Louisiana, making us particularly sensitive to economic and
other conditions in that state.
Our Louisiana agencies and facilities accounted for
approximately 63.5%, 78.8%, and 82.8% of net service revenue
during the years ended December 31, 2006, 2005 and 2004,
respectively. Any material change in the current economic or
competitive conditions in Louisiana, which could result from
events such as the implementation of certificate of need
regulations or changes in state tax laws, could have a
disproportionate effect on our overall business results.
Hurricanes
or other adverse weather events could negatively affect our
local economies or disrupt our operations, which could have an
adverse effect on our business or results of
operations.
Our market areas in the southern United States are particularly
susceptible to hurricanes. Such weather events can disrupt our
operations, result in damage to our properties and negatively
affect the local economies in which we operate. In late summer
2005, Hurricane Katrina and Hurricane Rita struck the Gulf Coast
region of the United States and caused extensive and
catastrophic physical damage to those areas. While we believe we
have recovered from the effects of Hurricane Katrina and
Hurricane Rita, future hurricanes could affect our operations or
the economies in those market areas and result in damage to
certain of our facilities and the
30
equipment located at such facilities, or equipment on rent with
customers in those areas. Our business or results of operations
may be adversely affected by these and other negative effects of
future hurricanes.
If we
are unable to maintain relationships with existing referral
sources or establish new referral sources, our growth and net
income could be adversely affected.
Our success depends significantly on referrals from physicians,
hospitals, and other healthcare providers in the communities in
which we deliver our services. Our referral sources are not
obligated to refer business to us and may refer business to
other healthcare providers. We believe many of our referral
sources refer business to us as a result of the quality of
patient service provided by our local employees in the
communities in which our agencies and facilities are located. If
we are unable to retain these employees, our referral sources
may refer business to other healthcare providers. Our loss of,
or failure to maintain, existing relationships or our failure to
develop new relationships could affect adversely our ability to
expand our operations and operate profitably.
Delays
in reimbursement may cause liquidity problems.
Our business is characterized by delays in reimbursement from
the time we request payment for our services to the time we
receive reimbursement or payment. A portion of our estimated
reimbursement (60.0% for an initial episode of care and 50.0%
for subsequent episodes of care) for each Medicare episode is
billed at the commencement of the episode and we typically
receive payment within approximately 12 days. The remaining
reimbursement is billed upon completion of the episode and is
typically paid within
14-17 days
from billing date. If we have information system problems or
issues arise with Medicare or other payors, we may encounter
further delays in our payment cycle. For example, in the past we
have experienced delays resulting from problems arising out of
the implementation by Medicare of new or modified reimbursement
methodologies or as a result of natural disasters, such as
hurricanes. We have also experienced delays in reimbursement
resulting from our implementation of new information systems
related to our accounts receivable and billing functions. Any
future timing delay may cause working capital shortages. As a
result, working capital management, including prompt and
diligent billing and collection, is an important factor in our
consolidated results of operations and liquidity. Our working
capital management procedures may not successfully negate this
risk. Significant delays in payment or reimbursement could have
an adverse impact on our liquidity and financial condition.
Future
cost containment initiatives undertaken by private third party
payors may limit our future net service revenue and net
income.
Initiatives undertaken by major insurers and managed care
companies to contain healthcare costs may affect our net income.
These payors attempt to control healthcare costs by contracting
with hospitals and other healthcare providers to obtain services
on a discounted basis. We believe that this trend may continue
and may limit reimbursements for healthcare services. If
insurers or managed care companies from whom we receive
substantial payments were to reduce the amounts they pay for
services, our profit margins may decline, or we may lose
patients if we choose not to renew our contracts with these
insurers at lower rates.
If the
structures or operations of our joint ventures are found to
violate the law, our financial condition and consolidated
results of operations could be materially adversely
impacted.
We have entered into 50 joint ventures with respect to the
ownership and operation of 40 home nursing agency locations,
three hospices, and six long-term acute care hospital locations,
and one home health pharmacy. As of December 31, 2006, we
had 40 equity joint ventures, two cooperative endeavors and
eight license leasing arrangements. Of these 50 joint ventures,
37 are with hospitals, four are with physicians, and nine are
with other parties. With respect to our four joint ventures with
physicians, three are for the ownership and operation of
long-term acute care hospitals, and one is for the ownership of
a home nursing agency. Our joint venture relationships are
structured as equity joint ventures, cooperative endeavors or
license leasing arrangements. Our joint ventures with hospitals
and physicians are governed by the federal anti-kickback statute
and similar state laws. These anti-kickback statutes prohibit
the payment or receipt of anything of value
31
in return for referrals of patients or services covered by
governmental healthcare programs, such as Medicare. The Office
of Inspector General of the Department of Health and Human
Services has published numerous safe harbors that exempt
qualifying arrangements from enforcement under the federal
anti-kickback statute. We have sought to satisfy as many safe
harbor requirements as possible in structuring these joint
ventures. For example, each of our equity joint ventures with
hospitals and physicians is structured in accordance with the
following principles:
|
|
|
|
|
The investment interest offered is not based upon actual or
expected referrals by the hospital or physician;
|
|
|
|
Our joint venture partners are not required to make or influence
referrals to the joint venture;
|
|
|
|
At the time the joint venture is formed, each hospital or
physician joint venture partner is required to make an actual
capital contribution to the joint venture equal to the fair
market value of its investment interest and is at risk to lose
its investment;
|
|
|
|
Neither we nor the joint venture entity lends funds to or
guarantees a loan to acquire interests in the joint venture for
a hospital or physician; and
|
|
|
|
Distributions to our joint venture partners are based solely on
their equity interests and not affected by referrals from the
hospital or physician
|
Although we have sought to satisfy as many safe harbor
requirements as possible, our joint ventures may not satisfy all
elements of the safe harbor requirements.
Our four joint ventures with physicians are also governed by the
federal Stark Law and similar state laws, which restrict
physicians from making referrals for particular healthcare
services to entities with which the physicians or their families
have a financial relationship. We also believe we have
structured our physician joint ventures in a way that meets
applicable exceptions under the federal Stark Law and similar
state physician referral laws. For example, we believe our one
physician joint ventures for a home nursing agency comply with
the rural provider exception to the Stark Law and that our three
physician joint ventures for long-term acute care hospitals
comply with the whole hospital exception to the Stark Law.
If any of our joint ventures were found to be in violation of
federal or state anti-kickback or physician referral laws, we
could be required to restructure them or refuse to accept
referrals from the physicians or hospitals with which we have
entered into a joint venture. We also could be required to repay
to Medicare amounts we have received pursuant to any prohibited
referrals, and we could suffer civil or criminal penalties,
including the loss of our licenses to operate and our ability to
participate in federal and state healthcare programs. If any of
our joint ventures were subject to any of these penalties, our
business could be damaged. In addition, our growth strategy is,
in part, based on the continued development of new joint
ventures with rural hospitals for the ownership and operation of
home nursing agencies. If the structure of any of these joint
ventures were found to violate federal or state anti-kickback
statutes or physician referral laws, we may be unable to
implement our growth strategy, which could have an adverse
impact on our future net income and consolidated results of
operations.
If we
are required to either repurchase or sell a substantial portion
of the equity interests in our joint ventures, our capital
resources and financial condition could be materially, adversely
impacted.
Upon the occurrence of fundamental changes to the laws and
regulations applicable to our joint ventures, or if a
substantial number of our joint venture partners were to
exercise the buy/sell provisions contained in many of our joint
venture agreements, we may be obligated to purchase or sell the
equity interests held by us or our joint venture partners. The
purchase price under these buy/sell provisions is typically
based on a multiple of the historical or projected earnings
before income taxes, depreciation and amortization of the joint
venture at the time the buy/sell option is exercised. In the
event the buy/sell provisions are exercised and we lack
sufficient capital to purchase the interest of our joint venture
partners, we may be obligated to sell our equity interest in
these joint ventures. If we are forced to sell our equity
interest, we will lose the benefit of those particular joint
venture operations. If these buy/sell provisions are exercised
and we choose to purchase
32
the interest of our joint venture partners, we may be obligated
to expend significant capital in order to complete such
acquisitions. If either of these events occur, our net service
revenue and net income could decline or we may not have
sufficient capital necessary to implement our growth strategy.
Shortages
in qualified nurses and other healthcare professionals could
increase our operating costs significantly or constrain our
ability to grow.
We rely on our ability to attract and retain qualified nurses
and other healthcare professionals. The availability of
qualified nurses nationwide has declined in recent years, and
competition for these and other healthcare professionals has
increased. Salary and benefit costs have risen accordingly. Our
ability to attract and retain these nurses and other healthcare
professionals depends on several factors, including our ability
to provide desirable assignments and competitive benefits and
salaries. We may not be able to attract and retain qualified
nurses or other healthcare professionals in the future. In
addition, the cost of attracting and retaining these
professionals and providing them with attractive benefit
packages may be higher than anticipated, which could cause our
net income to decline. Moreover, if we are unable to attract and
retain qualified professionals, the quality of services offered
to our patients may decline or our ability to grow may be
constrained.
The
loss of certain senior management could have a material adverse
effect on our operations and financial
performance.
Our success depends upon the continued employment of certain
members of our senior management, including our co-founder,
President, Chief Executive Officer and Chairman, Keith G. Myers,
our Executive Vice President, Chief Financial Officer and
Treasurer, Barry E. Stewart and our Executive Vice President,
Chief Operating Officer, Secretary and Director, John L. Indest.
We have entered into an employment agreement with each of these
officers in an effort to further secure their employment. The
loss of service of any of these officers could have a material
adverse effect on our operations if we were unable to find a
suitable replacement.
If we
are subject to substantial malpractice or other similar claims,
our net income could be materially, adversely
impacted.
The services we offer have an inherent risk of professional
liability and related, substantial damage awards. We and the
nurses and other healthcare professionals who provide services
on our behalf may be the subject of medical malpractice claims.
These nurses and other healthcare professionals could be
considered our agents and, as a result, we could be held liable
for their medical negligence. We cannot predict the effect that
any claims of this nature, regardless of their ultimate outcome,
could have on our business or reputation or on our ability to
attract and retain patients and employees. We maintain
malpractice liability insurance that provides primary coverage
on a claims-made basis of $1.0 million per incident and
$3.0 million in annual aggregate amounts. In addition, we
maintain multiple layers of umbrella coverage in the aggregate
amount of $10.0 million that provide excess coverage for
professional malpractice and other liabilities. We are
responsible for deductibles and amounts in excess of the limits
of our coverage. Claims that could be made in the future in
excess of the limits of such insurance, if successful, could
materially, adversely affect our ability to conduct business or
manage our assets. In addition, our insurance coverage may not
continue to be available to us at commercially reasonable rates,
in adequate amounts or on satisfactory terms.
The
application of state certificate of need and permit of approval
regulations and compliance with federal and state licensing
requirements could substantially limit our ability to operate
and grow our business.
Our ability to expand operations in a state will depend on our
ability to obtain a state license to operate. States may have a
limit on the number of licenses they issue. For example, as of
December 31, 2005 we operated 48 home nursing agencies in
Louisiana. Louisiana currently has a moratorium on the issuance
of new home nursing agency licenses through July 1, 2008.
We cannot predict whether this moratorium will be extended
beyond this date or whether any other states in which we
currently operate, or may wish to operate in the future, may
adopt a similar moratorium.
33
In addition to the moratorium imposed by the state of Louisiana,
nine of the states in which we currently operate, or plan to
operate in the future, require healthcare providers to obtain
prior approval, known as a certificate of need or a permit of
approval, for the purchase, construction or expansion of
healthcare facilities, to make certain capital expenditures or
to make changes in services or bed capacity. Of the states in
which we currently operate, or intend to operate in the future,
Alabama, Arkansas, Georgia, Kentucky, Mississippi, North
Carolina, South Carolina, Tennessee and West Virginia have
certificate of need or permit of approval laws. In granting
approval, these states consider the need in the service area for
additional or expanded healthcare facilities or services. The
failure to obtain any requested certificate of need, permit of
approval or other license could impair our ability to operate or
expand our business.
We
face competition, including from competitors with greater
resources, which may make it difficult for us to compete
effectively as a provider of post-acute healthcare
services.
We compete with local and regional home nursing and hospice
companies, hospitals, and other businesses that provide
post-acute healthcare services, some of which are large
established companies that have significantly greater resources
than we do. Our primary competition comes from local operators
in each of our markets. We expect our competitors to develop
joint ventures with providers, referral sources, and payors,
which could result in increased competition. The introduction by
our competitors of new and enhanced service offerings, in
combination with industry consolidation and the development of
competitive joint ventures, could cause a decline in net service
revenue, loss of market acceptance of our services, or make our
services less attractive. Future increases in competition from
existing competitors or new entrants may limit our ability to
maintain or increase our market share. We may not be able to
compete successfully against current or future competitors, and
competitive pressures may have a material, adverse impact on our
business, financial condition, or consolidated results of
operations.
If we
are unable to protect the proprietary nature of our software
systems and methodologies, our business and financial condition
could be harmed.
We have developed a proprietary software system, which we refer
to as our Service Value Point system that allows us to collect
assessment data, establish treatment plans, monitor patient
treatment, and evaluate our clinical and financial performance.
In addition, we rely on other proprietary methodologies or
information to which others may obtain access or independently
develop. To protect our proprietary information, we require
certain employees, consultants, financial advisors and strategic
partners to enter into confidentiality and non-disclosure
agreements. These agreements may not ultimately provide
meaningful protection for our proprietary information in the
event of any unauthorized use, misappropriation or disclosure.
If our competitors were able to replicate our Service Value
Point system, it could allow them to improve their operations
and thereby compete more effectively in the markets in which we
provide our services. If we are unable to protect the
proprietary nature of our Service Value Point system or our
other proprietary information or methodologies, our business and
financial performance could be harmed.
Failure
of, or problems with, our critical software or information
systems could harm our business and operating
results.
In addition to our Service Value Point system, our business is
substantially dependent on other non-proprietary software. We
utilize a third-party software information system for our
long-term acute care hospitals. Our various home nursing agency
databases were fully consolidated into an enterprise-wide system
during the first half of 2005. Problems with, or the failure of,
these systems could negatively impact our clinical performance
and our management and reporting capabilities. Any such problems
or failure could materially and adversely affect our operations
and reputation, result in significant costs to us, cause delays
in our ability to bill Medicare or other payors for our
services, or impair our ability to provide our services in the
future. The costs incurred in correcting any errors or problems
with regard to our proprietary and non-proprietary software may
be substantial and could adversely affect our net income.
Our information systems are networked via public network
infrastructure and standards based encryption tools that meet
regulatory requirements for transmission of protected healthcare
information over such
34
networks. However, threats from computer viruses, instability of
the public network on which our data transit relies, or other
instances that might render those networks unstable or disabled
would create operational difficulties for us, including the
ability to effectively transmit claims and maintain efficient
clinical oversight of our patients as well as the disruption of
revenue reporting and billing and collections management, which
could adversely affect our business or operations.
Future
acquisitions may be unsuccessful and could expose us to
unforeseen liabilities.
Our growth strategy involves the acquisition of home nursing
agencies in rural markets. These acquisitions involve
significant risks and uncertainties, including difficulties
integrating acquired personnel and other corporate cultures into
our business, the potential loss of key employees or patients of
acquired agencies, and the assumption of liabilities and
exposure to unforeseen liabilities of acquired agencies. We may
not be able to fully integrate the operations of the acquired
businesses with our current business structure in an efficient
and cost-effective manner. The failure to effectively integrate
any of these businesses could have a material adverse effect on
our operations.
We generally structure our acquisitions as asset purchase
transactions in which we expressly state that we are not
assuming any pre-existing liabilities of the seller and obtain
indemnification rights from the previous owners for acts or
omissions arising prior to the date of such acquisitions.
However, the allocation of liability arising from such acts or
omissions between the parties could involve the expenditure of a
significant amount of time, manpower and capital. Further, the
former owners of the agencies and facilities we acquire may not
have the financial resources necessary to satisfy our
indemnification claims relating to pre-existing liabilities. If
we were unsuccessful in a claim for indemnification from a
seller, the liability imposed could materially, adversely affect
our operations.
Our
acquisition and internal development activity may impose strains
on our existing resources.
We have grown significantly over the past four years. As we
continue to expand our markets, our growth could strain our
resources, including management, information and accounting
systems, regulatory compliance, logistics, and other internal
controls. Our resources may not keep pace with our anticipated
growth. If we do not manage our expected growth effectively, our
future prospects could be affected adversely.
We may
face increased competition for attractive acquisition and joint
venture candidates.
We intend to continue growing through the acquisition of
additional home nursing agencies and the formation of joint
ventures with rural hospitals for the operation of home nursing
agencies. We face competition for acquisition and joint venture
candidates, which may limit the number of acquisition and joint
venture opportunities available to us or lead to the payment of
higher prices for our acquisitions and joint ventures. Recently,
we have observed an increase in the acquisition prices for
select home nursing agencies. We cannot assure you that we will
be able to identify suitable acquisition or joint venture
opportunities in the future or that any such opportunities, if
identified, will be consummated on favorable terms, if at all.
Without successful acquisitions or joint ventures, our future
growth rate could decline. In addition, we cannot assure you
that any future acquisitions or joint ventures, if consummated,
will result in further growth.
We may
be unable to secure the additional capital necessary to
implement our growth strategy.
As of December 31, 2006, we had cash of $26.9 million.
Based on our current plan of operations, including acquisitions,
we believe this amount, when combined with a revolving line of
credit of approximately $22.5 million available under our
senior secured credit facility, which, subject to certain
conditions, may be increased to $25.0 million, will be
sufficient to fund our growth strategy and to meet our currently
anticipated operating expenses, capital expenditures and debt
service obligations for at least the next 12 months. If our
future net service revenue or cash flow from operations is less
than we currently anticipate, we may not have sufficient funds
to implement our growth strategy. Further, we cannot readily
predict the timing, size, and success of our acquisition and
internal development efforts and the associated capital
commitments. If we do
35
not have sufficient cash resources, our growth could be limited
unless we are able to obtain additional equity or debt financing.
We are
a holding company with no operations of our own.
We are a holding company with no operations of our own.
Accordingly, our ability to service our debt and pay dividends,
if any, is dependent upon the earnings from the business
conducted by our subsidiaries. The distributions of those
earnings or advances or other distributions of funds by these
subsidiaries to us are contingent upon the subsidiaries
earnings and are subject to various business considerations. In
addition, distributions by subsidiaries could be subject to
statutory restrictions, including state laws requiring that the
subsidiary be solvent, or contractual restrictions. If our
subsidiaries are unable to make sufficient distributions or
advances to us, we may not have the cash resources necessary to
service our debt or pay dividends.
Our
executive officers and directors and their affiliates hold a
substantial portion of our stock and could exercise significant
influence over matters requiring stockholder approval,
regardless of the wishes of other stockholders.
Our executive officers and directors, and individuals or
entities affiliated with them, beneficially own an aggregate of
approximately 22.7% of our outstanding common stock as of
December 31, 2006. The interests of these stockholders may
differ from your interests. If they were to act together, these
stockholders would be able to significantly influence all
matters that our stockholders vote upon, including the election
of directors, business combinations, the amendment of our
certificate of incorporation and other significant corporate
actions.
Certain
provisions of our charter, bylaws and Delaware law may delay or
prevent a change in control of our company.
Delaware law and our corporate documents contain provisions that
may enable our board of directors to resist a change in control
of our company. These provisions include:
|
|
|
|
|
a staggered board of directors;
|
|
|
|
limitations on persons authorized to call a special meeting of
stockholders;
|
|
|
|
the authorization of undesignated preferred stock, the terms of
which may be established and shares of which may be issued
without stockholder approval; and
|
|
|
|
advance notice procedures required for stockholders to nominate
candidates for election as directors or to bring matters before
an annual meeting of stockholders.
|
These anti-takeover defenses could discourage, delay or prevent
a transaction involving a change in control of our company.
These provisions could also discourage proxy contests and make
it more difficult for you and other stockholders to elect
directors of your choosing or cause us to take other corporate
actions you desire.
Our
stock price may be volatile and your investment in our common
stock could suffer a decline in value.
The price at which our common stock will trade may be volatile.
The stock market has from time to time experienced significant
price and volume fluctuations that have affected the market
prices of securities, particularly securities of healthcare
companies. The market price of our common stock may be
influenced by many factors, including:
|
|
|
|
|
our operating and financial performance;
|
|
|
|
variances in our quarterly financial results compared to
research analyst expectations;
|
|
|
|
the depth and liquidity of the market for our common stock;
|
|
|
|
future sales of our common stock or the perception that sales
could occur;
|
36
|
|
|
|
|
investor perception of our business, acquisitions and our
prospects;
|
|
|
|
developments relating to litigation or governmental
investigations;
|
|
|
|
changes or proposed changes in healthcare laws or regulations or
enforcement of these laws and regulations, or announcements
relating to these matters; or
|
|
|
|
general economic and stock market conditions.
|
In addition, the stock market, and the Nasdaq Global Market, or
Nasdaq, in particular, has experienced price and volume
fluctuations that have often been unrelated or disproportionate
to the operating performance of healthcare provider companies.
These broad market and industry factors may materially reduce
the market price of our common stock, regardless of our
operating performance. In the past, securities
class-action
litigation has often been brought against companies following
periods of volatility in the market price of their respective
securities. We may become involved in this type of litigation in
the future. Litigation of this type is often expensive to defend
and may divert the attention of our senior management as well as
resources from the operation of our business.
We
currently do not intend to pay dividends on our common stock
and, consequently, your only opportunity to achieve a return on
your investment is if the price of our common stock
appreciates.
We do not plan to declare dividends on shares of our common
stock in the foreseeable future. Further, our senior secured
credit facility imposes limits on our ability to pay dividends.
Consequently, your only opportunity to achieve a return on your
investment in our common stock will be if the market price of
our common stock appreciates and you sell your shares at a
profit. There is no guarantee that the price of our common stock
will ever exceed the price that you pay.
We
incur costs as a result of being a public company.
As a public company, we incur significant legal, accounting and
other expenses associated with our public company reporting
requirements and corporate governance requirements, including
requirements under the Sarbanes-Oxley Act of 2002, or
Sarbanes-Oxley, and the rules of the SEC and Nasdaq. We expect
these requirements to continue increasing our legal and
financial compliance costs and to make some activities more
time-consuming and costly. For example, we expect to continue
incurring significant costs in connection with the assessment of
our internal controls. We also expect these rules and
regulations may make it more expensive for us to obtain director
and officer liability insurance. We are currently evaluating and
monitoring developments with respect to these new rules, and we
cannot predict or estimate the amount of additional costs we may
incur or the timing of such costs.
If we
identify deficiencies in our internal control over financial
reporting, our business and our stock price could be adversely
affected.
Beginning with our annual report for the year ending
December 31, 2006, we are required to report on the
effectiveness of our internal control over financial reporting
as required by Section 404 of Sarbanes-Oxley. Under
Section 404, we are required to assess the effectiveness of
our internal control over financial reporting and report our
conclusion in our annual report. Our auditor is also required to
report its conclusion regarding the effectiveness of our
internal control over financial reporting. The existence of one
or more material weaknesses would require us and our auditor to
conclude that our internal control over financial reporting is
not effective. If there are identified deficiencies in our
internal control over financial reporting, we could be subject
to regulatory scrutiny and a loss of public confidence in our
financial reporting, which could have an adverse effect on our
business and our stock price.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
Not applicable.
37
As of December 31, 2006 we owned or managed 56 locations in
Louisiana, 23 in Mississippi, nine in Alabama, seven in Texas,
four in West Virginia, eight in Arkansas, 17 in Kentucky, six in
Florida, one in Tennessee, and one in Georgia. Our home office
is located in Lafayette, Louisiana in 19,159 square feet of
leased office space, under a lease that commenced on
March 1, 2004 and expires February 28, 2014.
Typically, our home nursing agencies are located in leased
facilities. Generally, the leases for our home nursing agencies
have initial terms of one year, but range from one to five
years. Most of the leases either contain multiple options to
extend the lease period in one-year increments or convert to a
month-to-month
lease upon the expiration of the initial term. Six of our
long-term acute care hospitals locations are hospitals within a
hospital, meaning we have a lease or sublease for space with the
host hospital. Generally, our leases or subleases for long-term
acute care hospitals have initial terms of five years, but range
from three to ten years. Most of our leases and subleases for
our long-term acute care hospitals contain multiple options to
extend the term in one-year increments.
|
|
Item 3.
|
Legal
Proceedings
|
We are involved in litigation and proceedings in the ordinary
course of our business. We do not believe that the outcome of
any of the matters in which we are currently involved,
individually or in the aggregate, will have a material adverse
effect upon our business, financial condition, or results of
operations.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
No matters were submitted to a vote of the Companys
stockholders during the fourth quarter of 2006.
PART II
|
|
Item 5.
|
Market
for Registrants Common Equity and Related Stockholder
Matters
|
Holders
The Companys common stock trades on the Nasdaq Global
Market under the symbol LHCG. As of March 12,
2007, there were approximately 93 registered holders of record
of the Companys common stock and the Company believes
there are approximately 8,650 beneficial holders.
Dividend
Policy
The Company has not paid any dividends on its common stock since
the initial public offering in 2005 and does not anticipate
paying dividends in the foreseeable future. We currently intend
to retain future earnings, if any, to support the development
and growth of our business. Payment of future dividends, if any,
will be at the discretion of our board of directors and subject
to any requirements under our then existing credit facility.
Price
Range of Common Stock
The following table provides the high and low prices of the
Companys Common Stock during 2006 and 2005 as quoted by
Nasdaq Global Market.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
2006
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
29.67
|
|
|
$
|
22.23
|
|
Third Quarter
|
|
|
24.78
|
|
|
|
18.70
|
|
Second Quarter
|
|
|
21.35
|
|
|
|
15.73
|
|
First Quarter
|
|
|
18.39
|
|
|
|
13.70
|
|
38
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
2005
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
17.46
|
|
|
$
|
14.79
|
|
Third Quarter
|
|
|
21.70
|
|
|
|
15.45
|
|
Second Quarter(1)
|
|
|
|
|
|
|
|
|
First Quarter(1)
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
LHC Group completed its initial public offering on June 14,
2005; therefore, there is no applicable price range for its
common stock for the first and second quarters of 2005. |
The closing price of our common stock as reported by Nasdaq on
March 12, 2007 was $29.50.
Performance
Graph
This item is incorporated by reference to our annual report to
stockholders for the fiscal year ended December 31, 2006.
Offering
Proceeds
The Company completed its initial public offering on
June 14, 2005. The net offering proceeds received by us,
after deducting the total expenses of $7,393,000 (including
$3,430,000 in underwriting discounts and commissions), were
approximately $41,607,000. As of December 31, 2006,
$21.9 million of the net offering proceeds have been used
to repay the following indebtedness: (1) $21.1 million
on the credit facility, bearing interest at prime plus 1.5% and
due April 10, 2010, with Residential Funding Corporation;
(2) $643,000 of outstanding obligations under our loan
agreement, bearing interest at 12.0% and due July 1, 2006,
with The Catalyst Fund, Ltd. and Southwest/Catalyst Capital,
Ltd.; and (3) approximately $178,000 of outstanding
indebtedness assumed by us in connection with acquisitions
completed by us in 2004. Additionally, $3.3 million has
been used to pay minority interest holders for their interests
and $14.0 million has been used to fund acquisitions since
the initial public offering.
On July 19, 2006, the Company closed its follow-on public
offering of 4,000,000 shares of common stock at a price of
$19.25 per share. Of the 4,000,000 shares of common
stock offered, 1,000,000 shares were offered by the
Company, with the remaining 3,000,000 shares of common
stock sold by the selling stockholders identified in the
prospectus supplement. The underwriters exercised an
over-allotment of an additional 600,000 shares, 150,000 of
which were sold by the Company. The additional net cash provided
to the Company from this offering after deducting expenses and
underwriting discounts and commissions amounted to approximately
$21 million.
On July 31, 2006, the Company used approximately
$14.7 million of the proceeds from its follow-on public
offering in order to acquire the Kentucky-based assets of
Lifeline Home Health Care, a privately-held company based in
Somerset, Kentucky.
39
|
|
Item 6.
|
Selected
Financial Data
|
The selected consolidated financial data presented below is
derived from our audited consolidated financial statements for
each of the years ended December 31, 2002 through
December 31, 2006. The financial data for the years ended
December 31, 2006, 2005 and 2004 should be read together
with our consolidated financial statements and related notes and
Managements Discussion and Analysis of Financial
Condition and Consolidated Results of Operations included
herein.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
|
(In thousands except share and per share data)
|
|
|
Consolidated Statements of
Income Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
215,248
|
|
|
$
|
152,711
|
|
|
$
|
116,090
|
|
|
$
|
68,515
|
|
|
$
|
47,373
|
|
Cost of service revenue
|
|
|
109,851
|
|
|
|
79,607
|
|
|
|
57,672
|
|
|
|
34,455
|
|
|
|
22,220
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
105,397
|
|
|
|
73,104
|
|
|
|
58,418
|
|
|
|
34,060
|
|
|
|
25,153
|
|
General and administrative expenses
|
|
|
71,125
|
|
|
|
45,663
|
|
|
|
35,168
|
|
|
|
23,411
|
|
|
|
15,778
|
|
Impairment loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31
|
|
|
|
|
|
Equity-based compensation expense(1)
|
|
|
|
|
|
|
3,856
|
|
|
|
1,788
|
|
|
|
864
|
|
|
|
124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
34,272
|
|
|
|
23,585
|
|
|
|
21,462
|
|
|
|
9,754
|
|
|
|
9,251
|
|
Interest expense
|
|
|
325
|
|
|
|
1,059
|
|
|
|
1,328
|
|
|
|
1,223
|
|
|
|
1,131
|
|
Non-operating (income) loss,
including gain on sale of assets
|
|
|
(2,033
|
)
|
|
|
(574
|
)
|
|
|
13
|
|
|
|
(106
|
)
|
|
|
(124
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes and minority interest and cooperative
endeavor allocations
|
|
|
35,980
|
|
|
|
23,100
|
|
|
|
20,121
|
|
|
|
8,637
|
|
|
|
8,245
|
|
Income tax expense
|
|
|
10,417
|
|
|
|
6,538
|
|
|
|
6,111
|
|
|
|
2,400
|
|
|
|
2,260
|
|
Minority interest and cooperative
endeavor allocations
|
|
|
4,795
|
|
|
|
4,545
|
|
|
|
4,158
|
|
|
|
2,837
|
|
|
|
2,699
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
20,768
|
|
|
|
12,017
|
|
|
|
9,852
|
|
|
|
3,400
|
|
|
|
3,285
|
|
Loss from discontinued operations,
net
|
|
|
(811
|
)
|
|
|
(1,915
|
)
|
|
|
(851
|
)
|
|
|
(557
|
)
|
|
|
(443
|
)
|
Gain on sale of discontinued
operations, net
|
|
|
637
|
|
|
|
|
|
|
|
312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
20,594
|
|
|
|
10,102
|
|
|
|
9,313
|
|
|
|
2,843
|
|
|
|
2,842
|
|
Change in the redemption value of
redeemable minority interests
|
|
|
1,163
|
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
stockholders
|
|
$
|
21,757
|
|
|
$
|
8,626
|
|
|
$
|
9,313
|
|
|
$
|
2,843
|
|
|
$
|
2,842
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share-basic(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.21
|
|
|
$
|
0.82
|
|
|
$
|
0.82
|
|
|
$
|
0.28
|
|
|
$
|
0.28
|
|
Loss from discontinued operations
|
|
|
(0.05
|
)
|
|
|
(0.13
|
)
|
|
|
(0.07
|
)
|
|
|
(0.04
|
)
|
|
|
(0.04
|
)
|
Gain on sale of discontinued
operations, net
|
|
|
0.04
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.20
|
|
|
|
0.69
|
|
|
|
0.77
|
|
|
|
0.24
|
|
|
|
0.24
|
|
Change in the redemption value of
redeemable minority interests
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
stockholders
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.77
|
|
|
$
|
0.24
|
|
|
$
|
0.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share-diluted(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.21
|
|
|
$
|
0.82
|
|
|
$
|
0.81
|
|
|
$
|
0.27
|
|
|
$
|
0.27
|
|
Loss from discontinued operations
|
|
|
(0.05
|
)
|
|
|
(0.13
|
)
|
|
|
(0.07
|
)
|
|
|
(0.04
|
)
|
|
|
(0.04
|
)
|
Gain on sale of discontinued
operations, net
|
|
|
0.04
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.20
|
|
|
|
0.69
|
|
|
|
0.76
|
|
|
|
0.23
|
|
|
|
0.23
|
|
Change in the redemption value of
redeemable minority interests
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
stockholders
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.76
|
|
|
$
|
0.23
|
|
|
$
|
0.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
17,090,583
|
|
|
|
14,628,737
|
|
|
|
12,085,154
|
|
|
|
12,085,154
|
|
|
|
11,926,226
|
|
Diluted
|
|
|
17,104,650
|
|
|
|
14,684,639
|
|
|
|
12,145,150
|
|
|
|
12,114,675
|
|
|
|
12,084,538
|
|
Cash dividends declared per common
share
|
|
|
|
|
|
|
.009
|
|
|
|
.039
|
|
|
|
.016
|
|
|
|
.013
|
|
40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
|
(In thousands)
|
|
|
Consolidated Balance Sheet
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
26,877
|
|
|
$
|
17,398
|
|
|
$
|
2,911
|
|
|
$
|
1,725
|
|
|
$
|
3,179
|
|
Total assets
|
|
|
152,694
|
|
|
|
104,418
|
|
|
|
47,519
|
|
|
|
27,915
|
|
|
|
21,485
|
|
Total debt
|
|
|
3,837
|
|
|
|
5,427
|
|
|
|
18,275
|
|
|
|
12,277
|
|
|
|
10,542
|
|
Total stockholders equity
|
|
|
121,889
|
|
|
|
78,444
|
|
|
|
16,351
|
|
|
|
6,909
|
|
|
|
3,593
|
|
|
|
|
(1) |
|
Equity-based compensation expense is allocated as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
|
(In thousands)
|
|
|
Cost of service revenue
|
|
$
|
|
|
|
$
|
565
|
|
|
$
|
58
|
|
|
$
|
5
|
|
|
$
|
|
|
General and administrative expenses
|
|
|
|
|
|
|
3,291
|
|
|
|
1,730
|
|
|
|
859
|
|
|
|
124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity-based compensation
expense
|
|
$
|
|
|
|
$
|
3,856
|
|
|
$
|
1,788
|
|
|
$
|
864
|
|
|
$
|
124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
All references to shares and per share amounts have been
retroactively restated to reflect our incorporation in the State
of Delaware and to give effect to a
three-for-two
stock split with respect to our common stock as if such events
occurred as of the beginning of the earliest period presented.
See Note 1 to our consolidated financial statements. |
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The following discussion and analysis contains
forward-looking statements about our plans and expectations of
what may happen in the future. Forward-looking statements are
based on a number of assumptions and estimates that are
inherently subject to significant risks and uncertainties, and
our results could differ materially from the results anticipated
by our forward-looking statements as a result of many known or
unknown factors, including, but not limited to, those factors
discussed on pages 27 to 37 under the heading Risk
Factors. Also, please read the cautionary notice regarding
forward-looking statements set forth at the beginning of this
annual report.
Please read the following discussion in conjunction with our
consolidated financial statements and the related notes
contained elsewhere in this annual report on
Form 10-K.
Overview
We provide post-acute healthcare services primarily to Medicare
beneficiaries in rural markets in the southern United States. We
provide these post-acute healthcare services through our home
nursing agencies, hospices, long-term acute care hospitals,
outpatient rehabilitation clinic, and a critical access
hospital. Since our founders began operations in 1994 with one
home nursing agency in Palmetto, Louisiana, we have grown to 132
locations in Louisiana, Mississippi, Alabama, Texas, West
Virginia, Arkansas, Kentucky, Florida, Tennessee, and Georgia as
of December 31, 2006.
Segments
We operate in two segments for financial reporting purposes:
home-based services and facility-based services. We derived
76.5%, 69.1% and 70.3% of our net service revenue during the
year ended December 31, 2006, 2005, and 2004, respectively,
from our home-based services segment and derived the balance of
our net service revenue from our facility-based services segment.
Through our home-based services segment we offer a wide range of
services, including skilled nursing, private duty nursing,
physical, occupational, and speech therapy, medically-oriented
social services, and hospice care. As of December 31, 2006,
we owned and operated 106 home nursing locations, six hospices,
a
41
diabetes self management company, and a home health pharmacy. Of
our 114 home-based services locations, 78 are wholly-owned by us
and 36 are majority-owned or controlled by us through joint
ventures. We also manage the operations of four home nursing
agencies and one hospice in which we have no ownership interest.
We intend to increase the number of home nursing agencies that
we operate through continued acquisition and development,
primarily in underserved rural markets, as we implement our
growth strategy. As we acquire and develop home nursing
agencies, we anticipate the percentage of our net service
revenue and operating income derived from our home-based
services segment will increase.
We provide facility-based services principally through our
long-term acute care hospitals and outpatient rehabilitation
clinics. As of December 31, 2006, we owned and operated
four long-term acute care hospitals with seven locations, of
which all but one are located within host hospitals. We also
owned and operated an outpatient rehabilitation clinic, a
critical access hospital, a pharmacy, a medical equipment
company, a health club, and provided contract rehabilitation
services to third parties. Of these 12 facility-based services
locations, six are wholly-owned by us and six are majority-owned
or controlled by us through joint ventures. We also manage the
operations of one inpatient rehabilitation facility in which we
have no ownership interest. Because of the recent changes in the
regulations applicable to long-term acute care hospitals
operated as hospitals within hospitals, we do not intend to
expand the number of hospital within a hospital long-term acute
care hospitals that we operate. Due to our emphasis on expansion
through the acquisition and development of home nursing
agencies, we anticipate that the percentage of our net service
revenue and operating income derived from our facility-based
segment will decline.
Development
Activities
From January 1, 2002 through December 31, 2006, we
acquired all or a majority of the economic interests in 62 home
nursing agencies for a total consideration of approximately
$36.9 million: eight in Louisiana, seven in Alabama, 14 in
Mississippi, six in Texas, one in Arkansas, 16 in Kentucky, six
in Florida, one in Tennessee, one in Georgia, and two in West
Virginia. During this same period, we also internally developed
22 home nursing agencies: ten in Louisiana, and 12 in
Mississippi. Also from January 1, 2002 through
December 31, 2006, we acquired all or a majority of the
economic interests in six hospices, three located in Louisiana,
two located in Arkansas, and one located in West Virginia, for
approximately $362,000.
From January 1, 2002 through December 31, 2006, we
acquired all or a majority of the economic interests in two
long-term acute care hospital locations and three outpatient
rehabilitation clinics located in Louisiana for approximately
$3.6 million. During this same period, we internally
developed four long-term acute care hospital locations, one
short-term acute care hospital, two inpatient rehabilitation
facilities and two outpatient rehabilitation clinics located in
Louisiana. During 2005, we converted the short-term acute care
hospital and inpatient rehabilitation facilities to long-term
acute care hospitals. Since January 2002, we have expanded the
number of licensed beds at our long-term acute care hospital
locations facilities from 22 beds to 156 beds as of
December 31, 2006.
In February 2004, we sold three hospices, two in Louisiana and
one in Mississippi and one home nursing agency in Louisiana for
$500,000. Also in February 2004, we sold one inpatient
rehabilitation facility located in Louisiana for $129,000 and
closed one outpatient rehabilitation clinic and one long-term
acute care hospital, both located in Louisiana. In October 2004,
we closed one home nursing agency and one outpatient
rehabilitation clinic. In December 2004, we closed one home
nursing agency.
In March 2006, we sold one home nursing agency in Louisiana for
$240,000. In April 2006, we sold one outpatient rehabilitation
clinic for a promissory note totaling $946,000 and closed
another. Both were located in Louisiana. In May 2006, we sold
one Long-Term Acute Care Hospital located in Louisiana for
$1.2 million. Typically, we sold or closed these locations
because they were not performing according to our expectations.
42
The following table is a summary of our acquisitions,
divestitures and internal development activities from
January 1, 2002 through December 31, 2006. This table
does not include the six management services agreements under
which we manage the operations of four home nursing agencies,
one hospice and one inpatient rehabilitation facility.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Acute Care
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospitals, Critical
|
|
|
Specialty and
|
|
|
|
|
|
|
|
|
|
Access Hospitals
|
|
|
Outpatient
|
|
|
|
Home Nursing
|
|
|
|
|
|
and Inpatient
|
|
|
Rehabilitation
|
|
Year
|
|
Agencies
|
|
|
Hospices
|
|
|
Rehabilitation Facilities
|
|
|
Clinics
|
|
|
Total at January 1, 2002
|
|
|
26
|
|
|
|
3
|
|
|
|
1
|
|
|
|
1
|
|
Developed
|
|
|
1
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
Acquired
|
|
|
7
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at January 1, 2003
|
|
|
34
|
|
|
|
4
|
|
|
|
3
|
|
|
|
1
|
|
Developed
|
|
|
7
|
|
|
|
1
|
|
|
|
2
|
|
|
|
2
|
|
Acquired
|
|
|
2
|
|
|
|
1
|
|
|
|
2
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at January 1, 2004
|
|
|
43
|
|
|
|
6
|
|
|
|
7
|
|
|
|
4
|
|
Developed
|
|
|
7
|
|
|
|
|
|
|
|
2
|
|
|
|
2
|
|
Acquired
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
Divested/Closed
|
|
|
(3
|
)
|
|
|
(3
|
)
|
|
|
(2
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at January 1, 2005
|
|
|
53
|
|
|
|
3
|
|
|
|
7
|
|
|
|
7
|
|
Converted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
Developed
|
|
|
2
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
Acquired
|
|
|
16
|
|
|
|
1
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at January 1, 2006
|
|
|
71
|
|
|
|
4
|
|
|
|
9
|
|
|
|
8
|
|
Developed
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired
|
|
|
31
|
|
|
|
2
|
|
|
|
|
|
|
|
1
|
|
Divested/Closed
|
|
|
(1
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2006
|
|
|
106
|
|
|
|
6
|
|
|
|
8
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recent
Developments
Medicare
Home-Based Services. The base payment rate for
Medicare home nursing in 2006 was $2,264 per
60-day
episode. Since the inception of the prospective payment system
in October 2000, the base episode rate payment has varied due to
both the impact of annual market basket based increases and
Medicare-related legislation. The passage of the MMA resulted in
two changes in Medicare reimbursement. First, for episodes ended
on or after April 1, 2004 through December 31, 2006,
the base episode rate increase (3.6%) was reduced by 0.8% to
2.8%. Secondly, a 5.0% payment increase was provided for
services furnished in a non-Metropolitan Statistical Area, or
MSA, setting for episodes ending on or after April 1, 2004
and before April 1, 2005. Approximately 55.4%, 46.3%, and
41.8%, respectively, of our net service revenue for the year
ended December 31, 2006, 2005, and 2004 was derived from
patients who reside in non-MSAs.
Home health payment rates are updated annually by either the
full home health market basket percentage, or by the home health
market basket percentage as adjusted by Congress. CMS
establishes the home health market basket index, which measures
inflation in the prices of an appropriate mix of goods and
services included in home health services.
On November 1, 2006, CMS released the final rule updating
the home health perspective payment systems for calendar year
2007. The rule finalizes the market basket increase of 3.3%, a
0.2% increase over the proposed rule. This equates to a 3.1%
update for urban HHAs and a 3.6% update for rural HHAs after
43
accounting for changes in the wage index. The update increases
the national
60-day
episode payment rate for urban home health agencies from the
current level of $2,264.38 to $2,339.00. Under the final rule,
HHAs will get the full home health market basket as long as they
submit required quality data using the OASIS. With some limited
exceptions, if an HHA does not provide this data, then its home
health market basket update of 3.3% will be reduced by two
percentage points. The final rule discontinues the temporary 5%
add-on payment for rural HHAs in 2007, except for episodes that
begin before January 1, 2007. The final rule does not
modify the current case-mix methodology for 2007.
In August 2006, CMS announced the payment rates for hospice care
furnished from October 1, 2006 through September 30,
2007. These rates are 3.4% higher more than the rates for the
previous year. In addition, CMS announced that the hospice cap
amount for the year ending October 31, 2006 is $20,585.
Facility-Based Services. Under the long-term
acute care hospital prospective payment system implemented on
October 1, 2002, each patient discharged from our long-term
acute care hospitals is assigned a long-term care
diagnosis-related group. CMS establishes these long-term care
diagnosis-related groups by categorizing diseases by diagnosis,
reflecting the amount of resources needed to treat a given
disease. For each patient, we are paid a pre-determined fixed
amount applicable to the particular long-term care
diagnosis-related group to which that patient is assigned.
Effective for discharges on or after October 1, 2006, CMS
has published the new relative weights applicable to the
long-term care diagnosis-related group system. In addition, on
May 12, 2006 CMS published a final rule maintaining the
standard federal rate at $38,086.04 and the budget neutrality
factor at 0, while decreasing the cost outlier fixed loss
threshold to $14,877. These updates became effective
July 1, 2006 and will apply through June 30, 2007.
CMS has also stated its intention to develop long-term acute
care hospital patient-specific criteria to refine the definition
of such facilities. To this end, CMS awarded a contract to RTI
for the purpose of evaluating patient and facility level
characteristics for long-term care hospitals in order to
differentiate the role of long-term acute care hospitals from
general acute care hospitals. RTI recently released its study
results, many of which are similar to MedPACs findings
released in a 2004 report. Like MedPAC, RTI recommended the
development and use of facility and patient criteria as a method
of ensuring that patients admitted to LTACHs are medically
complex and have a good chance of improvement. Also, while
MedPAC recommended that QIOs review LTACH admissions for medical
necessity and monitor whether facilities comply with the
criteria, RTI recommended that CMS clarify QIO roles in
overseeing the appropriateness of LTACH admissions.
Additionally, RTI examined several key issues that MedPAC had
not yet researched. The RTI report is advisory in nature, and it
is uncertain which, if any, of its recommendations will be
enacted, many of which require Congressional approval.
Under Medicare, we are reimbursed for rehabilitation services
based on a fee schedule for services provided adjusted by the
geographical area in which the facility is located. Outpatient
therapy services are subject to an annual cap of $1,780 per
beneficiary effective January 1, 2007. The Deficit
Reduction Act of 2005 and the Tax Relief and Health Care Act of
2006 provided for an exceptions process that
effectively prevents application of the caps. The exceptions
process ends January 1, 2008. We are unable to predict
whether Congress will extend the exceptions process for 2008. We
cannot assure you that one or more of our outpatient
rehabilitation clinics will not exceed the caps in the future.
Office
of Inspector General
OIG has a responsibility to report both to the Secretary of the
Department of Health and Human Services and to Congress any
program and management problems related to programs such as
Medicare. The OIGs duties are carried out through a
nationwide network of audits, investigations and inspections.
Each year, the OIG outlines areas it intends to study relating
to a wide range of providers. In fiscal year 2007, the OIG
indicated its intent to study topics relating to, among others,
home health, hospice, long-term care hospitals, and certain
outpatient rehabilitation services. No estimate can be made at
this time regarding the impact, if any, of the OIGs
findings.
44
Components
of Expenses
Cost
of Service Revenue
Our cost of service revenue consists primarily of the following
expenses incurred by our clinical and clerical personnel in our
agencies and facilities:
|
|
|
|
|
salaries and related benefits;
|
|
|
|
transportation, primarily mileage reimbursement; and
|
|
|
|
supplies and services, including payments to contract therapists.
|
General
and Administrative Expenses
Our general and administrative expenses consist primarily of the
following expenses incurred by our home office and
administrative field personnel:
|
|
|
|
|
salaries and related benefits;
|
|
|
|
insurance;
|
|
|
|
costs associated with advertising and other marketing
activities; and
|
|
|
|
rent and utilities;
|
|
|
|
|
|
accounting, legal and other professional services; and
|
|
|
|
office supplies;
|
|
|
|
|
|
Depreciation; and
|
|
|
|
Provision for bad debts.
|
Equity-Based
Compensation Expense
Under our KEEP Plan certain of our employees were granted KEEP
Units. The KEEP Units, which have no exercise price, vest over a
five-year period. The KEEP Units function as stock appreciation
rights whereby an individual is entitled to receive, on a per
unit basis, the increase in estimated fair value, as determined
by us, of our units from the date of grant until the date upon
which the employee dies, retires or is terminated for any reason
other than cause. Accordingly, the KEEP Units are subject to
variable accounting until such time as the obligation to the
employee is settled. Upon completion of the initial public
offering at a price of $14.00 per share, all obligations
relating to our KEEP Units were settled by conversion into
shares of our common stock and we incurred a final,
non-recurring equity-based compensation charge in the amount of
approximately $3.4 million ($1.7 million net of taxes).
Our equity-based compensation expense is allocated to our
home-based and facility-based services segments in accordance
with our home office allocation, which is calculated based on
the percentage of our net service revenue contributed by each
segment during the applicable period.
45
2006 and
2005 Operational Data
The following table sets forth, for the period indicated, data
regarding admissions and Medicare admissions to our home-based
segment and patient days and outpatient visits for our
facility-based segment. Certain historical data has been
restated in order to present a more comparative analysis of the
statistical data.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Year Ended
|
|
|
|
March 31, 2006
|
|
|
June 30, 2006
|
|
|
September 30, 2006
|
|
|
December 31, 2006
|
|
|
December 31, 2006
|
|
|
Home-Based Services
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average census
|
|
|
9,138
|
|
|
|
9,807
|
|
|
|
13,029
|
|
|
|
14,073
|
|
|
|
12,982
|
|
Average Medicare census
|
|
|
7,251
|
|
|
|
7,944
|
|
|
|
9,537
|
|
|
|
10,429
|
|
|
|
9,573
|
|
Admissions
|
|
|
5,570
|
|
|
|
5,852
|
|
|
|
7,377
|
|
|
|
8,173
|
|
|
|
26,972
|
|
Medicare admissions
|
|
|
4,018
|
|
|
|
4,210
|
|
|
|
5,225
|
|
|
|
5,685
|
|
|
|
19,138
|
|
Facility-Based Services
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days
|
|
|
11,699
|
|
|
|
11,110
|
|
|
|
11,674
|
|
|
|
10,978
|
|
|
|
45,461
|
|
Outpatient visits
|
|
|
8,775
|
|
|
|
5,157
|
|
|
|
4,287
|
|
|
|
2,907
|
|
|
|
21,126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Year Ended
|
|
|
|
March 31, 2005
|
|
|
June 30, 2005
|
|
|
September 30, 2005
|
|
|
December 31, 2005
|
|
|
December 31, 2005
|
|
|
Home-Based Services
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average census
|
|
|
7,078
|
|
|
|
7,229
|
|
|
|
7,501
|
|
|
|
8,376
|
|
|
|
7,515
|
|
Average Medicare census
|
|
|
5,738
|
|
|
|
6,020
|
|
|
|
6,271
|
|
|
|
6,785
|
|
|
|
6,177
|
|
Admissions
|
|
|
4,215
|
|
|
|
4,069
|
|
|
|
4,266
|
|
|
|
4,404
|
|
|
|
16,954
|
|
Medicare admissions
|
|
|
3,284
|
|
|
|
2,983
|
|
|
|
3,153
|
|
|
|
3,225
|
|
|
|
12,645
|
|
Facility-Based Services
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days
|
|
|
10,376
|
|
|
|
10,519
|
|
|
|
11,437
|
|
|
|
12,353
|
|
|
|
44,685
|
|
Outpatient visits
|
|
|
11,485
|
|
|
|
11,639
|
|
|
|
9,768
|
|
|
|
8,985
|
|
|
|
41,877
|
|
46
Consolidated
Results of Operations
The following table sets forth, for the periods indicated,
certain items included in our consolidated statement of income
as a percentage of our net service revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Net service revenue
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Cost of service revenue
|
|
|
51.0
|
|
|
|
52.1
|
|
|
|
49.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
49.0
|
|
|
|
47.9
|
|
|
|
50.3
|
|
General and administrative expenses
|
|
|
33.1
|
|
|
|
29.9
|
|
|
|
30.3
|
|
Equity-based compensation expense
|
|
|
|
|
|
|
2.5
|
|
|
|
1.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
15.9
|
|
|
|
15.5
|
|
|
|
18.5
|
|
Interest expense
|
|
|
.2
|
|
|
|
0.7
|
|
|
|
1.1
|
|
Non-operating income, including
gain on sales of assets
|
|
|
(0.9
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
Income tax expense
|
|
|
4.8
|
|
|
|
4.3
|
|
|
|
5.3
|
|
Minority interest and cooperative
endeavor allocations
|
|
|
2.2
|
|
|
|
3.0
|
|
|
|
3.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
9.6
|
%
|
|
|
7.9
|
%
|
|
|
8.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth, for the periods indicated, net
service revenue, cost of service revenue, general and
administrative expenses, equity-based compensation expense and
operating income by segment. The table also includes data
regarding total admissions and total Medicare admissions for our
home-based services segment and patient days and outpatient
visits for our facility-based services segment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands, except for admissions, patient day and
outpatient visit data)
|
|
|
Home-Based Services
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
164,701
|
|
|
$
|
105,587
|
|
|
$
|
81,624
|
|
Cost of service revenue
|
|
|
79,070
|
|
|
|
51,254
|
|
|
|
39,402
|
|
General and administrative expenses
|
|
|
55,700
|
|
|
|
33,650
|
|
|
|
25,227
|
|
Equity-based compensation expense
|
|
|
|
|
|
|
2,699
|
|
|
|
1,252
|
|
Operating income
|
|
|
29,931
|
|
|
|
17,984
|
|
|
|
15,743
|
|
Average census
|
|
|
12,982
|
|
|
|
7,515
|
|
|
|
5,653
|
|
Average Medicare census
|
|
|
9,573
|
|
|
|
6,177
|
|
|
|
4,460
|
|
Total admissions
|
|
|
26,972
|
|
|
|
16,954
|
|
|
|
15,601
|
|
Total Medicare admissions
|
|
|
19,138
|
|
|
|
12,645
|
|
|
|
11,531
|
|
Facility-Based Services
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
50,547
|
|
|
$
|
47,124
|
|
|
$
|
34,466
|
|
Cost of service revenue
|
|
|
30,781
|
|
|
|
28,353
|
|
|
|
18,270
|
|
General and administrative expenses
|
|
|
15,425
|
|
|
|
12,013
|
|
|
|
9,941
|
|
Equity-based compensation expense
|
|
|
|
|
|
|
1,157
|
|
|
|
536
|
|
Operating income
|
|
|
4,341
|
|
|
|
5,601
|
|
|
|
5,719
|
|
Patient days
|
|
|
45,461
|
|
|
|
44,685
|
|
|
|
32,023
|
|
Outpatient visits
|
|
|
21,126
|
|
|
|
41,877
|
|
|
|
28,092
|
|
47
Year
Ended December 31, 2006 Compared to Year Ended
December 31, 2005
Net
Service Revenue
Net service revenue for the year ended December 31, 2006
was $215.2 million, an increase of $62.5 million, or
41.0%, from $152.7 million in 2005. For the year ended
December 31, 2006 and 2005, 81.6% and 85.6%, respectively,
of net service revenue was derived from Medicare. For the year
ended December 31, 2006, home-based services accounted for
76.5% of revenue and facility-based services was 23.5% of
revenue compared with 69.1% and 30.9%, respectively, for the
comparable prior year period.
Home-Based Services. Net service revenue from
the home-based services for the year ended December 31,
2006 was $164.7 million, an increase of $59.1 million,
or 56.0%, from $105.6 million for the year ended
December 31, 2005. Organic growth in this service sector
was approximately $35.0 million, or 34.5%, during the
period. Total admissions increased 59.1% to 26,972 during the
period, versus 16,954 for the same period in 2005. Organic
growth in admissions was 22.8%. Average home-based patient
census for the year ended December 31, 2006, increased
72.7% to 12,982 patients as compared with
7,515 patients for the year ended December 31, 2005.
Organic growth in home-based patient census was 42.9%.
Approximately $26.2 million of the increase in net service
revenue was attributable to acquisition or internal development
activity during 2005. An additional $24.0 million increase
in net service revenue was attributable to acquisition or
internal development activity during 2006. The remaining
increase of approximately $8.9 million reflects our
internal growth. The increase in net service revenue from
internal growth resulted in part from a 42.9% increase in
organic census from 6,645 in the year ended December 31,
2005 to 9,497 in the year ended December 31, 2006.
Improvements in case mix and an increase in therapy utilization
within our home health episodes also contributed to the increase.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
2006
|
|
|
%
|
|
|
2005
|
|
|
2006
|
|
|
%
|
|
|
2005
|
|
|
2006
|
|
|
%
|
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Growth
|
|
|
Admits
|
|
|
Admits
|
|
|
Growth
|
|
|
Census
|
|
|
Census
|
|
|
Growth
|
|
|
Organic
|
|
$
|
101,464
|
|
|
$
|
136,508
|
|
|
|
34.5
|
%
|
|
|
15,279
|
|
|
|
18,755
|
|
|
|
22.8
|
%
|
|
|
6,645
|
|
|
|
9,497
|
|
|
|
42.9
|
%
|
Acquired
|
|
$
|
4,123
|
|
|
$
|
28,193
|
|
|
|
583.8
|
%
|
|
|
1,675
|
|
|
|
8,217
|
|
|
|
390.6
|
%
|
|
|
870
|
|
|
|
3,485
|
|
|
|
300.6
|
%
|
Total
|
|
$
|
105,587
|
|
|
$
|
164,701
|
|
|
|
56.0
|
%
|
|
|
16,954
|
|
|
|
26,972
|
|
|
|
59.1
|
%
|
|
|
7,515
|
|
|
|
12,982
|
|
|
|
72.7
|
%
|
Facility-Based Services. Net service revenue
from the facility-based services for the year ended
December 31, 2006, increased $3.4 million, or 7.3%, to
$50.5 million compared with $47.1 million for the year
ended December 31, 2005. Organic growth made up the total
growth in this service sector during the period. The increase in
net service revenue was due in part to an increase in patient
days of 1.7% to 45,461 in the year ended December 31, 2006,
from 44,685 in the year ended December 31, 2005. Outpatient
visits decreased 50.0% to 21,126 at December 31, 2006,
compared with 41,877 for the year ended December 31, 2005,
due to the sale of one of our outpatient clinics and the closure
of another clinic on April 1, 2006. Approximately
$2.1 million of the increase in net service revenue was
attributable to acquisition activity during 2005. The remaining
increase of approximately $1.3 million reflects our
internal growth.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
2006
|
|
|
%
|
|
|
Patient
|
|
|
Patient
|
|
|
%
|
|
|
2005
|
|
|
2006
|
|
|
%
|
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Growth
|
|
|
Days
|
|
|
Days
|
|
|
Growth
|
|
|
Discharges
|
|
|
Discharges
|
|
|
Growth
|
|
|
Organic
|
|
$
|
46,190
|
|
|
$
|
50,547
|
|
|
|
9.4
|
%
|
|
|
44,381
|
|
|
|
45,461
|
|
|
|
2.4
|
%
|
|
|
1,596
|
|
|
|
1,763
|
|
|
|
10.5
|
%
|
Acquired
|
|
$
|
934
|
|
|
$
|
|
|
|
|
(100.0
|
)%
|
|
|
304
|
|
|
|
|
|
|
|
(100.0
|
)%
|
|
|
42
|
|
|
|
|
|
|
|
(100.0
|
)%
|
Total
|
|
$
|
47,124
|
|
|
$
|
50,547
|
|
|
|
7.3
|
%
|
|
|
44,685
|
|
|
|
45,461
|
|
|
|
1.7
|
%
|
|
|
1,638
|
|
|
|
1,763
|
|
|
|
7.6
|
%
|
Cost
of Service Revenue
Cost of service revenue for the year ended December 31,
2006 was $109.9 million, an increase of $30.2 million,
or 38.0%, from $79.6 million for the year ended
December 31, 2005. Cost of service revenue represented
approximately 51.0% and 52.1% of our net service revenue for the
years ended December 31, 2006 and 2005, respectively.
Home-Based Services. Cost of service revenue
from the home-based services for the year ended
December 31, 2006 was $79.0 million, an increase of
$27.8 million, or 54.3%, from $51.3 million for the
year ended December 31, 2005. Approximately
$23.0 million of this increase resulted from an increase in
salaries
48
and benefits, of which $12.0 million was incurred as a
result of acquisition or development activity during 2005 and
$12.5 million was incurred as a result of acquisition or
development activity during 2006. Salaries and benefits expense
due to internal growth decreased approximately
$1.5 million. Supplies and services expense and
transportation expense contributed $2.7 million and
$2.1 million, respectively, to the increase in cost of
service revenue. Cost of service revenue in the home-based
segment for the year ended December 31, 2006 represented
48.0% of our net service revenue compared to 48.5% during the
year ended December 31, 2005.
Facility-Based Services. Cost of service
revenue from the facility-based services for the year ended
December 31, 2006 was $30.8 million, an increase of
$2.4 million, or 8.6%, from $28.4 million for the year
ended December 31, 2005. Approximately $1.9 million of this
increase resulted from an increase in salaries and benefits. Of
this increase in salaries and benefits, $1.3 million was
incurred as a result of acquisition and internal development
activity during 2005. The increase in salaries and benefits
expense from internal growth within our facility-based services
segment amounted to $600,000. Supplies and services expense
contributed approximately $489,000 of the increase in cost of
service revenue which while transportation expense contributed
approximately $82,000. Cost of service revenue in the
facility-based segment for the year ended December 31, 2006
represented 60.9% of our net service revenue compared to 60.2%
during the year ended December 31, 2005.
General
and Administrative Expenses
General and administrative expenses for the year ended
December 31, 2006 were $71.1 million, an increase of
$25.4 million, or 55.8%, from $45.7 million for the
year ended December 31, 2005. General and administrative
expenses represented approximately 33.1% and 29.9% of our net
service revenue for the years ended December 31, 2006 and
2005, respectively.
Home-Based Services. General and
administrative expenses from the home-based services for the
year ended December 31, 2006 were $55.7 million, an
increase of $22.0 million, or 65.5%, from
$33.7 million for the year ended December 31, 2005.
Approximately $10.3 million of this increase was
attributable to acquisition or internal development activity
during 2005. Internal growth accounted for approximately
$4.4 million and the remaining $7.3 million of the
increase in general and administrative expense was due to
acquisition and internal development activity during the 2006
period. Included in these increases is an increase to bad debt
expense of $800,000 related to receivables acquired in business
combinations in late 2005 and 2006. General and administrative
expenses in the home-based segment for the year ended
December 31, 2006 represented 33.8% of our net service
revenue compared to 31.9% during the year ended
December 31, 2005.
Facility-Based Services. General and
administrative expenses from the facility-based services for the
year ended December 31, 2006 were $15.4 million, an
increase of $3.4 million, or 28.3%, from $12.0 million
for the year ended December 31, 2005. Approximately
$1.7 million of the increase was attributable to the
increased acquisition and internal development activity during
the 2005 period and the remaining $1.7 million increase is
due to internal growth. General and administrative expenses in
the facility-based segment for the year ended December 31,
2006 represented 30.5% of our net service revenue compared to
25.5% during the year ended December 31, 2005.
Equity-Based
Compensation Expense
There was no Equity-based compensation expense for the year
ended December 31, 2006. Equity-based compensation expense
for the year ended December 31, 2005 was $3.9 million.
This was related to the
mark-to-market
valuation adjustment for the KEEP Units in conjunction with the
initial public offering. Of the $3.9 million expense we
incurred in the year ended December 31, 2005, approximately
$565,000 was attributable to cost of service revenue and
$3.3 million attributable to general and administrative
expenses.
Non-operating
income
Non-operating income for the year ended December 31, 2006
was $2.0 million, an increase of $1.4 million from
$600,000 for the year ended December 31, 2005. The increase
in non-operating income is due primarily
49
to $1.0 in proceeds received from the life insurance policy on
our former CFO who unexpectedly died in a plane crash after
retiring from the Company.
Income
Tax Expense
The effective tax rates for the years ended December 31,
2006 and 2005 were 33.4% and 34.7%, respectively. The effective
tax rate for the year ended December 31, 2006 decreased due
to $1.0 million credit related to the Gulf Opportunity Act.
The effective tax rate for the year ended December 31, 2005
was effected by an income tax benefit of $342,000 related to a
$900,000 equity-based compensation charge stemming from shares
issued by one of the Companys principal shareholders to an
officer of the Company in 2001. At the time, the Company did not
believe it would be able to deduct the equity-based compensation
charge for income tax purposes. In conjunction with the initial
public offering, the Company determined that it would be able to
deduct the $900,000 equity-based compensation charge and as a
result, has recognized an income tax benefit associated with
that charge of $342,000.
Minority
Interest and Cooperative Endeavor Allocations
The minority interest and cooperative endeavor allocations
expense for the year ended December 31, 2006 was
$4.8 million, an increase of $300,000, compared to
$4.5 million for the year ended December 31, 2005.
Minority interest and cooperative endeavor expense varies
depending on the operations of each joint venture.
Year
Ended December 31, 2005 Compared to Year Ended
December 31, 2004
Net
Service Revenue
Net service revenue for the year ended December 31, 2005
was $152.7 million, an increase of $36.6 million, or
31.5%, from $116.1 million in 2004. For the year ended
December 31, 2005 and 2004, 85.6% and 86.3%, respectively,
of net service revenue was derived from Medicare. For the year
ended December 31, 2005, home-based services accounted for
69.1% of revenue and facility-based services was 30.9% of
revenue compared with 70.3% and 29.7%, respectively, for the
comparable prior year period.
Home-Based Services. Net service revenue from
the home-based services for the year ended December 31,
2005 was $105.6 million, an increase of $24.0 million,
or 29.4%, from $81.6 million for the year ended
December 31, 2004. Organic growth in this service sector
was approximately $22.0 million, or 27.7%, during the
period. Total admissions increased 8.7% to 16,954 during the
period, versus 15,601 for the same period in 2004. Organic
growth in admissions was 1.2%. Average home-based patient census
for the year ended December 31, 2005, increased 32.9% to
7,515 patients as compared with 5,653 patients for the
year ended December 31, 2004. Organic growth in home-based
patient census was 23.3%. Approximately $5.8 million of the
increase in net service revenue was attributable to acquisition
or internal development activity during 2004. An additional
$7.1 million increase in net service revenue was
attributable to acquisition or internal development activity
during 2005. The remaining increase of approximately
$11.1 million reflects our internal growth. The increase in
net service revenue from internal growth resulted in part from a
23.3% increase in organic census from 5,389 in the year ended
December 31, 2004 to 6,645 in the year ended
December 31, 2005.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004
|
|
|
2005
|
|
|
%
|
|
|
2004
|
|
|
2005
|
|
|
%
|
|
|
2004
|
|
|
2005
|
|
|
%
|
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Growth
|
|
|
Admits
|
|
|
Admits
|
|
|
Growth
|
|
|
Census
|
|
|
Census
|
|
|
Growth
|
|
|
Organic
|
|
$
|
79,486
|
|
|
$
|
101,464
|
|
|
|
27.7
|
%
|
|
|
15,098
|
|
|
|
15,279
|
|
|
|
1.2
|
%
|
|
|
5,389
|
|
|
|
6,645
|
|
|
|
23.3
|
%
|
Acquired
|
|
$
|
2,138
|
|
|
$
|
4,123
|
|
|
|
92.8
|
%
|
|
|
503
|
|
|
|
1,675
|
|
|
|
233.0
|
%
|
|
|
264
|
|
|
|
870
|
|
|
|
229.5
|
%
|
Total
|
|
$
|
81,624
|
|
|
$
|
105,587
|
|
|
|
29.4
|
%
|
|
|
15,601
|
|
|
|
16,954
|
|
|
|
8.7
|
%
|
|
|
5,653
|
|
|
|
7,515
|
|
|
|
32.9
|
%
|
Facility-Based Services. Net service revenue
from facility-based services for the year ended
December 31, 2005, increased $12.7 million, or 36.7%,
to $47.1 million compared with $34.5 million for the
year ended December 31, 2004. Organic growth in this
service sector was approximately $12.9 million, or 38.7%,
during the period. The increase in net service revenue resulted
in part from a 24.8% increase in the aggregate number of
licensed beds at our long-term acute care hospitals and
inpatient rehabilitation facilities from 137
50
beds at December 31, 2004 to 171 beds at December 31,
2005. Additionally, patient days increased 39.5% from 32,023 in
the year ended December 31, 2004 to 44,685 in the year
ended December 31, 2005. Outpatient visits increased 49.1%
to 41,877 at December 31, 2005, compared with 28,092 for the
year ended December 31, 2004, due to the acquisition of two
outpatient clinics in 2004. Approximately $8.9 million of
the increase in net service revenue was attributable to
acquisition activity during 2004 while $0.9 million was
attributable to acquisition activity during 2005. The remaining
increase of approximately $2.8 million reflects our
internal growth.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004
|
|
|
2005
|
|
|
%
|
|
|
Patient
|
|
|
Patient
|
|
|
%
|
|
|
2004
|
|
|
2005
|
|
|
%
|
|
|
|
Revenue
|
|
|
Revenue
|
|
|
Growth
|
|
|
Days
|
|
|
Days
|
|
|
Growth
|
|
|
Discharges
|
|
|
Discharges
|
|
|
Growth
|
|
|
Organic
|
|
$
|
33,310
|
|
|
$
|
46,190
|
|
|
|
38.7
|
%
|
|
|
32,023
|
|
|
|
44,381
|
|
|
|
38.6
|
%
|
|
|
783
|
|
|
|
1,596
|
|
|
|
103.8
|
%
|
Acquired
|
|
$
|
1,156
|
|
|
$
|
934
|
|
|
|
(19.2
|
)%
|
|
|
|
|
|
|
304
|
|
|
|
|
%
|
|
|
|
|
|
|
42
|
|
|
|
|
%
|
Total
|
|
$
|
34,466
|
|
|
$
|
47,124
|
|
|
|
36.7
|
%
|
|
|
32,023
|
|
|
|
44,685
|
|
|
|
39.5
|
%
|
|
|
783
|
|
|
|
1,638
|
|
|
|
109.2
|
%
|
Cost
of Service Revenue
Cost of service revenue for the year ended December 31,
2005 was $79.6 million, an increase of $21.9 million,
or 38.0%, from $57.7 million for the year ended
December 31, 2004. Cost of service revenue represented
approximately 52.1% and 49.7% of our net service revenue for the
years ended December 31, 2005 and 2004, respectively.
Home-Based Services. Cost of service revenue
from the home-based services for the year ended
December 31, 2005 was $51.3 million, an increase of
$11.9 million, or 30.1%, from $39.4 million for the
year ended December 31, 2004. Approximately
$9.4 million of this increase resulted from an increase in
salaries and benefits, of which $2.4 million was incurred
as a result of acquisition or development activity during 2004.
The increase in salaries and benefits expense due to internal
growth accounted for approximately $2.5 million of the
increase in this category. The remaining increase in salaries
and benefits expense was attributable to 2005 acquisitions of
$4.5 million. Supplies and services expense and
transportation expense contributed $1.1 million and
$1.4 million, respectively, to the increase in cost of
service revenue. Cost of service revenue for the year ended
December 31, 2005 represented 48.5% of our net service
revenue compared to 48.3% during the year ended
December 31, 2004.
Facility-Based Services. Cost of service
revenue from the facility-based services for the year ended
December 31, 2005 was $28.4 million, an increase of
$10.1 million, or 55.2%, from $18.3 million for the
year ended December 31, 2004. Approximately
$7.0 million of this increase resulted from an increase in
salaries and benefits. Of this increase in salaries and
benefits, $3.3 million was incurred as a result of
acquisition and internal development activity during 2004 and
$300,000 from acquisition and internal development activity in
2005. The increase in salaries and benefits expense from
internal growth within our facility-based services segment
amounted to $3.4 million. Supplies and services expense
contributed approximately $3.4 million of the increase in
cost of service revenue which was offset by a $300,000 decrease
in transportation expense. Cost of service revenue for the year
ended December 31, 2005 represented 60.2% of our net
service revenue compared to 53.0% during the year ended
December 31, 2004.
General
and Administrative Expenses
General and administrative expenses for the year ended
December 31, 2005 were $45.7 million, an increase of
$10.5 million, or 29.8%, from $35.2 million for the
year ended December 31, 2004. General and administrative
expenses represented approximately 29.9% and 30.3% of our net
service revenue for the years ended December 31, 2005 and
2004, respectively.
Home-Based Services. General and
administrative expenses from the home-based services for the
year ended December 31, 2005 were $33.7 million, an
increase of $8.4 million, or 33.4%, from $25.2 million
for the year ended December 31, 2004. Approximately
$2.1 million of this increase was attributable to
acquisition or internal development activity during 2004.
Internal growth accounted for approximately $3.7 million
and the remaining $2.6 million of the increase in general
and administrative expense was due to acquisition and
51
internal development activity during the 2005 period. Included
in these increases is an increase to bad debt expense of
$1.2 million to provide for receivables that aged during
our billing system conversion. General and administrative
expenses in the home-based segment for the year ended
December 31, 2005 represented 31.9% of our net service
revenue compared to 30.9% during the year ended
December 31, 2004.
Facility-Based Services. General and
administrative expenses from the facility-based services for the
year ended December 31, 2005 were $12.0 million, an
increase of $2.1 million, or 20.8%, from $9.9 million
for the year ended December 31, 2004. The majority, or
$2.9 million, of the increase was attributable to the
increased acquisition and internal development activity during
the 2004 period. Acquisition and internal development activity
during the 2005 period accounted for $400,000 of the increase.
These increases were offset by a decrease in internal growth of
$1.2 million due to cost-cutting measures. General and
administrative expenses in the facility-based segment for the
year ended December 31, 2005 represented 25.5% of our net
service revenue compared to 28.8% during the year ended
December 31, 2004.
Equity-Based
Compensation Expense
Equity-based compensation expense for the year ended
December 31, 2005 was $3.9 million, an increase of
approximately $2.1 million from $1.8 million for the
year ended December 31, 2004. This increase was related to
the
mark-to-market
valuation adjustment for the KEEP Units in conjunction with the
initial public offering. Of the $3.9 million expense we
incurred in the year ended December 31, 2005, approximately
$565,000 was attributable to cost of service revenue and
$3.3 million attributable to general and administrative
expenses.
Income
Tax Expense
The effective tax rates for the years ended December 31,
2005 and 2004 were 34.7% and 38.3%, respectively. The effective
tax rate for the year ended December 31, 2005 decreased due
to the Company recording an income tax benefit of $342,000
related to a $900,000 equity-based compensation charge stemming
from shares issued by one of the Companys principal
shareholders to an officer of the Company in 2001. At the time,
the Company did not believe it would be able to deduct the
equity-based compensation charge for income tax purposes. In
conjunction with the initial public offering, the Company
determined that it would be able to deduct the $900,000
equity-based compensation charge and as a result, has recognized
an income tax benefit associated with that charge of $342,000.
Minority
Interest and Cooperative Endeavor Allocations
The minority interest and cooperative endeavor allocations
expense for the year ended December 31, 2005 was
$4.5 million, an increase of $500,000, compared to
$4.0 million for the year ended December 31, 2004.
Minority interest and cooperative endeavor expense varies
depending on the operations of each joint venture.
Liquidity
and Capital Resources
Our principal source of liquidity for our operating activities
is the collection of our accounts receivable, most of which are
collected from governmental and third party commercial payors.
Our reported cash flows from operating activities are impacted
by various external and internal factors, including the
following:
|
|
|
|
|
Operating Results Our net income has a
significant impact on our operating cash flows. Any significant
increase or decrease in our net income could have a material
impact on our operating cash flows.
|
|
|
|
Start Up Costs Following the completion of an
acquisition, we generally incur substantial start up costs in
order to implement our business strategy. There is generally a
delay between our expenditure of these start up costs and the
increase in net service revenue, and subsequent cash
collections, which adversely affects our cash flows from
operating activities.
|
52
|
|
|
|
|
Timing of Payroll Our employees are paid
bi-weekly on Fridays; therefore, operating cash flows decline in
reporting periods that end on a Friday. Conversely, for those
reporting periods ending on a day other than Friday, our cash
flows are higher because we have not yet paid our payroll.
|
|
|
|
Medical Insurance Plan Funding We are self
funded for medical insurance purposes. Any significant changes
in the amount of insurance claims submitted could have a direct
impact on our operating cash flows.
|
|
|
|
Medical Supplies A significant expense
associated with our business is the cost of medical supplies.
Any increase in the cost of medical supplies, or in the use of
medical supplies by our patients, could have a material impact
on our operating cash flows.
|
Cash used in investing activities is primarily for acquisitions
of home nursing agencies, while cash provided by financing
activities is derived from the proceeds from our issuance of
common stock.
Operating activities during the year ended December 31,
2006 provided $21.8 million in cash compared to
$6.8 million for year ended December 31, 2005. Net
income provided cash of $20.6 million. Non-cash items such
as depreciation and amortization, provision for bad debts,
equity-based compensation, directors restricted stock
expense, minority interest in earnings of subsidiaries, deferred
income taxes and gain on sale of assets totaled
$10.1 million. Changes in operating assets and liabilities,
excluding cash, offset these non-cash charges.
Days sales outstanding, or DSO, for the year ended
December 31, 2006, was 68 days compared with
65 days for the same period in 2005. DSO, when adjusted for
acquisitions and unbilled accounts receivables, was
59 days. The adjustment takes into account
$6.1 million of unbilled receivables that the Company is
delayed in billing at this time due to the lag time in receiving
the change of ownership after acquiring companies. For the
comparable period in 2005, adjusted DSO was 60 days, taking
into account $2.3 million in unbilled accounts receivable.
Investing activities used $27.5 million and
$12.5 million in cash for the year ended December 31,
2006 and 2005, respectively. In the year ended December 31,
2006, cash provided by investing activities was
$1.4 million from the sale of an extended care operation
and a home nursing agency, offset in part by cash used of
$3.9 million for the purchases of property and equipment
and $25.0 million in the cost of acquisitions.
Financing activities provided for $15.2 million and $20.3
in the year ended December 31, 2006 and 2005, respectively.
Cash provided by financing activities in the year ended
December 31, 2006 included $21.0 million in proceeds
from the follow-on public offering. This increase was offset by
cash used in financing activities in the year ended
December 31, 2006 which included net principal payments on
debt and capital leases of $1.6 million, offering costs
incurred of $300,000 and minority interest distributions of
$4.2 million.
At December 31, 2006, we had working capital of
$68.4 million compared to $49.2 million at
December 31, 2005, an increase of $19.2 million. This
increase in working capital was due primarily to proceeds from
the follow-on public offering and increases in accounts
receivable due to increased revenue.
Offering
Proceeds
The Company completed its initial public offering on
June 14, 2005. The net offering proceeds received by us,
after deducting the total expenses of $7,393,000 (including
$3,430,000 in underwriting discounts and commissions), were
approximately $41,607,000. As of December 31, 2006,
$21.9 million of the net offering proceeds have been used
to repay the following indebtedness: (1) $21.1 million
on the credit facility, bearing interest at prime plus 1.5% and
due April 10, 2010, with Residential Funding Corporation;
(2) $643,000 of outstanding obligations under our loan
agreement, bearing interest at 12.0% and due July 1, 2006,
with The Catalyst Fund, Ltd. and Southwest/Catalyst Capital,
Ltd.; and (3) approximately $178,000 of outstanding
indebtedness assumed by us in connection with acquisitions
completed by us in 2004. Additionally, $3.3 million has
been used to pay minority interest holders for their interests
and $14.0 million has been used to fund acquisitions since
the initial public offering.
53
On July 19, 2006, the Company closed its follow-on public
offering of 4,000,000 shares of common stock at a price of
$19.25 per share. Of the 4,000,000 shares of common
stock offered, 1,000,000 shares were offered by the
Company, with the remaining 3,000,000 shares of common
stock sold by the selling stockholders identified in the
prospectus supplement. The underwriters exercised an
over-allotment of an additional 600,000 shares, 150,000 of
which were sold by the Company. The additional net cash provided
to the Company from this offering after deducting expenses and
underwriting discounts and commissions amounted to approximately
$21 million.
On July 31, 2006, the Company used approximately
$14.7 million of the proceeds from its follow on public
offering in order to acquire the Kentucky-based assets of
Lifeline Home Health Care, a privately-held company based in
Somerset, Kentucky.
Indebtedness
Our total long-term indebtedness was $3.8 million at
December 31, 2006 and $5.4 million at
December 31, 2005, respectively, including the current
portions of $700,000 and $1.8 million. In April 2005, we
entered into an amended and restated senior secured credit
facility with Residential Funding Corporation due April 15,
2010. We, together with certain of our subsidiaries, may become
borrowers under the credit facility. Our obligations and the
obligations of our subsidiary borrowers under our credit
facility agreement are secured by a lien on substantially all of
our assets (including the capital stock or other forms of
ownership interests we hold in our subsidiaries and affiliates)
and the assets of those subsidiaries and affiliates.
Our credit facility makes available to us up to
$22.5 million in revolving loans. The total availability
may be increased up to a maximum of $25.0 million, subject
to certain terms and conditions. Total availability under our
credit facility may be limited from time to time based on the
value of our receivables. As of December 31, 2006, we had
no outstanding balance under our credit facility.
Interest on outstanding borrowings under our credit facility
accrues at a variable base rate (based on Wells Fargo
Banks prime rate or the federal funds rate), plus a margin
of 1.5%.
Our credit facility contains customary affirmative, negative and
financial covenants. For example, we are restricted in incurring
additional debt, disposing of assets, making investments,
allowing fundamental changes to our business or organization,
and making certain payments in respect of stock or other
ownership interests, such as dividends and stock repurchases.
Financial covenants include requirements that we maintain: a
debt to EBITDA ratio of no greater than 1.5 to 1.0 and a fixed
charge coverage ratio of not less than 1.4 to 1.0.
Our credit facility also contains customary events of default.
These include bankruptcy and other insolvency events,
cross-defaults to other debt agreements, a change in control
involving us or any subsidiary guarantor (other than due to this
offering), and the failure to comply with certain covenants.
Contingent
Convertible Minority Interests
During 2004, in conjunction with the acquisition/sale of joint
venture interests, the Company entered into agreements with
minority interest holders in three of its majority owned
subsidiaries that allowed these minority interest holders to put
their minority interests to the Company in the event the Company
is sold, merged or otherwise acquired or completes an initial
public offering (IPO). These put options were deemed
to be part of the underlying minority interest shares, thus
rendering the shares to be puttable shares. In September and
November of 2004, the Company entered into forward exchange
contracts with the minority interest holders in two of these
subsidiaries, Acadian Home Health Care Services, LLC
(Acadian) and Hebert, Thibodeaux, Albro and Touchet
Therapy Group, Inc. (Hebert) which required the
minority interest holders in these subsidiaries to sell their
interests to the Company in the event of an IPO. In conjunction
with the Companys IPO, the forward exchange contracts were
consummated and the minority interest holders of Acadian and
Hebert sold their minority interests to the Company in exchange
for cash and shares of the Companys common stock. The
Company had accrued the cash payment of approximately
$2.2 million to be paid under these forward exchange
contracts. Since the IPO, this amount has been paid in full.
54
In the third majority owned subsidiary, St. Landry Extended Care
Hospital, (St. Landry), the put option allows the
minority interest holders to convert their minority interests
into shares of the Company based upon St. Landrys
EBITDA for the prior fiscal year in relation to the
Companys EBITDA over the same period. The put option
became exercisable by the minority interest holders in St.
Landry upon the completion of the IPO. However, due to
applicable laws and regulations, the minority interest holders
can not convert their minority interests in St. Landry
unless certain conditions are met including, but not limited to,
the Company having stockholders equity in excess of
$75 million at the end of its most recent fiscal year or on
average during the previous three fiscal years. If the St.
Landry minority interest holders do not or are unable to convert
their minority interests into shares of the Company, the
minority interest holders shall have the option to redeem their
minority interests at any time following thirty days after the
IPO for cash consideration equal to the value of the shares the
minority interest holders would have received if they had
converted their minority interests into shares of the Company
multiplied by the average closing price of the Companys
shares for the thirty days preceding the date of the minority
interest holders exercise of the redemption option. As of
December 31, 2006, the Company has exceeded
$75 million in stockholders equity. As of
March 14, 2007, approximately 76.5% of the doctors have
converted their minority interests to cash.
The above put/redemption options and exchange agreements have
been presented in the historical financial statements under the
guidance in Accounting Series Release (ASR) No. 268
and EITF Topic D-98, which generally require a public
companys stock subject to redemption requirements that are
outside the control of the issuer to be excluded from the
caption stockholders equity and presented
separately in the issuers balance sheet. Under EITF Topic
D-98, once it becomes probable that the minority interest would
become redeemable, the minority interest should be adjusted to
its current redemption amount. As noted above, the St. Landry
put option allowed the minority interest holders in St.
Landrys to have their interests redeemed for cash upon the
completion of the IPO, and therefore, the Company recorded an
adjustment of approximately $1.5 million to minority
interests subject to exchange contracts
and/or put
options and to retained earnings which represents the redemption
value of St. Landrys interests at June 30, 2005. In
September 2005, certain minority interest holders redeemed their
interests in St. Landrys. This resulted in a cash payment
of approximately $214,000. In connection with the partial
redemption of certain minority interest in September 2005, we
decreased our minority interests by approximately $149,000 and
increased our retained earnings by the same amount.
Simultaneously, we recorded goodwill of $214,000 to represent
the value of the minority interests redeemed. Also at the end of
the September 30, 2005 quarter, we recorded a mark to
market charge of $404,000.
In November 2005, the agreement was amended to allow minority
interest holders to redeem their minority interests based on the
St. Landrys rolling twelve month EBITDA in relation to the
Companys EBITDA over the same period. At December 31,
2005, the Company recorded an additional mark to market benefit
of $266,000 to mark the liability to redemption value at the end
of the quarter.
In connection with the partial redemption of certain minority
interest in the year ended December 31, 2006, we decreased
one minority interest by approximately $1.0 million and
increased our retained earnings by the same amount.
Simultaneously, we recorded goodwill of $979,000 to represent
the value of the minority interest redeemed. Also for the year
ended December 31, 2006, we recorded a
mark-to-market
benefit of $124,000.
55
Commitments
The following table discloses aggregate information about our
contractual obligations and the periods in which payments are
due as of December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment due by period
|
|
|
|
|
|
|
Less Than
|
|
|
|
|
|
|
|
|
More Than
|
|
Contractual Cash Obligation
|
|
Total
|
|
|
1 Year
|
|
|
1-3 Years
|
|
|
3-5 Years
|
|
|
5 Years
|
|
|
|
(In thousands)
|
|
|
Long-term debt (includes line of
credit)
|
|
$
|
3,479
|
|
|
$
|
428
|
|
|
$
|
854
|
|
|
$
|
534
|
|
|
$
|
1,663
|
|
Capital lease obligations
|
|
|
358
|
|
|
|
211
|
|
|
|
147
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
|
12,849
|
|
|
|
5,191
|
|
|
|
5,263
|
|
|
|
1,420
|
|
|
|
975
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual cash obligations
|
|
$
|
16,686
|
|
|
$
|
5,830
|
|
|
$
|
6,264
|
|
|
$
|
1,954
|
|
|
$
|
2,638
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Off-Balance
Sheet Arrangements
We do not currently have any off-balance sheet arrangements with
unconsolidated entities or financial partnerships, such as
entities often referred to as structured finance or special
purpose entities, which would have been established for the
purpose of facilitating off-balance sheet arrangements or other
contractually narrow or limited purposes. In addition, we do not
engage in trading activities involving non-exchange traded
contracts. As such, we are not materially exposed to any
financing, liquidity, market or credit risk that could arise if
we had engaged in these relationships.
Critical
Accounting Policies
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements and the reported revenue and expenses
during the reported period. Actual results could differ from
those estimates. Changes in the accounting estimates are
reasonably likely to occur from period to period. Accordingly,
actual results could differ materially from our estimates. To
the extent that there are material differences between these
estimates and actual results, our financial condition or results
of operations will be affected. We base our estimates on past
experience and other assumptions that we believe are reasonable
under the circumstances, and we evaluate these estimates on an
ongoing basis. We refer to accounting estimates of this type as
critical accounting policies and estimates, which we discuss
further below.
Principles
of Consolidation
Our consolidated financial statements include all subsidiaries
and entities controlled by us. We define control as
ownership of a majority of the voting interest of an entity. Our
consolidated financial statements also include entities in which
we absorb a majority of the entitys expected losses,
receive a majority of the entitys expected residual
returns, or both, as a result of ownership, contractual or other
financial interests in the entity.
The decision to consolidate or not consolidate an entity would
not impact our earnings, as we would include our portion of
these entities profits and losses either through
consolidation or the equity method of accounting if we did not
consolidate.
All significant intercompany accounts and transactions have been
eliminated in consolidation. Business combinations accounted for
as purchases have been included in the consolidated financial
statements from the respective dates of acquisition.
56
The following table summarizes the percentage of net service
revenue earned by type of ownership or relationship we had with
the operating entity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Wholly owned subsidiaries
|
|
|
39.2
|
%
|
|
|
33.6
|
%
|
|
|
41.7
|
%
|
Equity joint ventures
|
|
|
45.7
|
|
|
|
50.1
|
|
|
|
40.3
|
|
Cooperative endeavors
|
|
|
1.5
|
|
|
|
2.0
|
|
|
|
5.3
|
|
License leasing arrangements
|
|
|
11.0
|
|
|
|
11.4
|
|
|
|
11.1
|
|
Management services
|
|
|
2.6
|
|
|
|
2.9
|
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following discussion sets forth our consolidation policy
with respect to our equity joint ventures, cooperative
endeavors, license leasing arrangements and management services
agreements.
Equity
Joint Ventures
Our equity joint ventures are structured as limited liability
companies in which we typically own a majority equity interest
ranging from 51.0% to 99.0%. Each member of all but one of our
equity joint ventures participates in profits and losses in
proportion to their equity interests. We have one equity joint
venture partner whose participation in losses is limited. We
consolidate these entities, as we absorb a majority of the
entities expected losses, receive a majority of the
entities expected residual returns and generally have
voting control.
Cooperative
Endeavors
We have arrangements with certain partners that involve the
sharing of profits and losses. Unlike our equity joint ventures,
we own 100.0% of the equity interests in our cooperative
endeavors. In these cooperative endeavors, we possess interests
in the net profits and losses ranging from 67.0% to 70.0%. We
have one cooperative endeavor partner whose participation in
losses is limited. We consolidate these entities, as we own
100.0% of the outstanding equity interests, absorb a majority of
the entities expected losses and receive a majority of the
entities expected residual returns.
License
Leasing Arrangements
We lease, through our wholly-owned subsidiaries, home health
licenses necessary to operate certain of our home nursing
agencies. As with our wholly owned subsidiaries, we own 100.0%
of the equity interests of these entities and consolidate them
based on such ownership, as well as our right to receive a
majority of the entities expected residual returns and our
obligation to absorb a majority of the entities expected
losses.
Management
Services
We have various management services agreements under which we
manage certain operations of agencies and facilities. We do not
consolidate these agencies or facilities, as we do not have an
equity interest and do not have a right to receive a majority of
the agencies or facilities expected residual returns
or an obligation to absorb a majority of the agencies or
facilities expected losses.
Revenue
Recognition
We report net service revenue at the estimated net realizable
amount due from Medicare, Medicaid, commercial insurance,
managed care payors, patients, and others for services rendered.
Under Medicare, our home nursing patients are classified into a
home health resource group prior to the receipt of services.
Based on this home health resource group we are entitled to
receive a prospective Medicare payment for delivering care over
a 60 day period. Medicare adjusts these prospective
payments based on a variety of factors, such as low utilization,
patient transfers, changes in condition and the level of
services provided. In calculating our reported net service
revenue from our home nursing services, we adjust the
prospective Medicare payments by
57
an estimate of the adjustments. We calculate the adjustments
based on a rolling average of these types of adjustments for
claims paid during the preceding three months. Historically we
have not made any material revisions to reflect differences
between our estimate of the Medicare adjustments and the actual
Medicare adjustments. For our home nursing services, we
recognize revenue based on the number of days elapsed during the
episode of care.
Under Medicare, patients in our long-term acute care facilities
are classified into long-term care diagnosis-related groups.
Based on this classification, we are then entitled to receive a
fixed payment from Medicare. This fixed payment is also subject
to adjustment by Medicare due to factors such as short stays. In
calculating our reported net service revenue for services
provided in our long-term acute care hospitals, we reduce the
prospective payment amounts by an estimate of the adjustments.
We calculate the adjustment based on a historical average of
these types of adjustments for claims paid during the preceding
three months. For our long-term acute care hospitals we
recognize revenue as services are provided.
For hospice services we are paid by Medicare under a prospective
payment system. We receive one of four predetermined daily or
hourly rates based upon the level of care we furnish. We record
net service revenue from our hospice services based on the daily
or hourly rate. We recognize revenue for hospice as services are
provided.
Under Medicare we are reimbursed for our rehabilitation services
based on a fee schedule for services provided adjusted by the
geographical area in which the facility is located. We recognize
revenue as these services are provided.
Our Medicaid reimbursement is based on a predetermined fee
schedule applied to each service we provide. Therefore, we
recognize revenue for Medicaid services as services are provided
based on this fee schedule. Our managed care payors reimburse us
in a manner similar to either Medicare or Medicaid. Accordingly,
we recognize revenue from our managed care payors in the same
manner as we recognize revenue from Medicare or Medicaid.
We record management services revenue as services are provided
in accordance with the various management services agreements to
which we are a party. The agreements generally call for us to
provide billing, management, and other consulting services
suited to and designed for the efficient operation of the
applicable home nursing agency or inpatient rehabilitation
facility. We are responsible for the costs associated with the
locations and personnel required for the provision of the
services. We are generally compensated based on a percentage of
net billings or an established base fee. In addition, for
certain of the management agreements, we may earn incentive
compensation.
Accounts
Receivable and Allowances for Uncollectible
Accounts
We report accounts receivable net of estimated allowances for
uncollectible accounts and adjustments. Accounts receivable are
uncollateralized and primarily consist of amounts due from
third-party payors and patients who receive final bills once all
documentation is completed. Using detailed accounts receivable
aging reports produced by our billing system, our collections
department monitors and pursues payment. We have adopted a
charity care policy that provides the criteria a patient must
meet in order to be considered indigent and his or her balance
considered for write-off. All other accounts that are deemed
uncollectible are turned over to an outside collection agency
for further collection efforts. To provide for accounts
receivable that could become uncollectible in the future, we
establish an allowance for uncollectible accounts to reduce the
carrying amount of such receivables to their estimated net
realizable value. The credit risk for concentrations of
receivables is limited due to the significance of Medicare as
the primary payor. The amount of the provision for bad debts is
based upon our assessment of historical and expected net
collections, business and economic conditions, trends in
government reimbursement and other collection indicators.
A portion of the estimated Medicare prospective payment system
reimbursement from each submitted home nursing episode is
received in the form of a request for accelerated payment, or
RAP, before all services are rendered. The estimated episodic
payment is billed at the commencement of the episode. We receive
a RAP for 60.0% of the estimated reimbursement at the initial
billing for the initial episode of care per patient
58
and the remaining reimbursement is received upon completion of
the episode. For any subsequent episodes of care contiguous with
the first episode of care for a patient we receive a RAP for
50.0% of the estimated reimbursement at initial billing. The
remaining 50.0% reimbursement is received upon completion of the
episode. We have earned net service revenue in excess of
billings rendered to Medicare. Only a nominal portion of the
amounts due to the Medicare program represent cash collected in
advance of providing services.
Our Medicare population is paid at a prospectively set amount
that can be determined at the time services are rendered. Our
Medicaid reimbursement is based on a predetermined fee schedule
applied to each individual service we provide. Our managed care
contracts are structured similar to either the Medicare or
Medicaid payment methodologies. Because of our payor mix, we are
able to calculate our actual amount due at the patient level and
adjust the gross charges down to the actual amount at the time
of billing. This negates the need for an estimated contractual
allowance to be booked at the time we report net service revenue
for each reporting period.
At December 31, 2006, our allowance for uncollectible
accounts, as a percentage of patient accounts receivable, was
approximately 10.3%. For the year ended December 31, 2006,
the provision for doubtful accounts increased to 2.2% of net
service revenue compared to 2.1% of net service revenue for the
same period in 2005. Adverse changes in general economic
conditions, billing operations, payor mix, or trends in federal
or state governmental coverage could affect our collection of
accounts receivable, cash flows and results of operations.
The following table sets forth our aging of accounts receivable
(based on the billing date) as of December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payor
|
|
0-30
|
|
|
31-60
|
|
|
61-90
|
|
|
91-120
|
|
|
121-150
|
|
|
151+
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Medicare
|
|
$
|
15,944
|
|
|
$
|
2,516
|
|
|
$
|
1,688
|
|
|
$
|
1,581
|
|
|
$
|
1,587
|
|
|
$
|
6,379
|
|
|
$
|
29,695
|
|
Medicaid
|
|
|
1,740
|
|
|
|
1,058
|
|
|
|
666
|
|
|
|
585
|
|
|
|
633
|
|
|
|
2,843
|
|
|
|
7,525
|
|
Other
|
|
|
2,947
|
|
|
|
1,799
|
|
|
|
1,980
|
|
|
|
1,366
|
|
|
|
1,091
|
|
|
|
9,395
|
|
|
|
18,578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
20,631
|
|
|
$
|
5,373
|
|
|
$
|
4,334
|
|
|
$
|
3,532
|
|
|
$
|
3,311
|
|
|
$
|
18,617
|
|
|
$
|
55,798
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
and Intangible Assets
Goodwill and other intangible assets with indefinite lives are
reviewed annually, or more frequently if circumstances indicate
impairment may have occurred.
The Company estimates the fair value of its identified reporting
units and compares those estimates against the related carrying
value. For each of the reporting units, the estimated fair value
is determined based on a multiple of earnings before interest,
taxes, depreciation, and amortization or on the estimated fair
value of assets in situations when it is readily determinable.
Included in intangible assets are other intangible assets such
as licenses to operate home-based
and/or
facility-based services and trade names. The Company has valued
these intangible assets separately from goodwill for each
acquisition completed during the year ended December 31,
2006. The Company has concluded that these licenses and trade
names have indefinite lives, as management has determined that
there are no legal, regulatory, contractual, economic or other
factors that would limit the useful life of these intangible
assets and the Company intends to renew and operate the licenses
and uses these trade names indefinitely. Prior to
January 1, 2006, the Company elected to recognize the fair
value of indefinite-lived licenses and trade names together with
goodwill as a single asset for financial reporting purposes.
Components of the Companys home nursing operating segment
are generally represented by individual subsidiaries or joint
ventures with individual licenses to conduct specific operations
within geographic markets as limited by the terms of each
license. Components of the Companys facility-based
services are represented by individual operating entities.
Effective January 1, 2004, management began aggregating the
components of these two segments into two reporting units for
purposes of evaluating impairment. Prior to January 1,
2004, management evaluated each operating entity separately for
impairment. Modifications to the Companys management of
the segments and reporting provided management with a basis to
change the reporting unit structure.
59
Recently
Issued Accounting Pronouncements
In December 2004, the FASB issued SFAS No. 123
(revised 2004), Share-Based Payment, which is a revision
of SFAS No. 123, Accounting for Stock-Based
Compensation. SFAS No. 123(R) supersedes APB
Opinion No. 25, Accounting for Stock Issued to
Employees, and amends SFAS No. 95, Statement of
Cash Flows. Generally the approach in
SFAS No. 123(R) is similar to the approach described
in SFAS No. 123. However, SFAS No. 123(R)
requires all share-based payments to employees, including grants
of employee stock options, to be recognized in the income
statement based on their fair values. Pro forma disclosure is no
longer an alternative.
We adopted SFAS No. 123(R) on January 1, 2006
using the modified prospective method in which compensation cost
is recognized beginning with the effective date (a) based
on the requirements of SFAS No. 123(R) for all
share-based payments granted after the effective date and
(b) based on the requirements of SFAS No. 123 for
all awards granted to employees prior to the effective date of
SFAS No. 123(R) that remain unvested on the effective
date.
In July 2006, the FASB issued FASB Interpretation No. 48,
Accounting for the Uncertainty in Income Taxes,
(FIN 48). FIN 48 is an interpretation of
FASB Statement No. 109, Accounting for Income
Taxes, and it seeks to reduce the diversity in practice
associated with certain aspects of measurement and recognition
in accounting for income taxes. In addition, FIN 48
requires expanded disclosure with respect to the uncertainty in
income taxes and is effective as of the beginning of our 2007
fiscal year. The Company is currently evaluating the impact, if
any, that FIN 48 will have on the financials statements.
In September 2006, the U.S. Securities and Exchange
Commission (SEC) adopted Staff Accounting
Bulletin No. 108 (SAB No. 108),
which expresses the SECs staff views on the process of
quantifying financial statement misstatements. SAB 108
requires that registrants consider evaluating errors under both
the rollover and iron curtain approaches
to determine if such errors are material, thus requiring a
restatement to prior period financial statements. SAB 108
is effective for fiscal years ending on or after
November 15, 2006 and allowed the registrant to avoid
restating prior period financial statements for such errors that
are governed by SAB 108 if the registrant properly
disclosed such errors in its financial statement during the
period of adoption. The Company adopted this new standard as of
December 31, 2006 and it did not have an impact on the
Companys consolidated financial position or results of
operations.
In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements
(SFAS No. 157), which defines fair value,
establishes a framework for measuring fair value in GAAP and
expands disclosures about fair value measurements.
SFAS No. 157 will be effective for financial
statements issued for fiscal years beginning after
November 15, 2007, and interim periods within those fiscal
years. The Company is currently evaluating the requirements of
this new standard and has not concluded its analysis on the
impact to the Companys consolidated financial position or
results of operations.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
As of December 31, 2006, we had cash of $26.9 million,
which consisted of highly liquid money market instruments with
maturities less than 90 days. Because of the short
maturities of these instruments, a sudden change in market
interest rates would not be expected to have a material impact
on the fair value of the portfolio. We would not expect our
operating results or cash flows to be materially affected by the
effect of a sudden change in market interest rates on our
portfolio. At times, cash in banks is in excess of the FDIC
insurance limit. The Company has not experienced any loss as a
result of those deposits and does not expect any in the future.
Our exposure to market risk relates to changes in interest rates
for borrowings under the new senior secured credit facility we
entered into in April 2005. A hypothetical 100 basis point
adverse move (increase) in interest rates would not have
materially affected the interest expense for the year ended
December 31, 2006 since there were no amounts outstanding
on the credit agreement during this period.
60
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
The consolidated financial statements and financial statement
schedules in Part IV, Item 15 of this report are
incorporated by reference into this Item 8.
|
|
Item 9.
|
Changes
In and Disagreements with Accountants on Accounting and
Financial Disclosure
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
Disclosure
Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer
evaluated the effectiveness of the design and operation of the
Companys disclosure controls and procedures
(as defined in
Rule 13a-15(e)
under the Securities Exchange Act of 1934, as amended (the
Exchange Act)) as of the end of the period covered
by this report. Based upon that evaluation, the Chief Executive
Officer and the Chief Financial Officer concluded that, as of
the end of the period covered by this report, the Companys
disclosure controls and procedures are effective in timely
making known to them material information relating to the
Company and the Companys subsidiaries required to be
disclosed in the Companys reports filed or submitted under
the Exchange Act.
Managements
Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting, as such term
is defined in Exchange Act
Rules 13a-15(f)/15d-15(f).
Under the supervision and with the participation of our
management, including our Chief Executive Officer and Chief
Financial Officer, we conducted an evaluation of the
effectiveness of our internal control over financial reporting
based on the framework in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based upon that
evaluation, our management concluded that our internal control
over financial reporting was effective as of December 31,
2006.
In connection with the 2005 audit of our financial statements
and managements required assessment of our disclosure
controls and procedures, Ernst & Young, LLP, our
independent registered public accounting firm, issued a
management letter which noted a material weakness in our
internal control over financial reporting relating to preventing
posting errors within the patient billing system for certain
rebilled accounts, specifically, that our personnel lacked
sufficient knowledge and experience in our billing and revenue
management software and we did not establish appropriate
controls to detect or correct errors relating to these rebilled
transactions. The correction of these posting errors resulted in
a $900,000 increase to revenue for the year ended
December 31, 2005. The potential effects of these posting
errors on our financial statements issued during the interim
periods of 2005 were not material. Subsequent to identifying
this material weakness, we initiated the process of improving
our internal controls over rebilled transactions through the
requirement of additional training on our software for those
individuals recording these transactions, the implementation of
strict procedural controls and documentation requirements over
rebilled transactions, and newly established monitoring, review
and approval controls over these transactions. The processes
that we have implemented in our internal controls over rebilled
transactions have remedied the issue and as of December 31,
2006, no material weaknesses in our internal control over
financial reporting were identified in the 2006 audit.
Managements assessment of the effectiveness of our
internal control over financial reporting as of
December 31, 2006 has been audited by Ernst &
Young LLP. Ernst & Young has issued an attestation
report on managements assessment of the Companys
internal control over financial reporting. The report is
included herein.
Changes
in Internal Control Over Financial Reporting
Except as described above, there have been no changes in our
internal control over financial reporting (as defined in
Rules 13a-15(f)
and
15d-a5(f)
under the Exchange Act, as amended) that occurred during the
quarter ended December 31, 2006 that have materially
affected, or are reasonably likely to materially affect, the our
internal control over financial reporting.
61
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
INTERNAL CONTROL OVER FINANCIAL REPORTING
TO THE BOARD OF DIRECTORS AND STOCKHOLDERS OF
LHC GROUP, INC.
We have audited managements assessment, included in the
accompanying Managements Report on Internal Control Over
Financial Reporting, that LHC Group, Inc. and subsidiaries
maintained effective internal control over financial reporting
as of December 31, 2006, based on criteria established in
Internal Control-Integrated Framework issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO). LHC
Group, Inc.s management is responsible for maintaining
effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over
financial reporting. Our responsibility is to express an opinion
on managements assessment and an opinion on the
effectiveness of the Companys internal control over
financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, evaluating
managements assessment, testing and evaluating the design
and operating effectiveness of internal control, and performing
such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable
basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may be inadequate
because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
In our opinion, managements assessment that LHC Group,
Inc. and subsidiaries maintained effective internal control over
financial reporting as of December 31, 2006, is fairly
stated, in all material respects, based on the COSO criteria.
Also, in our opinion, LHC Group, Inc. and subsidiaries
maintained, in all material respects, effective internal control
over financial reporting as of December 31, 2006, based on
the COSO criteria.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of LHC Group, Inc. and subsidiaries
as of December 31, 2006 and 2005, and the related
consolidated statements of income, changes in stockholders
equity, and cash flows for each of the three years in the period
ended December 31, 2006 and our report dated March 14,
2007 expressed an unqualified opinion thereon.
Ernst & Young LLP
New Orleans, Louisiana
March 14, 2007
62
|
|
Item 9B.
|
Other
Information
|
None.
PART III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
Executive
Officers and Directors
The information required by this Item is incorporated by
reference to the sections entitled Directors and Executive
Officers in the definitive Proxy Statement relating to the
Companys 2007 Annual Meeting of Stockholders.
Compliance
with Section 16(a) of the Exchange Act
The information required by this Item is incorporated by
reference to the sections entitled Directors and Executive
Officers in the definitive Proxy Statement relating to the
Companys 2007 Annual Meeting of Stockholders.
Code of
Conduct and Ethics
We have adopted a code of ethics that applies to all of our
directors, officers and employees. This code is publicly
available in the investor relations area of our website at
www.lhcgroup.com. This code of ethics is not incorporated
in this report by reference. Copies of our code of ethics may
also be requested in print by writing to Investor Relations at
LHC Group, Inc., 420 West Pinhook Rd., Suite A, Lafayette,
Louisiana, 70503.
|
|
Item 11.
|
Executive
Compensation
|
The information required by this Item is incorporated by
reference to the sections entitled Executive
Compensation in the definitive Proxy Statement relating to
the Companys 2007 Annual Meeting of Stockholders.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and
Managers
|
Equity
Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|
|
Number of Shares to
|
|
|
|
|
|
Remaining Available
|
|
|
|
be Issued Upon
|
|
|
Weighted-Average
|
|
|
for Future Issuance
|
|
|
|
Exercise of
|
|
|
Exercise Price of
|
|
|
Under Equity
|
|
|
|
Outstanding
|
|
|
Outstanding Price
|
|
|
Compensation Plans
|
|
|
|
Options, Warrants,
|
|
|
of Outstanding
|
|
|
(Excluding Securities
|
|
Plan Category
|
|
and Rights
|
|
|
Rights
|
|
|
Reflected in Column(a))
|
|
|
Equity compensation plans approved
by Stockholders:
|
|
|
21,000
|
|
|
|
17.45
|
|
|
|
1,108,688
|
(1)
|
Equity compensation plans not
approved by Stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
21,000
|
|
|
|
17.45
|
|
|
|
1,108,688
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
865,784 of these shares are reserved under the LHC Group, Inc.
2005 Long-Term Incentive Plan and are available for issuance
pursuant to the exercise or grant of stock options, stock
appreciation rights, restricted stock, restricted stock units,
performance shares or unrestricted stock. 242,904 of these
shares are reserved and available for issuance under the 2006
LHC Group, Inc. Employee Stock Purchase Plan. |
63
Security
Ownership of Certain Beneficial Owners and
Management
The information required by this Item is incorporated by
reference to the sections entitled Security Ownership of
Certain Beneficial Owners and Management in the definitive
Proxy Statement relating to the Companys 2007 Annual
Meeting of Stockholders.
|
|
Item 13.
|
Certain
Relationships and Related Transactions
|
The information required by this Item is incorporated by
reference to the sections entitled Certain Relationships
and Related Transactions in the definitive Proxy Statement
relating to the Companys 2007 Annual Meeting of
Stockholders.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
The information required by this Item is incorporated by
reference to the sections entitled Principal Accounting
Fees and Services in the definitive Proxy Statement
relating to the Companys 2007 Annual Meeting of
Stockholders.
64
PART IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a) Documents to be filed with
Form 10-K:
(1) Financial Statements
|
|
|
|
|
Report of Independent Registered
Public Accounting Firm
|
|
|
F-1
|
|
Balance Sheets as of
December 31, 2006 and 2005
|
|
|
F-2
|
|
For each of the three years in the
period ended December 31, 2006, 2005 and 2004
|
|
|
|
|
Statements of Income
|
|
|
F-3
|
|
Statements of Changes in
Stockholders Equity
|
|
|
F-4
|
|
Statements of Cash Flows
|
|
|
F-5
|
|
Notes to the Consolidated
Financial Statements
|
|
|
F-6
|
|
(2) Financial Statement Schedules
There are no financial statement schedules included in this
report.
(3) Exhibits
The Exhibits are listed in the Index of Exhibits Required
by Item 601 of
Regulation S-K
included herewith, which is incorporated by reference.
65
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of LHC Group, Inc.
We have audited the accompanying consolidated balance sheets of
LHC Group, Inc. and subsidiaries as of December 31, 2006
and 2005, and the related consolidated statements of income,
changes in stockholders equity, and cash flows for each of
the three years in the period ended December 31, 2006.
These financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the consolidated
financial position of LHC Group, Inc. and subsidiaries at
December 31, 2006 and 2005, and the consolidated results of
its operations and its cash flows for each of the three years in
the period ended December 31, 2006, in conformity with
U.S. generally accepted accounting principles.
As discussed in Note 2 to the consolidated financial
statements, the Company changed its method of accounting for
stock-based compensation on January 1, 2006.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
effectiveness of LHC Group, Inc.s internal control over
financial reporting as of December 31, 2006, based on
criteria established in Internal Control-Integrated Framework
issued by the Committee of Sponsoring Organizations of the
Treadway Commission and our report dated March 14, 2007,
expressed an unqualified opinion thereon.
Ernst & Young LLP
New Orleans, Louisiana
March 14, 2007
F-1
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
(Amounts in thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
26,877
|
|
|
$
|
17,398
|
|
Receivables:
|
|
|
|
|
|
|
|
|
Patient accounts receivable, less
allowance for uncollectible accounts of $5,769, and $2,544 at
December 31, 2006 and 2005, respectively
|
|
|
50,029
|
|
|
|
34,810
|
|
Other receivables
|
|
|
3,367
|
|
|
|
3,365
|
|
Employee receivables
|
|
|
34
|
|
|
|
1,888
|
|
Amounts due from governmental
entities
|
|
|
2,518
|
|
|
|
4,519
|
|
|
|
|
|
|
|
|
|
|
|
|
|
55,948
|
|
|
|
44,582
|
|
Deferred income taxes
|
|
|
1,935
|
|
|
|
152
|
|
Income taxes recoverable
|
|
|
|
|
|
|
869
|
|
Prepaid expenses and other current
assets
|
|
|
4,120
|
|
|
|
3,714
|
|
Assets held for sale
|
|
|
1,171
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
90,051
|
|
|
|
66,715
|
|
Property, building, and equipment,
net
|
|
|
11,705
|
|
|
|
10,224
|
|
Goodwill
|
|
|
39,681
|
|
|
|
26,103
|
|
Intangible assets, net
|
|
|
8,262
|
|
|
|
|
|
Other assets
|
|
|
2,995
|
|
|
|
1,576
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
152,694
|
|
|
$
|
104,618
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable and other accrued
liabilities
|
|
$
|
5,903
|
|
|
$
|
6,474
|
|
Salaries, wages, and benefits
payable
|
|
|
10,572
|
|
|
|
6,124
|
|
Amounts due to governmental
entities
|
|
|
3,223
|
|
|
|
3,080
|
|
Amounts payable under cooperative
endeavor agreements
|
|
|
51
|
|
|
|
37
|
|
Income taxes payable
|
|
|
1,219
|
|
|
|
|
|
Current portion of capital lease
obligations
|
|
|
211
|
|
|
|
400
|
|
Current portion of long-term debt
|
|
|
428
|
|
|
|
1,406
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
21,607
|
|
|
|
17,521
|
|
Deferred income taxes
|
|
|
2,104
|
|
|
|
1,573
|
|
Capital lease obligations, less
current portion
|
|
|
147
|
|
|
|
347
|
|
Long-term debt, less current
portion
|
|
|
3,051
|
|
|
|
3,274
|
|
Minority interests subject to
exchange contracts
and/or put
options
|
|
|
317
|
|
|
|
1,511
|
|
Other minority interests
|
|
|
3,579
|
|
|
|
1,948
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock
$0.01 par value: 40,000,000 shares authorized;
20,682,317 and 19,507,887 shares issued and 17,732,258 and
16,557,828 shares outstanding at December 31, 2006 and
2005, respectively
|
|
|
177
|
|
|
|
166
|
|
Treasury stock
2,950,059 shares at cost at December 31, 2006 and 2005
|
|
|
(2,856
|
)
|
|
|
(2,856
|
)
|
Additional paid-in capital
|
|
|
80,273
|
|
|
|
58,596
|
|
Retained earnings
|
|
|
44,295
|
|
|
|
22,538
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
121,889
|
|
|
|
78,444
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
152,694
|
|
|
$
|
104,618
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
F-2
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF INCOME
(Amounts in thousands, except share and per share
data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Net service revenue
|
|
$
|
215,248
|
|
|
$
|
152,711
|
|
|
$
|
116,090
|
|
Cost of service revenue
|
|
|
109,851
|
|
|
|
79,607
|
|
|
|
57,672
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
105,397
|
|
|
|
73,104
|
|
|
|
58,418
|
|
General and administrative expenses
|
|
|
71,125
|
|
|
|
45,663
|
|
|
|
35,168
|
|
Equity-based compensation expense(1)
|
|
|
|
|
|
|
3,856
|
|
|
|
1,788
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
34,272
|
|
|
|
23,585
|
|
|
|
21,462
|
|
Interest expense
|
|
|
325
|
|
|
|
1,059
|
|
|
|
1,328
|
|
Non-operating (income) loss,
including gain or loss on sales of assets
|
|
|
(2,033
|
)
|
|
|
(574
|
)
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes and minority interest and cooperative
endeavor allocations
|
|
|
35,980
|
|
|
|
23,100
|
|
|
|
20,121
|
|
Income tax expense
|
|
|
10,417
|
|
|
|
6,538
|
|
|
|
6,111
|
|
Minority interest and cooperative
endeavor allocations
|
|
|
4,795
|
|
|
|
4,545
|
|
|
|
4,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
20,768
|
|
|
|
12,017
|
|
|
|
9,852
|
|
Loss from discontinued operations
(net of income taxes of $497, $1,174, and $17 in the years ended
December 31, 2006, 2005, and 2004, respectively)
|
|
|
(811
|
)
|
|
|
(1,915
|
)
|
|
|
(851
|
)
|
Gain on sale of discontinued
operations (net of income taxes of $390 and $195 for the year
ended December 31, 2006 and 2004, respectively)
|
|
|
637
|
|
|
|
|
|
|
|
312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
20,594
|
|
|
|
10,102
|
|
|
|
9,313
|
|
Change in the redemption value of
redeemable minority interests
|
|
|
1,163
|
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
stockholders
|
|
$
|
21,757
|
|
|
$
|
8,626
|
|
|
$
|
9,313
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share
basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.21
|
|
|
$
|
0.82
|
|
|
$
|
0.82
|
|
Loss from discontinued operations,
net
|
|
|
(0.05
|
)
|
|
|
(0.13
|
)
|
|
|
(0.07
|
)
|
Gain on sale of discontinued
operations, net
|
|
|
0.04
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.20
|
|
|
|
0.69
|
|
|
|
0.77
|
|
Change in the redemption value of
redeemable minority interests
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
shareholders
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share
diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.21
|
|
|
$
|
0.82
|
|
|
$
|
0.81
|
|
Loss from discontinued operations,
net
|
|
|
(0.05
|
)
|
|
|
(0.13
|
)
|
|
|
(0.07
|
)
|
Gain on sale of discontinued
operations, net
|
|
|
0.04
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.20
|
|
|
|
0.69
|
|
|
|
0.76
|
|
Change in the redemption value of
redeemable minority interests
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
shareholders
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
17,090,583
|
|
|
|
14,628,737
|
|
|
|
12,085,154
|
|
Diluted
|
|
|
17,104,660
|
|
|
|
14,684,639
|
|
|
|
12,145,150
|
|
|
|
|
(1) |
|
Equity-based compensation is allocated as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Cost of service revenue
|
|
$
|
|
|
|
$
|
565
|
|
|
$
|
58
|
|
General and administrative expenses
|
|
|
|
|
|
|
3,291
|
|
|
|
1,730
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity-based compensation
expense
|
|
$
|
|
|
|
$
|
3,856
|
|
|
$
|
1,788
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
F-3
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY
(Amounts in thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Additional
|
|
|
Receivable
|
|
|
|
|
|
|
|
|
|
Issued
|
|
|
Treasury
|
|
|
Paid-In
|
|
|
From
|
|
|
Retained
|
|
|
|
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Capital
|
|
|
Officer
|
|
|
Earnings
|
|
|
Total
|
|
|
Balances at January 1, 2004
|
|
$
|
121
|
|
|
|
15,000,004
|
|
|
$
|
(782
|
)
|
|
|
2,914,850
|
|
|
$
|
2,361
|
|
|
$
|
|
|
|
$
|
5,209
|
|
|
$
|
6,909
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,313
|
|
|
|
9,313
|
|
Sale of shares to officer in
exchange for note
|
|
|
|
|
|
|
|
|
|
|
40
|
|
|
|
(150,000
|
)
|
|
|
683
|
|
|
|
(123
|
)
|
|
|
|
|
|
|
600
|
|
Rescission of share sale to officer
|
|
|
|
|
|
|
|
|
|
|
(1,500
|
)
|
|
|
150,000
|
|
|
|
1,377
|
|
|
|
123
|
|
|
|
|
|
|
|
|
|
Dividends to stockholders
($0.039 per share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(471
|
)
|
|
|
(471
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2004
|
|
|
121
|
|
|
|
15,000,004
|
|
|
|
(2,242
|
)
|
|
|
2,914,850
|
|
|
|
4,421
|
|
|
|
|
|
|
|
14,051
|
|
|
|
16,351
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,102
|
|
|
|
10,102
|
|
Dividends to stockholders
($0.009 per share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(139
|
)
|
|
|
(139
|
)
|
Sale of 3,500,000 shares of
common stock at the initial public offering price of $14 per
share, net of underwriting discount and offering costs of $7,393
|
|
|
35
|
|
|
|
3,500,000
|
|
|
|
|
|
|
|
|
|
|
|
41,572
|
|
|
|
|
|
|
|
|
|
|
|
41,607
|
|
Issuance of common stock to two
joint venture partners upon conversion of their equity interests
into shares of common stock
|
|
|
5
|
|
|
|
518,036
|
|
|
|
|
|
|
|
|
|
|
|
7,247
|
|
|
|
|
|
|
|
|
|
|
|
7,252
|
|
Issuance of common stock upon
conversion of outstanding KEEP units
|
|
|
5
|
|
|
|
481,680
|
|
|
|
|
|
|
|
|
|
|
|
5,239
|
|
|
|
|
|
|
|
|
|
|
|
5,244
|
|
Issuance of 8,167 shares of
vested restricted stock
|
|
|
|
|
|
|
8,167
|
|
|
|
|
|
|
|
|
|
|
|
117
|
|
|
|
|
|
|
|
|
|
|
|
117
|
|
Treasury shares redeemed for
payment of income taxes
|
|
|
|
|
|
|
|
|
|
|
(614
|
)
|
|
|
35,209
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(614
|
)
|
Recording minority interest in
joint venture at redemption value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,476
|
)
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2005
|
|
|
166
|
|
|
|
19,507,887
|
|
|
|
(2,856
|
)
|
|
|
2,950,059
|
|
|
|
58,596
|
|
|
|
|
|
|
|
22,538
|
|
|
|
78,444
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,594
|
|
|
|
20,594
|
|
Sale of 1,150,000 shares of
common stock at $19.25 per share, net of underwriting
discount and offering costs of $1,403
|
|
|
11
|
|
|
|
1,150,000
|
|
|
|
|
|
|
|
|
|
|
|
20,711
|
|
|
|
|
|
|
|
|
|
|
|
20,722
|
|
Stock option compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
128
|
|
|
|
|
|
|
|
|
|
|
|
128
|
|
Exercise of stock options
|
|
|
|
|
|
|
8,000
|
|
|
|
|
|
|
|
|
|
|
|
165
|
|
|
|
|
|
|
|
|
|
|
|
165
|
|
Nonvested stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
484
|
|
|
|
|
|
|
|
|
|
|
|
484
|
|
Issuance of 1,167 shares of
vested restricted stock
|
|
|
|
|
|
|
1,167
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
Issuance of nonvested stock
|
|
|
|
|
|
|
8,167
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under
Employee Stock Purchase Plan
|
|
|
|
|
|
|
7,096
|
|
|
|
|
|
|
|
|
|
|
|
166
|
|
|
|
|
|
|
|
|
|
|
|
166
|
|
Change in redemption value of
redeemable minority interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,163
|
|
|
|
1,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2006
|
|
$
|
177
|
|
|
|
20,682,317
|
|
|
$
|
(2,856
|
)
|
|
|
2,950,059
|
|
|
$
|
80,273
|
|
|
$
|
|
|
|
$
|
44,295
|
|
|
$
|
121,889
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
F-4
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
20,594
|
|
|
$
|
10,102
|
|
|
$
|
9,313
|
|
Adjustments to reconcile net income
to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
expense
|
|
|
2,427
|
|
|
|
1,751
|
|
|
|
1,021
|
|
Provision for bad debts
|
|
|
4,778
|
|
|
|
3,188
|
|
|
|
1,556
|
|
Equity based compensation expense
|
|
|
|
|
|
|
3,856
|
|
|
|
1,788
|
|
Stock based compensation expense
|
|
|
635
|
|
|
|
177
|
|
|
|
|
|
Minority interest in earnings of
subsidiaries
|
|
|
4,471
|
|
|
|
4,527
|
|
|
|
3,304
|
|
Deferred income taxes
|
|
|
(1,253
|
)
|
|
|
673
|
|
|
|
(85
|
)
|
Gain on divestitures and sale of
assets
|
|
|
(979
|
)
|
|
|
(211
|
)
|
|
|
(339
|
)
|
Changes in operating assets and
liabilities, net of acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(15,625
|
)
|
|
|
(14,478
|
)
|
|
|
(10,945
|
)
|
Prepaid expenses, other assets
|
|
|
(1,466
|
)
|
|
|
(196
|
)
|
|
|
(648
|
)
|
Accounts payable and accrued
expenses
|
|
|
6,022
|
|
|
|
(2,681
|
)
|
|
|
1,480
|
|
Net amounts due under cooperative
endeavor agreements
|
|
|
14
|
|
|
|
172
|
|
|
|
(415
|
)
|
Net amounts due governmental
entities
|
|
|
2,144
|
|
|
|
(105
|
)
|
|
|
532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
21,762
|
|
|
|
6,775
|
|
|
|
6,562
|
|
Investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, building,
and equipment
|
|
|
(3,938
|
)
|
|
|
(2,134
|
)
|
|
|
(4,144
|
)
|
Proceeds from sale of property and
equipment
|
|
|
7
|
|
|
|
|
|
|
|
180
|
|
Proceeds from sale of entities
|
|
|
1,440
|
|
|
|
730
|
|
|
|
470
|
|
Cost of acquisitions, primarily
goodwill, intangible assets and patient accounts receivable
|
|
|
(25,009
|
)
|
|
|
(11,137
|
)
|
|
|
(1,700
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(27,500
|
)
|
|
|
(12,541
|
)
|
|
|
(5,194
|
)
|
Financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, net of
underwriting discounts of $1,104 in 2006 and $3,430 in 2005
|
|
|
21,033
|
|
|
|
45,570
|
|
|
|
|
|
Dividends paid
|
|
|
|
|
|
|
(227
|
)
|
|
|
(445
|
)
|
Principal payments on debt
|
|
|
(1,201
|
)
|
|
|
(2,937
|
)
|
|
|
(1,625
|
)
|
Payments on capital leases
|
|
|
(389
|
)
|
|
|
(1,105
|
)
|
|
|
(446
|
)
|
Proceeds from issuance of debt
|
|
|
|
|
|
|
24
|
|
|
|
1,205
|
|
Net (payments) proceeds from lines
of credit and revolving debt arrangements
|
|
|
|
|
|
|
(14,288
|
)
|
|
|
5,478
|
|
Offering costs incurred
|
|
|
(311
|
)
|
|
|
(2,224
|
)
|
|
|
(1,739
|
)
|
Proceeds from exercise of stock
options
|
|
|
135
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common
stock under ESPP
|
|
|
140
|
|
|
|
|
|
|
|
|
|
Minority interest contributions,
net of (distributions)
|
|
|
(4,190
|
)
|
|
|
(4,560
|
)
|
|
|
(2,610
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
15,217
|
|
|
|
20,253
|
|
|
|
(182
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash
|
|
|
9,479
|
|
|
|
14,487
|
|
|
|
1,186
|
|
Cash at beginning of period
|
|
|
17,398
|
|
|
|
2,911
|
|
|
|
1,725
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash at end of period
|
|
$
|
26,877
|
|
|
$
|
17,398
|
|
|
$
|
2,911
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash
flow information
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
342
|
|
|
$
|
1,068
|
|
|
$
|
1,344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
$
|
9,370
|
|
|
$
|
5,821
|
|
|
$
|
5,783
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental
disclosure of non-cash transactions:
In the year ended December 31, 2006 the company sold a
clinic for promissory notes totaling $946 and recognized a loss
on the sale of $28.
In the year ended December 31, 2005, the Company issued
common stock valued at $7,252 to two joint venture partners upon
the acquisition of their minority interest. Additionally, the
Companys shareholders equity from the initial public
offering was reduced by offering costs incurred by the Company
of $3,951. The Company financed the purchase of an airplane for
$3.0 million. The Company also financed the purchase of
various types of insurance in the amount of $2.2 million.
See accompanying notes.
F-5
LHC
GROUP, INC. AND SUBSIDIARIES
LHC Group, Inc. (the Company) is a healthcare
provider specializing in the post-acute continuum of care
primarily for Medicare beneficiaries in rural markets in the
southern United States. The Company provides home-based
services, primarily through home nursing agencies and hospices,
and facility-based services, primarily through long-term acute
care hospitals and outpatient rehabilitation clinics. The
Company, through its wholly and majority-owned subsidiaries,
equity joint ventures, and controlled affiliate, currently
operates in Louisiana, Mississippi, Arkansas, Alabama, Texas,
West Virginia, Kentucky, Florida, Tennessee, and Georgia.
The Company operated as Louisiana Health Care Group, Inc.
(LHCG), until March 2001, when the shareholders of
LHCG transferred to The Health Care Group, Inc.
(THCG), all of the issued and outstanding shares of
common stock of LHCG in exchange for shares in THCG. On
January 1, 2003, the Company began operating as LHC Group,
LLC, a Louisiana limited liability company. The THCG
shareholders exchanged their shares for membership interests in
the Company (units).
Prior to February 9, 2005, the Company operated under the
terms of an operating agreement which provided that the Company
did not have a finite life and that the members personal
liability was limited to his or her capital contribution. There
was only one class of member interest.
Plan
of Merger and Recapitalization
In January 2005, LHC Group, LLC established a wholly-owned
Delaware subsidiary, LHC Group, Inc. Effective February 9,
2005, LHC Group, LLC merged with and into LHC Group, Inc. In
connection with the merger, each outstanding membership unit in
LHC Group, LLC was converted into shares of the $0.01 par
value common stock of LHC Group, Inc. based on an exchange ratio
of
three-for-two.
Each KEEP Unit was also converted during the initial public
offering into shares of common stock of LHC Group, Inc. pursuant
to the same
three-for-two
ratio. LHC Group, Inc. has 40,000,000 shares of
$0.01 par value common stock authorized and
5,000,000 shares of $0.01 par value preferred stock
authorized. All references to common stock, share, and per share
amounts have been retroactively restated to reflect the merger
and recapitalization as if the merger and recapitalization had
taken place as of the beginning of the earliest period presented.
As used herein, the Company includes LHC Group, Inc.
and all predecessor entities.
Initial
Public Offering
On June 9, 2005, the Company began its initial public
offering of 4,800,000 shares of its common stock at a price
of $14.00 per share. The Company offered
3,500,000 shares along with 1,300,000 shares that were
sold by certain stockholders of LHC Group. The Company received
no proceeds from the sale of the shares by the selling
stockholders. The shares began trading on the NASDAQ National
Market under the symbol LHCG on June 9, 2005.
The initial public offering was completed on June 14, 2005.
The underwriters exercised an option to purchase an additional
720,000 shares from certain stockholders solely to cover
over-allotments. The Company received $45,570,000, net of
underwriting discounts of $3,430,000 in proceeds from the
offering. The Company incurred approximately $3,963,000 in costs
related to the initial public offering through December 31,
2005.
|
|
2.
|
Significant
Accounting Policies
|
Use of
Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements
F-6
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
and the reported revenue and expenses during the reported
period. Actual results could differ from those estimates.
Critical
Accounting Policies
The most critical accounting policies relate to the principles
of consolidation, revenue recognition, accounts receivable and
allowances for uncollectible accounts, and accounting for
goodwill and intangible assets.
Principles
of Consolidation
The consolidated financial statements include all subsidiaries
and entities controlled by the Company. Control is generally
defined by the Company as ownership of a majority of the voting
interest of an entity. The consolidated financial statements
include entities in which the Company absorbs a majority of the
entitys expected losses, receives a majority of the
entitys expected residual returns, or both, as a result of
ownership, contractual or other financial interests in the
entity.
All significant inter-company accounts and transactions have
been eliminated in consolidation. Business combinations
accounted for as purchases have been included in the
consolidated financial statements from the respective dates of
acquisition.
The following describes the Companys consolidation policy
with respect to its various ventures excluding wholly owned
subsidiaries:
Equity
Joint Ventures
The Companys joint ventures are structured as limited
liability companies in which the Company typically owns a
majority equity interest ranging from 51% to 99%. Each member of
all but one of the Companys equity joint ventures
participates in profits and losses in proportion to their equity
interests. The Company has one joint venture partner whose
participation in losses is limited. The Company consolidates
these entities as the Company absorbs a majority of the
entities expected losses, receives a majority of the
entities expected residual returns and generally has
voting control over the entity.
Cooperative
Endeavors
The Company has arrangements with certain partners that involve
the sharing of profits and losses. Unlike the equity joint
ventures, the Company owns 100% of the equity in these
cooperative endeavors. In these cooperative endeavors, the
Company possesses interests in the net profits and losses
ranging from 67% to 70%. The Company has one cooperative
endeavor partner whose participation in losses is limited. The
Company consolidates these entities as the Company owns 100% of
the outstanding equity and the Company absorbs a majority of the
entities expected losses and receives a majority of the
entities expected residual returns.
License
Leasing Arrangements
The Company, through wholly owned subsidiaries, leases home
health licenses necessary to operate certain of its home nursing
agencies. As with wholly owned subsidiaries, the Company owns
100% of the equity of these entities and consolidates them based
on such ownership as well as the Companys right to receive
a majority of the entities expected residual returns and
the Companys obligation to absorb a majority of the
entities expected losses.
F-7
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Management
Services
The Company has various management services agreements under
which the Company manages certain operations of agencies and
facilities. The Company does not consolidate these agencies or
facilities, as the Company does not have an ownership interest
and does not have a right to receive a majority of the
agencies or facilities expected residual returns or
an obligation to absorb a majority of the agencies or
facilities expected losses.
The following table summarizes the percentage of net service
revenue earned by type of ownership or relationship the Company
had with the operating entity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Wholly owned subsidiaries
|
|
|
39.2
|
%
|
|
|
33.6
|
%
|
|
|
41.7
|
%
|
Equity joint ventures
|
|
|
45.7
|
|
|
|
50.1
|
|
|
|
40.3
|
|
Cooperative endeavors
|
|
|
1.5
|
|
|
|
2.0
|
|
|
|
5.3
|
|
License leasing arrangements
|
|
|
11.0
|
|
|
|
11.4
|
|
|
|
11.1
|
|
Management services
|
|
|
2.6
|
|
|
|
2.9
|
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Recognition
The Company reports net service revenue at the estimated net
realizable amount due from Medicare, Medicaid, commercial
insurance, managed care payors, patients, and others for
services rendered. Under Medicare, the Companys home
nursing patients are classified into a group referred to as a
home health resource group prior to the receipt of services.
Based on this home health resource group the Company is entitled
to receive a prospective Medicare payment for delivering care
over a 60 day period referred to as an episode. Medicare
adjusts these prospective payments based on a variety of
factors, such as low utilization, patient transfers, changes in
condition and the level of services provided. In calculating the
Companys reported net service revenue from home nursing
services, the Company adjusts the prospective Medicare payments
by an estimate of the adjustments. The Company calculates the
adjustments based on a historical average of these types of
adjustments. For home nursing services, the Company recognizes
revenue based on the number of days elapsed during the episode
of care.
For the Companys long-term acute care hospitals, revenue
is recognized as services are provided. Under Medicare, patients
in the Companys long-term acute care facilities are
classified into long-term diagnosis-related groups. Based on
this classification, the Company is then entitled to receive a
fixed payment from Medicare. This fixed payment is also subject
to adjustment by Medicare due to factors such as short stays. In
calculating reported net service revenue for services provided
in the Companys long-term acute care hospitals, the
Company reduces the prospective payment amounts by an estimate
of the adjustments. The Company calculates the adjustment based
on a historical average of these types of adjustments for claims
paid.
For hospice services the Company is paid by Medicare under a per
diem payment system. The Company receives one of four
predetermined daily or hourly rates based upon the level of care
the Company furnished. The Company records net service revenue
from hospice services based on the daily or hourly rate. The
Company recognizes revenue for hospice as services are provided.
Under Medicare the Company is reimbursed for rehabilitation
services based on a fee schedule for services provided adjusted
by the geographical area in which the facility is located. The
Company recognizes revenue as these services are provided.
The Companys Medicaid reimbursement is based on a
predetermined fee schedule applied to each service provided.
Therefore, revenue is recognized for Medicaid services as
services are provided based on
F-8
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
this fee schedule. The Companys managed care payors
reimburse the Company in a manner similar to either Medicare or
Medicaid. Accordingly, the Company recognizes revenue from
managed care payors in the same manner as the Company recognizes
revenue from Medicare or Medicaid.
The Company records management services revenue as services are
provided in accordance with the various management services
agreements to which the Company is a party. The agreements
generally call for the Company to provide billing, management,
and other consulting services suited to and designed for the
efficient operation of the applicable home nursing agency or
inpatient rehabilitation facility. The Company is responsible
for the costs associated with the locations and personnel
required for the provision of the services. The Company is
generally compensated based on a percentage of net billings or
an established base fee. In addition, for certain of the
management agreements, the Company may earn incentive
compensation.
Net service revenue was comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Home-based services
|
|
|
76.5
|
%
|
|
|
69.1
|
%
|
|
|
70.3
|
%
|
Facility-based services
|
|
|
23.5
|
|
|
|
30.9
|
|
|
|
29.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth the percentage of net service
revenue earned by category of payor:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Payor:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
81.6
|
%
|
|
|
85.6
|
%
|
|
|
86.3
|
%
|
Medicaid
|
|
|
6.1
|
|
|
|
6.0
|
|
|
|
4.8
|
|
Other
|
|
|
12.3
|
|
|
|
8.4
|
|
|
|
8.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home-Based
Services
Home Nursing Services. The Company receives a
standard prospective Medicare payment for delivering care. The
base payment, established through federal legislation, is a flat
rate that is adjusted upward or downward based upon differences
in the expected resource needs of individual patients as
indicated by clinical severity, functional severity, and service
utilization. The magnitude of the adjustment is determined by
each patients categorization into one of 80 payment
groups, known as home health resource groups, and the costliness
of care for patients in each group relative to the average
patient. The Companys payment is also adjusted for
differences in local prices using the hospital wage index. The
Company performs payment variance analyses to verify the models
utilized in projecting total net service revenue are accurately
reflecting the payments to be received.
Medicare rates are subject to change. Due to the length of the
Companys episodes of care, a situation may arise where
Medicare rate changes affect prior periods net service
revenue. In the event that Medicare rates experience change, the
net effect of that change will be reflected in the current
reporting period.
Final payments from Medicare may reflect one of five retroactive
adjustments to ensure the adequacy and effectiveness of the
total reimbursement: (a) an outlier payment if the
patients care was unusually costly; (b) a low
utilization adjustment if the number of visits was fewer than
five; (c) a partial payment if the patient transferred to
another provider before completing the episode; (d) a
change-in-condition
adjustment if the patients medical status changes
significantly, resulting in the need for more or less care; or
(e) a payment adjustment based upon the level of therapy
services required in the population base. Management estimates
F-9
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the impact of these payment adjustments based on historical
experience and records this estimate during the period the
services are rendered.
Hospice Services. The Companys Medicare
hospice reimbursement is based on an
annually-updated
prospective payment system. Hospice payments are also subject to
two caps. One cap relates to individual programs receiving more
than 20% of its total Medicare reimbursement from inpatient care
services. The second cap relates to individual programs
receiving reimbursements in excess of a cap amount,
calculated by multiplying the number of beneficiaries during the
period by a statutory amount that is indexed for inflation. The
determination for each cap is made annually based on the
12-month
period ending on October 31 of each year. This limit is
computed on a
program-by-program
basis. We have not received notification that any of our
hospices have exceeded the cap on inpatient care seniors during
2006. None of the Companys hospices exceeded either cap
during the year ended December 31, 2005, or 2004.
Facility-Based
Services
Long-Term Acute Care Services. The Company is
reimbursed by Medicare for services provided under the long-term
acute care hospital prospective payment system, which was
implemented on October 1, 2002. Each patient is assigned a
long-term care diagnosis-related group. The Company is paid a
predetermined fixed amount applicable to that particular group.
This payment is intended to reflect the average cost of treating
a Medicare patient classified in that particular long-term care
diagnosis-related group. For selected patients, the amount may
be further adjusted based on length of stay and
facility-specific costs, as well as in instances where a patient
is discharged and subsequently readmitted, among other factors.
Similar to other Medicare prospective payment systems, the rate
is also adjusted for geographic wage differences.
Outpatient Rehabilitation Services. Outpatient
therapy services are reimbursed on a fee schedule, subject to
annual limitations. Outpatient therapy providers receive a fixed
fee for each procedure performed, adjusted by the geographical
area in which the facility is located. The Company recognizes
revenue as the services are provided. There are also annual per
Medicare beneficiary caps that limit Medicare coverage for
outpatient rehabilitation services.
Accounts
Receivable and Allowances for Uncollectible
Accounts
The Company reports accounts receivable net of estimated
allowances for uncollectible accounts and adjustments. Accounts
receivable are uncollateralized and primarily consist of amounts
due from third-party payors and patients. To provide for
accounts receivable that could become uncollectible in the
future, the Company establishes an allowance for uncollectible
accounts to reduce the carrying amount of such receivables to
their estimated net realizable value. The credit risk for other
concentrations of receivables is limited due to the significance
of Medicare as the primary payor. The Company does not believe
that there are any other significant concentrations of
receivables from any particular payor that would subject it to
any significant credit risk in the collection of accounts
receivable.
The amount of the provision for bad debts is based upon the
Companys assessment of historical and expected net
collections, business and economic conditions, and trends in
government reimbursement. Uncollectible accounts are written off
when the Company has determined the account will not be
collected.
A portion of the estimated Medicare prospective payment system
reimbursement from each submitted home nursing episode is
received in the form of a request for accelerated payment
(RAP). The Company submits a RAP for 60% of the
estimated reimbursement for the initial episode at the start of
care. The full amount of the episode is billed after the episode
has been completed. The RAP received for that particular episode
is deducted from the final payment. If the final bill is not
submitted within the greater of 120 days from the start of
the episode, or 60 days from the date the RAP was paid, any
RAPs received for that episode will be recouped by
Medicare from any other claims in process for that particular
provider. The RAP and final
F-10
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
payment must then be resubmitted. For any subsequent episodes of
care contiguous with the first episode for a particular patient,
the Company submits a RAP for 50% instead of 60% of the
estimated reimbursement. The remaining 50% reimbursement is
requested upon completion of the episode. The Company has earned
net service revenue in excess of billings rendered to Medicare.
Only a nominal portion of the amounts due to the Medicare
program represent cash collected in advance of providing
services.
Goodwill
and Intangible Assets
Goodwill and other intangible assets with indefinite lives are
reviewed annually, or more frequently if circumstances indicate
impairment may have occurred.
The Company estimates the fair value of its identified reporting
units and compares those estimates against the related carrying
value. For each of the reporting units, the estimated fair value
is determined based on a multiple of earnings before interest,
taxes, depreciation, and amortization or on the estimated fair
value of assets in situations when it is readily determinable.
Included in intangible assets, net are other intangible assets
such as licenses to operate home-based
and/or
facility-based services and trade names. The Company has valued
these intangible assets separately from goodwill for each
acquisition completed during the year ended December 31,
2006. The Company has concluded that these licenses and trade
names have indefinite lives, as management has determined that
there are no legal, regulatory, contractual, economic or other
factors that would limit the useful life of these intangible
assets and the Company intends to renew and operate the licenses
and use these trade names indefinitely. Prior to January 1,
2006, the Company elected to recognize the fair value of
indefinite-lived licenses and trade names together with goodwill
as a single asset for financial reporting purposes.
Components of the Companys home nursing operating segment
are generally represented by individual subsidiaries or joint
ventures with individual licenses to conduct specific operations
within geographic markets as limited by the terms of each
license. Components of the Companys facility-based
services are represented by individual operating entities.
Effective January 1, 2004, management aggregates the
components of these two segments into two reporting units for
purposes of evaluating impairment.
Other
Significant Accounting Policies
Due
to/from Governmental Entities
Prior to October 1, 2000, the Company recorded Medicare
home nursing services revenues at the lower of actual costs, the
per visit cost limit, or a per beneficiary cost limit on an
individual provider basis. Additionally, the Companys
critical access hospital and long-term acute care hospitals are
reimbursed for certain activities based on tentative rates.
Final reimbursement is determined based on submission of annual
cost reports and audits by the fiscal intermediary. Adjustments
are accrued on an estimated basis in the period the related
services were rendered and further adjusted as final settlements
are determined. These adjustments are accounted for as changes
in estimates. There have been no significant changes in
estimates during the twelve months ended December 31, 2006
and 2005.
Property,
Building, and Equipment
Property, building, and equipment are stated at cost.
Depreciation is computed using the straight-line method over the
estimated useful lives of the individual assets, generally
ranging from three to ten years and up to thirty-nine years on
buildings. Depreciation expense for the years ended
December 31, 2006, 2005, and 2004 was $2.4 million,
$1.8 million, and $1.0, respectively.
Capital leases, primarily consisting of transportation
equipment, are included in equipment. Capital leases are
recorded at the present value of the future rentals at lease
inception and are amortized over the shorter of
F-11
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the applicable lease term or the useful life of the equipment.
Amortization of assets under the capital lease obligations is
included in depreciation and amortization expense.
Long-Lived
Assets
The Company reviews the recoverability of long-lived assets
whenever events or circumstances occur which indicate recorded
costs may not be recoverable. If the expected future cash flows
(undiscounted) are less than the carrying amount of such assets,
the Company recognizes an impairment loss for the difference
between the carrying amount of the assets and their estimated
fair value.
Income
Taxes
The Company accounts for income taxes using the liability
method. Under the liability method, deferred taxes are
determined based on differences between the financial reporting
and tax bases of assets and liabilities, and are measured using
the enacted tax laws that will be in effect when the differences
are expected to reverse. Management provides a valuation
allowance for any net deferred tax assets when it is more likely
than not that a portion of such net deferred tax assets will not
be recovered.
Minority
Interest and Cooperative Endeavor Agreements
The interest held by third parties in subsidiaries owned or
controlled by the Company is reported on the consolidated
balance sheets as minority interest. Minority interest reported
in the consolidated statements of income reflects the respective
interests in the income or loss of the subsidiaries attributable
to the other parties, the effect of which is removed from the
Companys consolidated results of operations.
Several of the Companys home health agencies have
cooperative endeavor agreements with third parties that allow
the third parties to be paid or recover a fee based on the
profits or losses of the respective agencies. The Company
accrues for the settlement of the third partys profits or
losses during the period the amounts are earned. Under the
agreements, the Company has incurred net amounts due to the
third parties of $246,000, $316,000, and $753,000 for the twelve
months ended December 31, 2006, 2005 and 2004,
respectively. The cooperative endeavor agreements have terms
expiring through June 2008.
For agreements where the third party is a healthcare
institution, the agreements typically require the Company to
lease building and equipment and receive housekeeping and
maintenance from the healthcare institutions. Ancillary services
related to these arrangements are also typically provided by the
healthcare institution.
Minority
Interest Subject to Exchange Contracts
and/or Put
Options
During 2004, in conjunction with the acquisition/sale of joint
venture interests, the Company entered into agreements with
minority interest holders in three of its majority owned
subsidiaries that allowed these minority interest holders to put
their minority interests to the Company in the event the Company
is sold, merged or otherwise acquired or completes an initial
public offering (IPO). These put options were deemed
to be part of the underlying minority interest shares, thus
rendering the shares to be puttable shares. In September and
November of 2004, the Company entered into forward exchange
contracts with the minority interest holders in two of these
subsidiaries, Acadian Home Health Care Services, LLC
(Acadian) and Hebert, Thibodeaux, Albro and Touchet
Therapy Group, Inc. (Hebert) which required the
minority interest holders in these subsidiaries to sell their
interests to the Company in the event of an IPO. In conjunction
with the Companys IPO, the forward exchange contracts were
consummated and the minority interest holders of Acadian and
Hebert sold their minority interests to the Company in exchange
for cash and shares of the Companys common stock. The
Company paid approximately $2.2 million under these forward
exchange contracts.
F-12
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In the third majority owned subsidiary, St. Landry Extended
Care Hospital, (St. Landry), the put option allows
the minority interest holders to convert their minority
interests into shares of the Company based upon St.
Landrys EBITDA for the prior fiscal year in relation to
the Companys EBITDA over the same period. The put option
became exercisable by the minority interest holders in St.
Landry upon the completion of the IPO. However, due to
applicable laws and regulations, the minority interest holders
can not convert their minority interests in St. Landry
unless certain conditions are met including, but not limited to,
the Company having stockholders equity in excess of
$75 million at the end of its most recent fiscal year or on
average during the previous three fiscal years. If the St.
Landry minority interest holders do not or are unable to convert
their minority interests into shares of the Company, the
minority interest holders shall have the option to redeem their
minority interests at any time following thirty days after the
IPO for cash consideration equal to the number of shares the
minority interest holders would have received if they had
converted their minority interests into shares of the Company
multiplied by the average closing price of the Companys
shares for the thirty days preceding the date of the minority
interest holders exercise of the redemption option. As of
December 31, 2006, the Company has exceeded
$75 million in stockholders equity. As of
March 14, 2007, approximately 76.5% of the doctors have
converted their minority interests to cash.
The above put/redemption options and exchange agreements have
been presented in the historical financial statements under the
guidance in Accounting Series Release (ASR) No. 268
and EITF Topic D-98, which generally require a public
companys stock subject to redemption requirements that are
outside the control of the issuer to be excluded from the
caption stockholders equity and presented
separately in the issuers balance sheet. Under EITF Topic
D-98, once it becomes probable that the minority interest would
become redeemable, the minority interest should be adjusted to
its current redemption amount. As noted above, the St. Landry
put option allowed the minority interest holders in St.
Landrys to have their interests redeemed for cash upon the
completion of the IPO and, therefore, the Company recorded an
adjustment of approximately $1.5 million to minority
interests subject to exchange contracts
and/or put
options and to retained earnings which represents the redemption
value of St. Landry interests at June 30, 2005. In
September 2005, certain minority interest holders redeemed their
interests in St. Landrys. This resulted in a cash
payment of approximately $214,000. In connection with the
partial redemption of certain minority interest in September
2005, we decreased our minority interests by approximately
$149,000 and increased our retained earnings by the same amount.
Simultaneously, we recorded goodwill of $214,000 to represent
the value of the minority interests redeemed. Also at the end of
the September 30, 2005 quarter, we recorded a mark to
market charge of $404,000.
In November 2005, the agreement was amended to allow minority
interest holders to redeem their minority interests based on the
St. Landrys rolling twelve month EBITDA in relation to the
Companys EBITDA over the same period. At December 31,
2005, the Company recorded an additional mark to market benefit
of $266,000 to mark the liability to redemption value at the end
of the quarter.
In connection with the partial redemption of certain minority
interest in the year ended December 31, 2006, the Company
decreased minority interest by approximately $1,039,000 and
increased retained earnings by the same amount. Simultaneously,
The Company recorded goodwill of $979,000 to represent the value
of the minority interest redeemed. Also for the year ended
December 31, 2006, the Company recorded a mark to market
benefit of $124,000.
Equity-Based
Compensation Expense
During 2003, the Company began sponsoring a Key Employee Equity
Participation (KEEP) Plan whereby certain
individuals were granted participation equity units (KEEP
Units). The KEEP Plan was terminated in conjunction with
the initial public offering when the outstanding units were
converted to 481,680 shares of common stock. The KEEP Plan
functioned as a stock appreciation rights plan whereby an
individual was entitled to receive, on a per KEEP Unit basis,
the increase in estimated fair value of the
F-13
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Companys common stock from the date of grant until the
date that the employee dies, retires, or is terminated for other
than cause. Accordingly, the KEEP Units were subject to variable
accounting until such time as the obligation to the employee was
settled. The Company had a call right, under which, it could
purchase all or a portion of the KEEP Units. The individuals
receiving KEEP Units vested in those rights in a graded manner
over a five-year period and, accordingly, the Company recorded
compensation expense for the vested portion of the KEEP Units.
The KEEP Units had no exercise price.
Compensation expense, and a corresponding increase in paid-in
capital, was also recognized each period for any change in value
associated with certain KEEP Units that were held by an officer
of the Company.
In conjunction with the initial public offering, the outstanding
KEEP Units were converted to common stock. In conjunction with
this conversion, the Company incurred a charge to equity based
compensation of approximately $3.0 million. For the years
ended December 31, 2005 and 2004, the Company recorded
approximately $3.9 million and $1.8 million
respectively in equity based compensation related to the KEEP
Units. There was no equity based compensation related to the
KEEP units recorded for the year ended December 31, 2006.
Stock-based
Compensation
The Company adopted Statement of Financial Accounting Standards
(SFAS) No. 123(R) (revised 2004), Share-Based
Payment, a revision of SFAS No. 123, Accounting
for Stock-Based Compensation, on January 1, 2006 using
the modified prospective method. This method requires
compensation cost to be recognized beginning with the effective
date (a) based on the requirements of
SFAS No. 123(R) for all share-based payments granted
after the effective date and (b) based on the requirements
of SFAS No. 123 for all awards granted to employees
prior to the effective date of SFAS No. 123(R) that
remain unvested on the effective date. Under this method, prior
periods are not restated to reflect the impact of adopting the
new standard.
Prior to adopting SFAS No. 123R, the Company accounted
for issuances of restricted stock and stock option grants in
accordance with Accounting Principles Board Opinion No. 25,
Accounting for Stock Issued to Employees and related
interpretations (APB 25). Accordingly, the
Company did not recognize compensation cost in the Consolidated
Statements of Income for years prior to adoption of
SFAS No. 123R in connection with the issuance of the
stock options, as the options granted had an exercise price
equal to the market value of the Companys common stock on
the date of grant. The Company did recognize compensation cost
in connection with the issuance of restricted stock.
F-14
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following proforma information illustrates the effect on net
income and earnings per share as if the Company had applied the
fair value recognition provisions of SFAS No. 123 to
options granted in all periods presented. For purposes of this
proforma disclosure, the value of the options is estimated using
the Black-Scholes option pricing formula and amortized to
expense over the options vesting period (in thousands,
except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
2004
|
|
|
Net income, as reported
|
|
$
|
10,102
|
|
|
$
|
9,313
|
|
Redeemable minority interests
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
stockholders, as reported
|
|
|
8,626
|
|
|
|
9,313
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
included in reported net income
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
determined under fair value method
|
|
|
(53
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma income available to
common stockholders
|
|
$
|
8,573
|
|
|
$
|
9,313
|
|
|
|
|
|
|
|
|
|
|
Net income per common share:
|
|
|
|
|
|
|
|
|
As reported:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.69
|
|
|
$
|
0.77
|
|
Diluted
|
|
$
|
0.69
|
|
|
$
|
0.76
|
|
Pro Forma:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.69
|
|
|
$
|
0.77
|
|
Diluted
|
|
$
|
0.68
|
|
|
$
|
0.76
|
|
Net income available to common
stockholders per common share:
|
|
|
|
|
|
|
|
|
As reported:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.59
|
|
|
$
|
0.77
|
|
Diluted
|
|
$
|
0.59
|
|
|
$
|
0.76
|
|
Pro Forma:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.59
|
|
|
$
|
0.77
|
|
Diluted
|
|
$
|
0.58
|
|
|
$
|
0.76
|
|
Black-Scholes option pricing model assumptions:
|
|
|
|
|
|
|
December 31,
|
|
|
|
2005
|
|
|
Risk free interest rate
|
|
|
3.72-4.54
|
%
|
Expected life (years)
|
|
|
5
|
|
Volatility
|
|
|
41.62-43.50
|
|
Expected annual dividend yield
|
|
|
|
|
Earnings
Per Share
Basic per share information is computed by dividing the item by
the weighted-average number of shares outstanding during the
period. Diluted per share information is computed by dividing
the item by the weighted-average number of shares outstanding
plus dilutive potential shares.
F-15
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table sets forth shares used in the computation of
basic and diluted per share information for the years ended
December 31, 2006, 2005 and 2004.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Weighted average number of shares
outstanding for basic per share calculation
|
|
|
17,090,583
|
|
|
|
14,628,737
|
|
|
|
12,085,154
|
|
Effect of dilutive potential
shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
|
2,399
|
|
|
|
790
|
|
|
|
|
|
Restricted stock
|
|
|
11,678
|
|
|
|
1,112
|
|
|
|
|
|
KEEP Units
|
|
|
|
|
|
|
54,000
|
|
|
|
59,996
|
|
Adjusted weighted average shares
for diluted per share calculation
|
|
|
17,104,660
|
|
|
|
14,684,639
|
|
|
|
12,145,150
|
|
Recently
Issued Accounting Pronouncements
In July 2006, the FASB issued FASB Interpretation No. 48,
Accounting for the Uncertainty in Income Taxes,
(FIN 48). FIN 48 is an interpretation of
FASB Statement No. 109, Accounting for Income
Taxes, and it seeks to reduce the diversity in practice
associated with certain aspects of measurement and recognition
in accounting for income taxes. In addition, FIN 48
requires expanded disclosure with respect to the uncertainty in
income taxes and is effective as of the beginning of our 2007
fiscal year. The Company is currently evaluating the impact, if
any, that FIN 48 will have on the financials statements.
In September 2006, the U.S. Securities and Exchange
Commission (SEC) adopted Staff Accounting
Bulletin No. 108 (SAB No. 108),
which expresses the SECs staff views on the process of
quantifying financial statement misstatements. SAB 108
requires that registrants consider evaluating errors under both
the rollover and iron curtain approaches
to determine if such errors are material, thus requiring a
restatement to prior period financial statements. SAB 108
is effective for fiscal years ending on or after
November 15, 2006 and allowed the registrant to avoid
restating prior period financial statements for such errors that
are governed by SAB 108 if the registrant properly
disclosed such errors in its financial statement during the
period of adoption. The Company adopted this new standard as of
December 31, 2006 and it did not have an impact on the
Companys consolidated financial position or results of
operations.
In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements
(SFAS No. 157), which defines fair value,
establishes a framework for measuring fair value in GAAP and
expands disclosures about fair value measurements.
SFAS No. 157 will be effective for financial
statements issued for fiscal years beginning after
November 15, 2007, and interim periods within those fiscal
years. The Company is currently evaluating the requirements of
this new standard and has not concluded its analysis on the
impact to the Companys consolidated financial position or
results of operations.
Reclassifications
Certain prior year amounts on the Consolidated Statements of
Cash Flows have been reclassified to conform with the current
year presentation.
|
|
3.
|
Acquisitions
and Divestitures
|
The following acquisitions were completed pursuant to the
Companys strategy of becoming the leading provider of
post-acute healthcare services to Medicare patients in selected
rural markets in the southern United States. The purchase
price of each acquisition was determined based on the
Companys analysis of comparable acquisitions and target
markets potential cash flows. Goodwill generated from the
acquisitions was recognized based on the expected contributions
of each acquisition to the overall corporate strategy. The
F-16
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Company expects the goodwill recognized in connection with the
acquisition of existing operations to be fully tax deductible.
2006
Acquisitions
During the year ended December 31, 2006, the Company
acquired the existing operations of seven entities, including
assets of $2,204,000, primarily patient accounts receivable, the
minority interest in one of its joint ventures and a license
which was being leased for $22,063,000 in cash and $1,431,000 in
acquisition costs. Goodwill of $13,717,000 and other intangibles
of $8,109,000 were assigned to the home based services segment.
In conjunction with certain minority interest holders redeeming
their interests in St. Landry, $979,000 of goodwill, which is
deductible for income tax purposes, was recognized in the
facility based services segment.
2006
Divestitures
During the year ended December 31, 2006, the Company sold
one of its long-term acute care hospitals for $1,200,000 and
recognized a gain of $958,000 on the sale of this hospital. In
conjunction with this transaction, the Company allocated and
retired $155,000 of goodwill related to this hospital. The
Company also sold a clinic for promissory notes totaling
$946,000 and recognized a loss on the sale of $28,000. Goodwill
of $891,000 was retired in conjunction with the sale of the
clinic. Additionally, the Company closed one location of another
clinic and terminated virtually all of its private duty
business. Finally, the Company sold one of its home health
agencies for $240,000 and retired goodwill of $50,000. The
Company recognized a gain of $98,000 on the sale of this agency.
The Company has identified one long-term acute care hospital and
one pharmacy operation as held for sale as of December 31,
2006. Goodwill of $402,000 and other assets related to these
operations are classified as assets held for sale on the balance
sheet.
2005
Acquisitions
During the year ended December 31, 2005, the Company
acquired the existing operations of seven entities for
$9,541,000 in cash and a promissory note for $250,000 to be paid
over five years. The Company also obtained the right to appoint
a majority of the members of the Board of Directors of a non
profit critical access hospital which was in arrears in payment
of a promissory note of approximately $2.1 million to the
Company. Goodwill of $10,135,000 was assigned to the home based
services segment.
In conjunction with the initial public offering, the Company
issued 518,036 shares of common stock to two of its joint
ventures. The Company accrued a cash payment of
$2.2 million related to one of the acquisitions as of
June 30, 2005 of which the entire amount has been paid as
of December 31, 2005. This transaction resulted in the
recording of goodwill of $8.5 million, which is deductible
for income tax purposes, in the home-based services and
$872,000, which is not deductible for income tax purposes, in
the facility-based services segment.
In conjunction with certain minority interest holders redeeming
their interests in St. Landry, $214,000 of goodwill, which is
not deductible for income tax purposes, was recognized in the
facility based services segment.
2005
Divestitures
The Company sold a minority interest in an extended care
operation and in a pharmacy operation which was wholly owned,
during the three months ended March 31, 2005. The Company
received $873,000 in cash and recognized a gain on these sales
of $526,000. The Company retained majority interests in both
operations.
F-17
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In the three months ended September 30, 2005, the Company
executed a rescission of the sale of the pharmacy operation
resulting in a loss on the complete transaction of approximately
$8,000. There was no goodwill recognized in the transaction.
2004
Acquisitions
The Company made seven acquisitions during 2004 for $790,000 in
cash. These acquisitions were primarily the purchase of the
entities existing operations. Goodwill of $770,000 was
assigned to the home-based services segment and goodwill of
$20,000 was assigned to the facility-based services segment.
The Company also acquired a 70% interest in an outpatient
rehabilitation facility through a stock purchase agreement for
$207,000 in cash. Goodwill of $17,000 was assigned to the
facility-based services segment. The Company also acquired a
100% interest in another outpatient rehabilitation facility
through a stock purchase agreement for $750,000 in cash and a
promissory note for $650,000. Goodwill of $1,220,000 was
assigned to the facility-based services segment.
Additionally, the Company acquired a portion of the minority
interest in a majority-owned home nursing joint venture by
issuing a $300,000 promissory note. A $300,000 increase in the
home-based services segments goodwill was recognized in
connection with this transaction.
2004
Divestitures
The Company sold its majority interest in three hospice
subsidiaries to the minority interest holder. The Company
received $300,000 and recognized a gain on the sale of $347,000.
The Company also sold its interest in a rehabilitation facility
to another owner in the facility for $129,000, receiving cash of
$45,000 and a promissory note for $84,000. The Company
recognized a loss on the sale of $40,000.
The Company sold the rights to operate a home care facility in a
specific area to an unrelated party for $200,000. The Company
received $125,000 in cash and a promissory note for the balance.
The Company recognized a gain on the sale of $200,000.
In connection with the planned divestiture of certain entities
in 2004, management recognized an impairment loss on two
operating entities in 2003.
The following table summarizes the operating results of the
divestitures described above which have been presented as loss
from discontinued operations in the accompanying consolidated
statements of income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Net service revenue
|
|
$
|
8,548
|
|
|
$
|
9,838
|
|
|
$
|
6,890
|
|
Costs, expenses and minority
interest and cooperative endeavor allocations
|
|
|
9,856
|
|
|
|
12,927
|
|
|
|
8,263
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations
before income taxes
|
|
|
(1,308
|
)
|
|
|
(3,089
|
)
|
|
|
(1,373
|
)
|
Income taxes
|
|
|
497
|
|
|
|
1,174
|
|
|
|
522
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
$
|
(811
|
)
|
|
$
|
(1,915
|
)
|
|
$
|
(851
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-18
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table summarizes the changes in goodwill by
segment:
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Home-based services segment:
|
|
|
|
|
|
|
|
|
Balances at beginning of period
|
|
$
|
21,692
|
|
|
$
|
3,104
|
|
Goodwill acquired during the
period from acquisitions
|
|
|
13,603
|
|
|
|
10,135
|
|
Goodwill retired during the period
|
|
|
(50
|
)
|
|
|
|
|
Goodwill acquired during the
period from purchase of minority interest
|
|
|
495
|
|
|
|
8,453
|
|
|
|
|
|
|
|
|
|
|
Balance at end of period
|
|
$
|
35,740
|
|
|
$
|
21,692
|
|
|
|
|
|
|
|
|
|
|
Facility-based services segment:
|
|
|
|
|
|
|
|
|
Balance at beginning of period
|
|
$
|
4,411
|
|
|
$
|
3,325
|
|
Goodwill retired during the period
|
|
|
(1,046
|
)
|
|
|
|
|
Goodwill classified as held for
sale during the period
|
|
|
(402
|
)
|
|
|
|
|
Goodwill acquired during the
period from purchase of minority interest
|
|
|
|
|
|
|
872
|
|
Goodwill acquired during the
period from redemption of minority interest
|
|
|
978
|
|
|
|
214
|
|
|
|
|
|
|
|
|
|
|
Balance at end of period
|
|
$
|
3,941
|
|
|
$
|
4,411
|
|
|
|
|
|
|
|
|
|
|
The above transactions were considered to be immaterial
individually and in the aggregate. Accordingly, no supplemental
pro forma information is required.
Significant components of the Companys deferred tax assets
and liabilities were as follows:
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Conversion from cash basis
accounting
|
|
$
|
(61
|
)
|
|
$
|
(76
|
)
|
Amortization of intangible assets
|
|
|
(842
|
)
|
|
|
(532
|
)
|
Tax in excess of book depreciation
|
|
|
(1,407
|
)
|
|
|
(1,112
|
)
|
Prepaid expenses
|
|
|
(931
|
)
|
|
|
(781
|
)
|
Non-accrual experience accounting
method
|
|
|
(633
|
)
|
|
|
(673
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,874
|
)
|
|
|
(3,174
|
)
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Allowance for uncollectible
accounts
|
|
|
2,045
|
|
|
|
861
|
|
Accrued employee benefits
|
|
|
791
|
|
|
|
429
|
|
Stock compensation
|
|
|
181
|
|
|
|
|
|
Capital loss carryforward
|
|
|
|
|
|
|
52
|
|
NOL carryforward
|
|
|
|
|
|
|
57
|
|
Accrued self-insurance
|
|
|
688
|
|
|
|
354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,705
|
|
|
|
1,753
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax liability
|
|
$
|
(169
|
)
|
|
$
|
(1,421
|
)
|
|
|
|
|
|
|
|
|
|
F-19
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of the Companys income tax expense from
continuing operations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands)
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
9,803
|
|
|
$
|
5,021
|
|
|
$
|
5,393
|
|
State
|
|
|
1,867
|
|
|
|
844
|
|
|
|
634
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,670
|
|
|
|
5,865
|
|
|
|
6,027
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(1,053
|
)
|
|
|
580
|
|
|
|
75
|
|
State
|
|
|
(200
|
)
|
|
|
93
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,253
|
)
|
|
|
673
|
|
|
|
84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
10,417
|
|
|
$
|
6,538
|
|
|
$
|
6,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the differences between income taxes from
continuing operations computed at the federal statutory rate and
provisions for income taxes for each period are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands)
|
|
|
Income taxes computed at federal
statutory tax rate
|
|
$
|
10,915
|
|
|
$
|
6,309
|
|
|
$
|
5,427
|
|
State income taxes, net of federal
benefit
|
|
|
935
|
|
|
|
740
|
|
|
|
629
|
|
Tax exempt proceeds from life
insurance
|
|
|
(380
|
)
|
|
|
|
|
|
|
|
|
Tax exempt interest income
|
|
|
(80
|
)
|
|
|
(78
|
)
|
|
|
|
|
Tax benefit on compensation charge
|
|
|
|
|
|
|
(342
|
)
|
|
|
|
|
Gulf Opportunity Act tax credit
|
|
|
(1,027
|
)
|
|
|
(164
|
)
|
|
|
|
|
Nondeductible expenses
|
|
|
54
|
|
|
|
73
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
10,417
|
|
|
$
|
6,538
|
|
|
$
|
6,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term
Debt
Long-term debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Notes payable:
|
|
|
|
|
|
|
|
|
Due in monthly installments of
$143,000 through July 2006 at 5.5%
|
|
|
|
|
|
|
842
|
|
Due in yearly installments of
$50,000 through August 2010 at prime
|
|
|
190
|
|
|
|
250
|
|
Due in monthly installments of
$20,565 through October 2015 at LIBOR plus 225 basis points
(7.6% at December 31, 2006)
|
|
|
2,898
|
|
|
|
2,929
|
|
Due in monthly installments of
$48,500 through March 2006 at 5.7%
|
|
|
|
|
|
|
144
|
|
Due in monthly installments of
$12,500 through November 2009 at 3.08%
|
|
|
391
|
|
|
|
515
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,479
|
|
|
|
4,680
|
|
Less current portion of long-term
debt
|
|
|
428
|
|
|
|
1,406
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,051
|
|
|
$
|
3,274
|
|
|
|
|
|
|
|
|
|
|
F-20
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In August 2005, the Company entered into a promissory note with
Bancorp Equipment Finance, Inc. to purchase an airplane, for a
principal amount of $2,975,000 with interest on any outstanding
principal balance at the one month LIBOR rate plus
225 basis points (7.6% at December 31, 2006). The note
is collateralized by the airplane and is payable in
119 monthly installments of $20,565 followed by one balloon
installment in the amount of $1,920,565.
In August 2005, the Company entered into a promissory note with
the seller of
A-1 Nursing
Registry, Inc.
(A-1)
in conjunction with the purchase of the assets of
A-1. The
principal amount of the note is $250,000 and it bears interest
at 6.25%.
Certain of the Companys loan agreements contain certain
restrictive covenants, including limitations on indebtedness and
the maintenance of certain financial ratios. At
December 31, 2006 and 2005, the Company was in compliance
with all covenants.
The scheduled principal payments on long-term debt are as
follows for each of the next five years following
December 31, 2005 (in thousands):
|
|
|
|
|
2007
|
|
$
|
428
|
|
2008
|
|
|
435
|
|
2009
|
|
|
419
|
|
2010
|
|
|
287
|
|
2011
|
|
|
247
|
|
Thereafter
|
|
|
1,663
|
|
|
|
|
|
|
|
|
$
|
3,479
|
|
|
|
|
|
|
Other
Credit Arrangements
The Company maintains a revolving-debt arrangement. Under the
terms of this arrangement, the Company may be advanced funds up
to a defined limit of eligible accounts receivable not to exceed
the borrowing limit. At December 31, 2006 and 2005, the
borrowing limit was $22.5 million and there were no amounts
outstanding. The total availability may be increased up to a
maximum of $25.0 million, subject to certain terms and
conditions. Interest accrues on outstanding amounts at a varying
rate and is based on the Wells Fargo Bank, N.A. prime rate plus
1.5% (9.75% at December 31, 2006). The annual facility fee
is 0.5% of the total availability. The agreement expires on
April 15, 2010.
Public
Offering
On July 19, 2006, the Company closed its follow-on public
offering of 4,000,000 shares of common stock at a price of
$19.25 per share. Of the 4,000,000 shares of common
stock offered, 1,000,000 shares were offered by the
Company, with the remaining 3,000,000 shares of common
stock sold by the selling stockholders identified in the
prospectus supplement. The underwriters exercised an
over-allotment of an additional 600,000 shares, 150,000 of
which were sold by the Company. The additional net cash provided
to the Company from this offering after deducting expenses and
underwriting discounts and commissions amounted to approximately
$20.7 million.
Share
Based Compensation
On January 20, 2005, the board of directors and
stockholders of the Company approved the 2005 Long-Term
Incentive Plan (the Incentive Plan). The Incentive
Plan provides for 1,000,000 shares of common stock that may
be issued or transferred pursuant to awards made under the plan.
A variety of discretionary awards
F-21
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
for employees, officers, directors and consultants are
authorized under the Incentive Plan, including incentive or
non-qualified statutory stock options and restricted stock. All
awards must be evidenced by a written award certificate which
will include the provisions specified by the compensation
committee of the board of directors. The compensation committee
will determine the exercise price for non-statutory stock
options. The exercise price for any option cannot be less than
the fair market value of our common stock as of the date of
grant.
Also on January 20, 2005, the 2005 Director
Compensation Plan was adopted. The shares issued under our
2005 Director Compensation Plan are issued from the
1,000,000 shares reserved for issuance under our Incentive
Plan. In 2005, 13,500 stock options were granted at the fair
market value of the underlying stock with a weighted average
option price of $14.45. These options vested immediately and
have a contractual life of 10 years. The weighted average
exercise price ranges between $14.00-$17.05. All 13,500 options
were exercisable at December 31, 2005.
Additionally, the independent directors were granted initial
restricted stock awards under the Director Compensation Plan.
During 2005, 24,500 units were granted at an average market
value at the date of the award of $14.44.
The Company accounted for these issuances of restricted stock
and stock option grants in accordance with Accounting Principles
Board Opinion No. 25, Accounting for Stock Issued to
Employees and related interpretations
(APB 25). Accordingly, the Company did not
recognize compensation cost in connection with the issuance of
the stock options, as the options granted had an exercise price
equal to the market value of the Companys common stock on
the date of grant. During the year ended December 31, 2005,
the Company did recognize compensation cost in connection with
the issuance of restricted stock in the amount of $177,000.
Stock
Options
The Company uses the Black-Scholes option pricing model to
estimate the fair value of stock-based awards with the following
weighted-average assumptions.
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2006
|
|
|
Risk free interest rate
|
|
|
5.03
|
%
|
Expected life (years)
|
|
|
5
|
|
Expected volatility
|
|
|
38.39
|
|
Expected annual dividend yield
|
|
|
|
|
The following table represents stock options activity for the
year ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted Average
|
|
|
|
|
|
|
Number of
|
|
|
Average Exercise
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
Shares
|
|
|
Price
|
|
|
Contractual Term
|
|
|
Intrinsic Value
|
|
|
Options outstanding at
December 31, 2005
|
|
|
13,500
|
|
|
$
|
14.45
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
15,500
|
|
|
|
19.75
|
|
|
|
|
|
|
|
|
|
Options exercised
|
|
|
(8,000
|
)
|
|
|
16.88
|
|
|
|
|
|
|
|
|
|
Options forfeited or expired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding at
December 31, 2006
|
|
|
21,000
|
|
|
|
17.44
|
|
|
|
|
|
|
|
|
|
Options exercisable at
December 31, 2006
|
|
|
21,000
|
|
|
|
17.44
|
|
|
|
9.0 years
|
|
|
$
|
232,500
|
|
F-22
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The weighted average grant date fair value of options granted
during the years 2006 and 2005 were $8.26 and $6.12,
respectively. There were no options granted during 2004. The
total intrinsic value of options exercised during the year ended
December 31, 2006 was $29,800. No options were exercised in
the years ended December 31, 2005 or 2004. The Company has
recorded $134,000 in compensation expense related to stock
option grants in the year ended December 31, 2006. The
proforma expense for the same period in 2005 was $53,000. All
options are fully vested and exercisable at December 31,
2006.
Nonvested
Stock
During 2006 and 2005, respectively, 3,500 and 24,500 nonvested
shares of stock were granted to our independent directors under
the 2005 Director Compensation Plan. One third of these
shares vested immediately, and the remaining vest over the two
year period following the grant date. During 2006, 86,114
nonvested shares were granted to employees. These shares vest
over a five year period. These shares were granted pursuant to
the 2005 Long-Term Incentive Plan. The fair value of nonvested
shares is determined based on the closing trading price of the
Companys shares on the grant date. The weighted average
grant date fair values of nonvested shares granted during the
years ended December 31, 2006 and 2005 were $18.66 and
$14.44, respectively.
The following table represents the nonvested stock activity for
the year ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
Number of
|
|
|
Average Grant
|
|
|
|
Shares
|
|
|
Date Fair Value
|
|
|
Nonvested shares outstanding at
December 31, 2005
|
|
|
16,333
|
|
|
$
|
14.44
|
|
Granted
|
|
|
89,614
|
|
|
|
18.66
|
|
Vested
|
|
|
(9,333
|
)
|
|
|
15.14
|
|
Forfeited
|
|
|
(9,898
|
)
|
|
|
18.23
|
|
Nonvested shares outstanding at
December 31, 2006
|
|
|
86,716
|
|
|
|
18.29
|
|
As of December 31, 2006, there was $1.4 million of
total unrecognized compensation cost related to nonvested shares
granted. That cost is expected to be recognized over the
weighted average period of 3.8 years. The total fair value
of shares vested in the years ended December 31, 2006 and
2005 were $190,000 and $118,000, respectively. The Company
records compensation expense related to nonvested share awards
at the grant date for shares that are awarded fully vested, and
over the vesting term on a straight line basis for shares that
vest over time. The Company has recorded $449,000 and $177,000
in compensation expense related to nonvested stock grants in the
years ended December 31, 2006 and 2005 respectively.
Employee
Stock Purchase Plan
The Company has a plan whereby eligible employees may purchase
the Companys common stock at 95% of the market price on
the last day of the calendar quarter. There are
250,000 shares reserved for the plan. The Company issued
7,096 shares of common stock under the plan at a weighted
average per share price of $19.75 during the year ended
December 31, 2006. At December 31, 2006 there were
242,904 shares available for future issuance.
Treasury
Stock
In conjunction with the conversion of the KEEP units to common
stock during the initial public offering, the recipients
incurred withholding tax liabilities. The Company allowed KEEP
unit holders to turn in shares of common stock at
December 30, 2005 to satisfy those tax obligations. The
Company redeemed 35,209 shares of common stock related to
these tax obligations at December 30, 2005.
F-23
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
7.
|
Related
Party Transactions
|
Employee
Receivables
At December 31, 2005, the Company had recorded a receivable
from employees of $1.9 million related to withholding taxes
on the KEEP units that were converted to common stock in
conjunction with the initial public offering. The amount was
settled in January 2006 by either a cash payment or the
assignment of common stock to the Company.
Additionally, as a result of Hurricanes Katrina and Rita, the
Company established a loan fund to allow affected employees to
borrow up to six months of their salary to aid in their recovery
from the hurricanes. The loan agreements bear interest of 3.5%.
The employees will begin payment on the loans one year after the
date of the agreement through payroll deductions. As of
December 31, 2006 and 2005, these loans totaled $363,000
and $456,000, respectively, and are included in other assets on
the balance sheet.
Catalyst
Fund, Ltd. and Southwest/Catalyst Capital, Ltd.
Investments
In July 2001, the Company entered into a loan agreement with the
Catalyst Fund, Ltd., and Southwest/Catalyst Capital, Ltd.
(Catalyst Entities), involving an aggregate amount
of $2,000,000. These loans were evidenced by individual
promissory notes, each in the principal amount of $1,000,000,
accruing interest at a rate of 12.0% per annum and payable
in equal monthly installments of approximately $26,000 in
principal and interest, due through July 1, 2006. As of
June 30, 2005, this note was paid in full.
Repurchase
of Common Stock from Certain Stockholders
In March 2001, certain stockholders agreed to sell the
equivalent of an aggregate of 3,881,663 shares of the
Companys currently outstanding common stock to the
Company. The purchase price was paid pursuant to a promissory
note in the principal amount of approximately $1,000,000. The
note bore interest at a rate of 15.5%, and payments of
approximately $25,000 were due each month. At December 31,
2004, $319,000 in principal was outstanding under this note. The
note was paid in full during 2005. An additional payment under a
non-compete agreement was paid to the former stockholders in
2005 as the Company met certain performance-based criteria.
The repurchased shares were held in escrow as collateral for the
payment of the purchase price. As payments under the promissory
note were made, a proportion of the total repurchased shares
were released. This proportion was determined by dividing the
principal amount paid in the particular installment by a price
per share of $0.268. The sole and exclusive remedy available in
the event of default under the promissory note was foreclosure
on the remaining collateral. At December 31, 2004,
1,190,608 treasury units were considered restricted under the
terms of this agreement. During 2005, all shares were released
in conjunction with the repayment of the note.
Indebtedness
of Officer of the Company
In October 2004, an officer repaid in full a promissory note
held by the Company in the principal amount of $90,000. The
promissory note, which had an interest rate of 7% per
annum, was formerly secured by 33,000 KEEP Units held by the
officer. In connection with its repayment by the officer, the
promissory note was canceled and the Companys security
interest in the officers KEEP Units was terminated.
The officer was the obligor under another promissory note in the
Companys favor in the principal amount of $123,000, which
note had an interest rate of 6% per annum and was due on or
before March 3, 2010. The officer was entitled under the
note to prepay all or any part of this obligation without
penalty. This promissory note was intended to serve as payment
of the purchase price for 150,000 shares of common stock
purchased by the officer under a subscription agreement, dated
March 3, 2004. The Company recognized a
F-24
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
compensation charge of $600,000 in connection with the issuance
of these shares of common stock. As security for the repayment
of the promissory note, the officer concurrently executed an Act
of Pledge in which he granted the Company the right to sell any
or all of his shares of common stock in the event of default
under or nonpayment of the promissory note. In exchange for the
return of the 150,000 shares of common stock formerly
issued to the officer, this promissory note was canceled on
June 30, 2004. The Company issued this officer 225,000 KEEP
Units in connection with the return of the 150,000 shares
of common stock described above.
Beginning in 2001, the Company recognized compensation charges
related to stock grants made to this officer. These charges
totaled $1,500,000 at the date of the return of the stock
described above.
The Company, through a wholly owned subsidiary, entered into a
lease agreement in 2001 for a Medicare and a Medicaid license
and the associated provider numbers. The initial term of the
agreement was five years and at its expiration, the Company
acquired the licenses for $1.1 million. Through two of its
wholly owned subsidiaries, the Company entered into one lease
agreement in 2003 and another in 2005 for a Medicare and a
Medicaid license and the associated provider numbers. The
agreements are each for an initial term of five years and will
be automatically extended for a consecutive five-year term
unless the lessee gives written notice to the lessor
180 days prior to the expiration date of the initial term.
The initial lease terms expire in 2008 and 2010. Expense related
to these leases was $525,000 in 2006, $436,000 in 2005 and
$545,000 in 2004. Payments due under these leases are $ $243,000
in 2007, $182,000 in 2008. These payments do not include
payments for the license granted in 2005 as these are dependent
on net quarterly profits. Each license has a $160,000 limit per
year on the amount that can be paid.
The Company leases office space and equipment at its various
locations. Total rental expense was approximately $7,563,000 in
2006, $5,391,000 in 2005 and $4,318,000 in 2004. Future minimum
rental commitments under non-cancelable operating leases, are as
follows for the periods ending December 31 (in thousands):
|
|
|
|
|
2007
|
|
$
|
5,190
|
|
2008
|
|
|
3,645
|
|
2009
|
|
|
1,619
|
|
2010
|
|
|
844
|
|
2011
|
|
|
576
|
|
Thereafter
|
|
|
975
|
|
|
|
|
|
|
|
|
$
|
12,849
|
|
|
|
|
|
|
F-25
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
As of December 31, 2006, future minimum payments by year
and in the aggregate, under non-cancelable capital leases with
initial terms of one year or more, consisted of the following
(in thousands):
|
|
|
|
|
2007
|
|
$
|
211
|
|
2008
|
|
|
88
|
|
2009
|
|
|
58
|
|
2010
|
|
|
|
|
2011
|
|
|
|
|
Thereafter
|
|
|
|
|
|
|
|
|
|
Total minimum lease payments
|
|
|
358
|
|
Current portion of capital lease
obligations
|
|
|
211
|
|
|
|
|
|
|
Capital lease obligations,
long-term
|
|
$
|
147
|
|
|
|
|
|
|
The cost of assets held under capital leases was $1,070,000 and
$1,404,000 at December 31, 2006 and 2005, respectively. The
related accumulated amortization was $603,000 and $489,000 at
December 31, 2006 and 2005, respectively.
The Company sponsors a profit-sharing 401(k) plan that covers
substantially all eligible full-time employees. The plan allows
participants to contribute up to 15% of their compensation and
allows discretionary Company contributions as determined by the
Companys board of directors. Discretionary contributions
authorized to the plan during the years ended December 31,
2005, and 2004, were $0 and $474,000 respectively. Effective
January 1, 2006, the Company implemented a discretionary
match of up to 2% of participating employee contributions. The
employer contribution will vest 20% after two years, and 20%
each additional year until it is fully vested in year six. At
December 31, 2006, $693,000 related to this match is
included in salaries, wages, and benefits payable.
|
|
10.
|
Commitments
and Contingencies
|
Contingencies
The terms of several joint venture operating agreements grant a
buy/sell option that would require the Company to either
purchase or sell the existing membership interest in the joint
venture within 30 days of the receipt of the notice to
exercise the provision (See Note 2). Either the Company or
its joint venture partner has the right to exercise the buy/sell
option. The party receiving the exercise notice has the right to
either purchase the interests held by the other party, sell its
interests to the other party or dissolve the partnership. The
purchase price formula for the interests is set forth in the
joint venture agreement and is typically based on a multiple of
the earnings before income taxes, depreciation and amortization
of the joint venture. Total revenue earned by the Company from
joint ventures subject to these arrangements was $13,921,000,
$13,681,000, and $23,178,000 for the year ended
December 31, 2006, 2005 and 2004, respectively. There is
one joint venture operating agreement remaining as of
December 31, 2006 with a buy/sell option. As of
March 14, 2007, approximately 76.5% of the doctors have
converted their minority interests to cash. The Company has not
received notice from any joint venture partners of their intent
to exercise the buy/sell option nor has the Company notified any
joint venture partners of any intent to exercise the buy/sell
option.
The Company is involved in various legal proceedings arising in
the ordinary course of business. Although the results of
litigation cannot be predicted with certainty, management
believes the outcome of pending litigation will not have a
material adverse effect, after considering the effect of the
Companys insurance coverage, on the Companys
consolidated financial statements.
F-26
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Compliance
The laws and regulations governing the Companys
operations, along with the terms of participation in various
government programs, regulate how the Company does business, the
services offered, and interactions with patients and the public.
These laws and regulations, and their interpretations, are
subject to frequent change. Changes in existing laws or
regulations, or their interpretations, or the enactment of new
laws or regulations could materially and adversely affect the
Companys operations and financial condition.
The Company is subject to various routine and non-routine
governmental reviews, audits, and investigations. In recent
years, federal and state civil and criminal enforcement agencies
have heightened and coordinated their oversight efforts related
to the healthcare industry, including with respect to referral
practices, cost reporting, billing practices, joint ventures,
and other financial relationships among healthcare providers.
Violation of the laws governing the Companys operations,
or changes in the interpretation of those laws, could result in
the imposition of fines, civil or criminal penalties, the
termination of the Companys rights to participate in
federal and state-sponsored programs, and the suspension or
revocation of the Companys licenses.
If the Companys long-term acute care hospitals fail to
meet or maintain the standards for Medicare certification as
long-term acute care hospitals, such as average minimum length
of patient stay, they will receive payments under the
prospective payment system applicable to general acute care
hospitals rather than payment under the system applicable to
long-term acute care hospitals. Payments at rates applicable to
general acute care hospitals would likely result in the Company
receiving less Medicare reimbursement than currently received
for patient services. Moreover, all but one of the
Companys long-term acute care hospitals are subject to
additional Medicare criteria because they operate as separate
hospitals located in space leased from, and located in, a
general acute care hospital, known as a host hospital. This is
known as a hospital within a hospital model. These
additional criteria include requirements concerning financial
and operational separateness from the host hospital.
The Company anticipates there may be changes to the standard
episode-of-care
payment from Medicare in the future. Due to the uncertainty of
the revised payment amount, the Company cannot estimate the
impact that changes in the payment rate, if any, will have on
its future financial statements.
The Company believes that it is in material compliance with all
applicable laws and regulations and is not aware of any pending
or threatened investigations involving allegations of potential
wrongdoing. While no such regulatory inquiries have been made,
compliance with such laws and regulations can be subject to
future government review and interpretation as well as
significant regulatory action, including fines, penalties, and
exclusion from the Medicare program.
|
|
11.
|
Concentration
of Risk
|
The Companys Louisiana facilities accounted for
approximately 63.5%, 78.8%, and 82.8% of net service revenue
during the years ended December 31, 2006, 2005, and 2004,
respectively. Any material change in the current economic or
competitive conditions in Louisiana could have a
disproportionate effect on the Companys overall business
results.
The Companys segments consist of (a) home-based
services and (b) facility-based services. Home-based
services include home nursing services and hospice services.
Facility-based services include long-term acute care services
and outpatient rehabilitation services. The accounting policies
of the segments are the same as those described in the summary
of significant accounting policies.
F-27
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
164,701
|
|
|
$
|
50,547
|
|
|
$
|
215,248
|
|
Cost of service revenue
|
|
|
79,070
|
|
|
|
30,781
|
|
|
|
109,851
|
|
General and administrative expenses
|
|
|
55,700
|
|
|
|
15,425
|
|
|
|
71,125
|
|
Equity-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
29,931
|
|
|
|
4,341
|
|
|
|
34,272
|
|
Interest expense
|
|
|
210
|
|
|
|
115
|
|
|
|
325
|
|
Non operating (income) loss,
including gain on sale of assets
|
|
|
(1,404
|
)
|
|
|
(629
|
)
|
|
|
(2,033
|
)
|
Income from continuing operations
before income taxes and minority interest and cooperative
endeavor allocations
|
|
|
31,125
|
|
|
|
4,855
|
|
|
|
35,980
|
|
Minority interest and cooperative
endeavor allocations
|
|
|
3,075
|
|
|
|
1,720
|
|
|
|
4,795
|
|
Income from continuing operations
before income taxes
|
|
|
28,050
|
|
|
|
3,135
|
|
|
|
31,185
|
|
Total assets
|
|
|
117,585
|
|
|
|
35,109
|
|
|
|
152,694
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2005
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
105,587
|
|
|
$
|
47,124
|
|
|
$
|
152,711
|
|
Cost of service revenue
|
|
|
51,254
|
|
|
|
28,353
|
|
|
|
79,607
|
|
General and administrative expenses
|
|
|
33,650
|
|
|
|
12,013
|
|
|
|
45,663
|
|
Equity-based compensation expense
|
|
|
2,699
|
|
|
|
1,157
|
|
|
|
3,856
|
|
Operating income
|
|
|
17,984
|
|
|
|
5,601
|
|
|
|
23,585
|
|
Interest expense
|
|
|
690
|
|
|
|
369
|
|
|
|
1,059
|
|
Non operating (income) loss,
including gain on sale of assets
|
|
|
(132
|
)
|
|
|
(442
|
)
|
|
|
(574
|
)
|
Income from continuing operations
before income taxes and minority interest and cooperative
endeavor allocations
|
|
|
17,426
|
|
|
|
5,674
|
|
|
|
23,100
|
|
Minority interest and cooperative
endeavor allocations
|
|
|
3,142
|
|
|
|
1,403
|
|
|
|
4,545
|
|
Income from continuing operations
before income taxes
|
|
|
14,284
|
|
|
|
4,271
|
|
|
|
18,555
|
|
Total assets
|
|
|
70,889
|
|
|
|
33,729
|
|
|
|
104,618
|
|
F-28
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2004
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
81,624
|
|
|
$
|
34,466
|
|
|
$
|
116,090
|
|
Cost of service revenue
|
|
|
39,402
|
|
|
|
18,270
|
|
|
|
57,672
|
|
General and administrative expenses
|
|
|
25,227
|
|
|
|
9,941
|
|
|
|
35,168
|
|
Equity-based compensation expense
|
|
|
1,252
|
|
|
|
536
|
|
|
|
1,788
|
|
Operating income
|
|
|
15,743
|
|
|
|
5,719
|
|
|
|
21,462
|
|
Interest expense
|
|
|
893
|
|
|
|
435
|
|
|
|
1,328
|
|
Non operating income(loss),
including gain on sale of assets
|
|
|
(380
|
)
|
|
|
393
|
|
|
|
13
|
|
Income from continuing operations
before income taxes and minority interest and cooperative
endeavor allocations
|
|
|
15,230
|
|
|
|
4,891
|
|
|
|
20,121
|
|
Minority interest and cooperative
endeavor allocations
|
|
|
3,048
|
|
|
|
1,110
|
|
|
|
4,158
|
|
Income from continuing operations
before income taxes
|
|
|
12,182
|
|
|
|
3,781
|
|
|
|
15,963
|
|
Total assets
|
|
|
30,049
|
|
|
|
17,470
|
|
|
|
47,519
|
|
|
|
13.
|
Fair
Value of Financial Instruments
|
The carrying amounts of the Companys cash, receivables,
accounts payable, and accrued liabilities approximate their fair
values because of their short maturity.
The carrying amount of the Companys lines of credit and
capital lease obligations approximate their fair values because
the interest rates are considered to be at market rates. The
fair value of the long-term debt is based on the current
interest rates on the Companys variable debt.
|
|
14.
|
Allowance
for Uncollectible Accounts and Property, Building, and
Equipment
|
The following table summarizes the activity and ending balances
in the allowance for uncollectible accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning
|
|
|
|
|
|
|
|
|
End of
|
|
|
|
of Year
|
|
|
Additions and
|
|
|
|
|
|
Year
|
|
|
|
Balance
|
|
|
Expenses
|
|
|
Deductions
|
|
|
Balance
|
|
|
|
(In thousands)
|
|
|
Year ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
$
|
2,544
|
|
|
$
|
4,778
|
|
|
$
|
1,543
|
|
|
$
|
5,769
|
|
2005
|
|
|
1,168
|
|
|
|
3,188
|
|
|
|
1,812
|
|
|
|
2,544
|
|
2004
|
|
|
418
|
|
|
|
1,556
|
|
|
|
806
|
|
|
|
1,168
|
|
F-29
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table describes the components of property,
building, and equipment:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Land
|
|
$
|
135
|
|
|
$
|
137
|
|
Building and improvements
|
|
|
2,891
|
|
|
|
2,377
|
|
Transportation equipment
|
|
|
3,480
|
|
|
|
3,339
|
|
Furniture and other equipment
|
|
|
10,321
|
|
|
|
7,519
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,827
|
|
|
|
13,372
|
|
Less accumulated depreciation and
amortization
|
|
|
5,122
|
|
|
|
3,148
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
11,705
|
|
|
$
|
10,224
|
|
|
|
|
|
|
|
|
|
|
|
|
15.
|
Unaudited
Summarized Quarterly Financial Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
Second Quarter
|
|
|
Third Quarter
|
|
|
Fourth Quarter
|
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
45,251
|
|
|
$
|
48,513
|
|
|
$
|
57,266
|
|
|
$
|
64,218
|
|
Gross margin
|
|
|
21,782
|
|
|
|
24,078
|
|
|
|
27,779
|
|
|
|
31,758
|
|
Net income
|
|
|
4,136
|
|
|
|
4,256
|
|
|
|
5,271
|
|
|
|
6,931
|
|
Net income available to common
stockholders
|
|
|
4,979
|
|
|
|
4,428
|
|
|
|
5,199
|
|
|
|
7,151
|
|
Basic earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.26
|
|
|
$
|
0.26
|
|
|
$
|
0.30
|
|
|
$
|
0.39
|
|
Net income available to common
shareholders
|
|
$
|
0.31
|
|
|
$
|
0.27
|
|
|
$
|
0.30
|
|
|
$
|
0.40
|
|
Diluted earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.26
|
|
|
$
|
0.26
|
|
|
$
|
0.30
|
|
|
$
|
0.39
|
|
Net income available to common
shareholders
|
|
$
|
0.31
|
|
|
$
|
0.27
|
|
|
$
|
0.30
|
|
|
$
|
0.40
|
|
Weighted average shares
outstanding Basic
|
|
|
16,557,828
|
|
|
|
16,561,398
|
|
|
|
17,557,576
|
|
|
|
17,730,698
|
|
Diluted
|
|
|
16,563,368
|
|
|
|
16,576,068
|
|
|
|
17,574,541
|
|
|
|
17,751,390
|
|
F-30
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
Second Quarter
|
|
|
Third Quarter
|
|
|
Fourth Quarter
|
|
|
|
2005
|
|
|
2005
|
|
|
2005
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
35,506
|
|
|
$
|
35,973
|
|
|
$
|
38,557
|
|
|
$
|
42,675
|
|
Gross margin
|
|
|
17,744
|
|
|
|
17,279
|
|
|
|
18,340
|
|
|
|
19,741
|
|
Net income
|
|
|
3,287
|
|
|
|
887
|
|
|
|
2,758
|
|
|
|
3,170
|
|
Net income available to common
stockholders
|
|
|
3,287
|
|
|
|
(600
|
)
|
|
|
2,354
|
|
|
|
3,585
|
|
Basic earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.27
|
|
|
$
|
0.07
|
|
|
$
|
0.17
|
|
|
$
|
0.19
|
|
Net income available to common
shareholders
|
|
$
|
0.27
|
|
|
$
|
(0.04
|
)
|
|
$
|
0.14
|
|
|
$
|
0.21
|
|
Diluted earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.26
|
|
|
$
|
0.07
|
|
|
$
|
0.17
|
|
|
$
|
0.19
|
|
Net income available to common
shareholders
|
|
$
|
0.26
|
|
|
$
|
(0.04
|
)
|
|
$
|
0.14
|
|
|
$
|
0.21
|
|
Weighted average shares
outstanding Basic
|
|
|
12,085,154
|
|
|
|
13,174,690
|
|
|
|
16,591,870
|
|
|
|
16,592,134
|
|
Diluted
|
|
|
12,207,532
|
|
|
|
13,277,039
|
|
|
|
16,594,774
|
|
|
|
16,595,901
|
|
F-31
SIGNATURES
Pursuant to the requirements of Section 13 or 15
(d) of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
LHC GROUP, INC.
Keith G. Myers
President and Chief Executive Officer
Date March 16, 2007
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Keith G. Myers and Barry
E. Stewart and either of them (with full power in each to act
alone) as true and lawful
attorneys-in-fact
with full power of substitution, for him and in his name, place
and stead, in any and all capacities, to sign any and all
amendments to this Annual Report on
Form 10-K,
and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the Securities and
Exchange Commission, hereby ratifying and confirming all that
said
attorneys-in-fact,
or their substitute or substitutes, may lawfully do or cause to
be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed by the following persons on
behalf of the registrant and in the capacities and on the dates
indicated:
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
/s/ Keith
G. Myers
Keith
G. Myers
|
|
President, Chief Executive Officer
and Chairman of the Board of Directors
|
|
March 16, 2007
|
|
|
|
|
|
/s/ Barry
E. Stewart
Barry
E. Stewart
|
|
Executive Vice President, Chief
Financial Officer
|
|
March 16, 2007
|
|
|
|
|
|
/s/ John
L. Indest
John
L. Indest
|
|
Executive Vice President, Chief
Operating Officer, Secretary and Director
|
|
March 16, 2007
|
|
|
|
|
|
/s/ Dan
S. Wilford
Dan
S. Wilford
|
|
Director
|
|
March 16, 2007
|
|
|
|
|
|
/s/ Ronald
T. Nixon
Ronald
T. Nixon
|
|
Director
|
|
March 16, 2007
|
|
|
|
|
|
/s/ Ted
W. Hoyt
Ted
W. Hoyt
|
|
Director
|
|
March 16, 2007
|
|
|
|
|
|
/s/ George
A. Lewis
George
A. Lewis
|
|
Director
|
|
March 16, 2007
|
|
|
|
|
|
/s/ John
B. Breaux
John
B. Breaux
|
|
Director
|
|
March 16, 2007
|
|
|
|
|
|
/s/ Nancy
G. Brinker
Nancy
G. Brinker
|
|
Director
|
|
March 16, 2007
|
|
|
|
|
|
/s/ W.J.
Billy
Tauzin
W.J.
Billy Tauzin
|
|
Director
|
|
March 16, 2007
|
66
EXHIBIT INDEX
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibits
|
|
|
2
|
.1
|
|
Asset purchase Agreement, dated
June 19, 2006, by and among the Registrant, The Lifeline
Health Group, Inc. and various subsidiaries of The Lifeline
Health Group, Inc. (previously filed as Exhibit 2.1 to the
Registrants
Form 8-K
on June 19, 2006).
|
|
3
|
.1
|
|
Certificate of Incorporation of
LHC Group, Inc. (previously filed as an exhibit to the
Form S-1/A
(File No. 333-120792)
on February 14, 2005)
|
|
3
|
.2
|
|
Bylaws of LHC Group, Inc.
(previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on May 9, 2005)
|
|
4
|
.1
|
|
Specimen Stock Certificate of
LHCs Common Stock, par value $0.01 per share
(previously filed as an exhibit to the
Form S-1/
A (File
No. 333-120792)
on February 14, 2005)
|
|
4
|
.2
|
|
Reference is made to
Exhibits 3.1 and 3.2 (previously filed as an exhibit to the
Form S-1/A
(File No. 333-120792)
on February 14, 2005 and May 9, 2005, respectively)
|
|
10
|
.1
|
|
St. Landry Payment Amendment
Agreement, dated November 9, 2005, between LHC Group, Inc.
and the members of St. Landrys Extended Care Hospital, LLC
(previously filed as an exhibit to the
Form 10-Q
on November 14, 2005).
|
|
10
|
.2
|
|
Exchange Agreement between
Louisiana Healthcare Group, LLC, LHC Group, LLC and Beta
HomeCare, Inc., dated September 14, 2004 (previously filed
as an exhibit to the
Form S-1/A
(File No. 333-120792)
on November 26, 2004).
|
|
10
|
.3
|
|
Exchange Agreement between
Louisiana Healthcare Group, LLC, LHC Group, LLC and Hebert,
Thibodeaux, Albro and Touchet Therapy Group, dated
November 23, 2004 (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on November 26, 2004).
|
|
10
|
.4
|
|
LHC 2003 Key Employee Equity
Participation Plan (previously filed as an exhibit to the
Form S-1/A
(File No. 333-120792)
on November 26, 2004).
|
|
10
|
.5
|
|
LHC Group, Inc. 2005 Long-Term
Incentive Plan (previously filed as an exhibit to the
Form S-1/A
(File No. 333-120792)
on February 14, 2005).
|
|
10
|
.6
|
|
Form of Award under LHC Group,
Inc. 2005 Director Compensation Plan. (previously filed as
an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005)
|
|
10
|
.7
|
|
Employment Agreement between LHC
Group, Inc. and Keith G. Myers (previously filed as an exhibit
to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.8
|
|
Employment Agreement between LHC
Group, Inc. and Barry E. Stewart (previously filed as an exhibit
to the Registrants
Form 8-K
on May 26, 2006).
|
|
10
|
.9
|
|
Employment Agreement between LHC
Group, Inc. and John L. Indest (previously filed as an exhibit
to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.10
|
|
Employment Agreement between LHC
Group, Inc. and Daryl J. Doise (previously filed as an exhibit
to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.11
|
|
Form of Indemnity Agreement
between LHC Group and directors and certain officers (previously
filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.12
|
|
LHC Group, Inc. 2005 Director
Compensation Plan (previously filed as an exhibit to the
Form S-1/A
(File No. 333-120792)
on February 14, 2005).
|
|
10
|
.13
|
|
Second Amended and Restated Loan
and Security Agreement among Residential Funding Corporation,
LHC Group, Inc. and its subsidiaries listed as Borrowers on the
signature pages attached thereto, dated April 13, 2005
(previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on May 9, 2005).
|
|
10
|
.14
|
|
Lease Agreement by and among
Mississippi Baptist Medical Center, Inc., Mississippi Baptist
Health Systems, Inc., Mississippi HomeCare of Jackson, LLC,
Mississippi Health Care Group, LLC and LHC Group, LLC, dated
September 30, 2003 (previously filed as an exhibit to the
Form S-1/A
(File No. 333-120792)
on May 9, 2005).
|
|
10
|
.15
|
|
Operating Agreement of Acadian
Home Health Care Services, LLC, dated January 1, 2004
(previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on May 9, 2005)
|
|
10
|
.16
|
|
Operating Agreement of St. Landry
Extended Care Hospital, LLC, dated April 15, 2004
(previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on May 20, 2005).
|
67
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibits
|
|
|
10
|
.17
|
|
Operating Agreement of LHCG-III,
LLC d/b/a Extended Care Hospital of Lafayette, dated
January 1, 2005 (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on May 20, 2005).
|
|
10
|
.18
|
|
Operating Agreement of Acadian
Home Care, LLC, dated April 1, 2004 (previously filed as an
exhibit to the
Form S-1/A
(File
No. 333-120792)
on May 20, 2005).
|
|
10
|
.19
|
|
Amendment to LHC Group, Inc.
2005 Director Compensation Plan (previously filed as
Exhibit 99.1 to the Registrants
Form 8-K
on June 12, 2006).
|
|
10
|
.20
|
|
LHC Group, Inc. 2006 Employee
Stock Purchase Plan (previously filed as Exhibit 99.2 to
the Registrants
Form 8-K
on June 12, 2006).
|
|
10
|
.21
|
|
Separation Agreement, General
Release of All Claims and Covenant Not to Sue by and between LHC
Group, Inc. and R. Barr Brown, dated June 5, 2006
(previously filed as Exhibit 10.1 to the Registrants
Form 8-K
dated June 5, 2006 and filed June 7, 2006).
|
|
21
|
.1
|
|
Subsidiaries of the Registrant.
|
|
23
|
.1
|
|
Consent of Ernst & Young
LLP
|
|
31
|
.1
|
|
Certification of Keith G. Myers,
Chief Executive Officer pursuant to
Rule 13a-14(a)/15d-14(a),
as adopted pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
31
|
.2
|
|
Certification of Barry E. Stewart,
Chief Financial Officer pursuant to
Rule 13a-14(a)/15d-14(a),
as adopted pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
32
|
.1*
|
|
Certification of Keith G. Myers,
Chief Executive Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002
|
|
32
|
.2*
|
|
Certification of Barry E. Stewart,
Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002
|
|
|
|
* |
|
This exhibit is furnished to the SEC as an accompanying document
and is not deemed to be filed for purposes of
Section 18 of the Securities Exchange Act of 1934 or
otherwise subject to the liabilities of that Section, and the
document will not be deemed incorporated by reference into any
filing under the Securities Act of 1933. |
68